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Abstract 
  
Mutations in the phosphoinositide 5-phosphatase OCRL1 cause Lowe Syndrome 
and Dents-2 disease, both involving selective renal proximal tubulopathy. Epithelial 
cells lining renal proximal tubules are highly polarised with distinct apical and 
basolateral membranes separated by intercellular junctions. Using Madin Darby 
canine kidney (MDCK) cells as a model of the renal tubular epithelium, we found a 
pool of OCRL1 targeted intercellular junctions and was required for the correct 
organisation of apical and basolateral membranes. One of the first events when 
cells were depleted of OCRL1 was a block in apical recycling. Apical cargo 
accumulated in exaggerated Rab11 positive recycling compartments with ectopic 
accumulation of the OCRL1 substrate PI(4,5)P2. Among the apical cargo were Gp135 
and key regulators of apical membrane formation, including Cdc42 and the Par6-
aPKC polarity complex. Rescue of recycling required the 5-phosphatase domain of 
OCRL1, suggesting down-regulation of 5-phosphoinositides is necessary for cargo 
exit from apical recycling endosomes. Eventually, the Rab11 positive vesicles 
containing apical cargo were targeted to the plasma membrane to re-form the 
apical domain. However, instead of being targeted to the cell apex, the apical 
vesicles were trafficked towards the lateral membrane where lumens formed, 
resembling the bile canaliculi in hepatocytes. This process was co-ordinated with 
cell division. Lateral lumens formed close to the midbody formed during 
cytokinesis. During cytokinesis Rab11 normally regulates a trafficking pathway to 
the midbody. Therefore, in cells lacking OCRL1 apical cargo held up in Rab11 
positive compartments may be aberrantly trafficked along this pathway when cells 
divide. We also found that the orientation and subsequent resolution of mitoses 
was altered in cells lacking OCRL1, which may contribute to improper positioning of 
the midbody and subsequent failure to polarise correctly. In summary, these results 
implicate OCRL1 in multiple steps of the process that co-ordinates apical recycling 
and cell division in polarised cells.  
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OCRL1 and human disease 
 
Overview 
 
Mutations in the OCRL1 gene are associated with Lowe Syndrome and a subset of 
Dent’s disease. Lowe Syndrome is a rare X-linked disorder affecting the eyes, the 
kidneys, and the central nervous system (Loi, 2006; Lowe et al., 1952). Lowe 
Syndrome patients present with cataracts at birth and frequently develop 
additional ocular abnormalities such as glaucoma. The central nervous system (CNS) 
involvement is attributed by low muscle tone (hypotonia), cognitive delay and 
behavioural problems. However the most fatal aspect of the disease is the renal 
selective proximal tubulopathy, characterised by low molecular weight proteinuria 
and hypercalciuria. Dent-2 disease has similar renal defects but only mild 
neurological and ocular symptoms (Shrimpton et al., 2009; Utsch et al., 2006). 
 
All Lowe Syndrome patients display loss of function mutations in the OCRL1 gene, 
coding for a phosphoinositide phosphatase. The majority of Dent’s patients have 
mutations in the CLCN5 gene, coding for a chloride transporter. However 
approximately 15% of all Dent’s patients have mutations in OCRL1 and not CLCN5, 
when it is known as Dents-2 disease (Hoopes et al., 2005). The overlapping renal 
symptoms of Lowe Syndrome and Dent’s disease suggest OCRL1 and CLCN5 may be 
involved in similar reabsorption pathways in the renal proximal tubule. 
 
 
Phosphoinositides 
 
OCRL1 is involved in the metabolism of phosphoinositides, these are minor but 
essential components of all eukaryotic cell membranes. Phosphoinositides contain 
two fatty acyl chains and a glycerol backbone esterified to a polar inositol head 
group that extends into the cytoplasm. There are seven different combinations 
which are formed by differential phosphorylation of the inositol ring at positions 
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D3, D4 and D5 (Liu and Bankaitis, 2010). A single phosphorylation event at one of 
these sites forms either PI(3)P, PI(4)P, or PI(5)P, and multiple phosphorylations can 
give rise to PI(3,4)P2, PI(4,5)P2, PI(3,5)P2, or PI(3,4,5)P3. The different combinations 
of phosphoinositides can be interconverted in a manner that is spatially and 
temporally regulated by phosphoinositide kinases and phosphatases. In addition, 
phospholipases hydrolyse some phosphoinositide species to produce a variety of 
inositol phosphates.  
 
Phosphoinositide metabolising enzymes are heterogeneously localised in the cell, 
which in turn results in the accumulation of different species at distinct organelles 
(figure 1.1). PI(3)P is typically enriched on early endocytic membranes and the 
multivesicular body (MVB) compartment (Gillooly et al., 2000). The Golgi apparatus 
has a high PI 4-kinase activity (Wang et al., 2003) and therefore PI(4)P is the 
dominant species on membranes of the Golgi apparatus (Roy and Levine., 2004). 
PI(4,5)P2 and PI(3,4,5)P3 are particularly enriched at the plasma membrane (Czech 
et al., 2000). Most of the plasma membrane PI(4,5)P2 is generated by 
phosphorylation of PI(4)P by PIP 5-kinases which localise there (Mao and Yin, 2007). 
PI(3,5)P2 concentrates on late compartments of the endocytic pathway, the MVB, 
and the lysosome (Ikonomov et al., 2006). PI(5)P is also present on endosomes and 
is thought to localise to the nucleus (Clarke et al., 2001). This pattern of 
phosphoinositide distribution represents the most abundant species at each 
organelle but small functionally relevant pools of other phosphoinositides are 
present in membrane micro-domains; for example, pools of PI(4)P exist at the 
plasma membrane which is predominantly rich in PI(4,5)P2 (Balla et al., 2005; Roy 
and Levine, 2004) and small pools of PI(4,5)P2 are thought to be present on 
intracellular membranes that predominantly contain PI(3)P or PI(4)P (Watt et al., 
2002). 
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Figure 1.1: Predominant localisation of the major phosphoinositides in the cell. 
The main phosphoinositide species in the plasma membrane is PI(4,5)P2. Golgi 
membranes are enriched in PI(4)P. Early endosomes mostly contain PI(3)P and late 
compartments in the endocytic pathway are enriched in PI(3,5)P2.  
 
 
A number of human diseases have been linked to phosphoinositide metabolising 
enzymes, emphasising the importance of this process in cell function. Mutations in 
myotubularin (MTM) 3-phosphatases have been linked to myotubular myopathy 
and Charcot-Marie-Tooth disease (Clague et al., 2005). In addition the 3-
phosphatase PTEN (phosphatase and tensin homologue) is a potent tumour 
suppressor mutated in many human cancers (Ali et al., 1999). Of the 10 members of 
the 5-phosphatase family, several have been linked to human disease. SHIP2 (SH2 
containing inositol 5-phoshatase 2) has been implicated in diabetes through its role 
in regulating the cellular response to insulin (Clement et al., 2001) and 
synaptojanin-1 may play a role in the onset of Down Syndrome associated 
Alzheimer’s disease (Voronov et al., 2008). As mentioned above, OCRL1 is the 5-
phosphatase associated with Lowe Syndrome and Dents-2 disease. Pathological 
mutations in the OCRL1 gene cause complete loss of the protein product either 
because of gene deletion mutations or because mutations cause the protein to be 
unstable and subsequently enzymatically degraded. Therefore a lack of enzyme 
activity is thought to underlie the disease and not truncated protein induced 
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dominant effects. OCRL1 removes the phosphate group at the 5th position of both 
PI(4,5)P2 and PI(3,4,5)P3 (Lowe et al., 2005). Skin fibroblasts derived from Lowe 
Syndrome patients have reduced 5-phosphatase activity (Suchy et al., 1995) and 
concurrently elevated levels of PI(4,5)P2, suggesting that this may contribute to the 
symptoms of the disease (Wenk et al., 2003; Zhang et al., 1998). 
  
 
Phosphoinositide binding domains 
 
One of the main functions of phosphoinositides is the recruitment and regulation of 
effector proteins that contain phosphoinositide binding domains. Each species of 
phosphoinositide recruits a specific complement of proteins appropriate for each 
membrane compartment. Binding of proteins to phosphoinositides is often through 
electrostatic interactions with the negative charges of the phosphate groups on the 
inositol ring (Lemmon, 2008). Some proteins, including the small GTPases interact 
with phosphoinositides through unstructured cytoplasmic regions rich in basic 
residues (Heo et al., 2006), while other proteins contain highly conserved modular 
domains (Lemmon, 2008). The best studied of these domains are the PH, PX, 
ANTH/ENTH and FYVE families (Lemmon, 2003). Most PH (pleckstrin homology) 
domains interact with multiple phosphoinositides, however a subset of PH domains 
are specific for PI(3,4)P2, PI(4,5)P2 or PI(3,4,5)P3 (Lietzke et al., 2000). The majority 
of PX (phox homology) domains, and all FYVE (Fab-1, YGL023, Vps27, and EEA1) 
domains specifically recognise endosomal PI(3)P (Kutateladze, 2010), while the 
ANTH (AP180 N-terminal homology) and ENTH (Epsin N-terminal homology) 
domains are specific for plasma membrane PI(4,5)P2 (Itoh et al., 2006). Proteins 
containing phosphoinositide binding domains become associated with a particular 
membrane in part because of its phosphoinositide composition, however other 
factors co-operate with phosphoinositides to recruit peripheral proteins to 
membranes, particularly GTPase proteins, discussed next.  
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Phosphoinositides and GTPases 
 
Phosphoinositides do not function alone to specify membrane identity, members of 
the Ras superfamily of small GTPases including the Rab and Arf (ADP-ribosylation 
factor) families act together with phosphoinositides to create distinct membrane 
domains (Mizuno-Yamasaki et al., 2012). In a similar manner to phosphoinositides, 
GTPases are heterogeneously localised in the cell and function to recruit a specific 
repertoire of effector proteins to the membrane (Hutagalung and Novick, 2011). 
Another parallel between phosphoinositides and GTPase proteins involves their 
dynamic regulation. GTPases can exist in either an active (GTP bound) or inactive 
(GDP) state. Guanine nucleotide exchange factors (GEFs) convert the inactive GDP 
bound protein to an active GTP bound form, whilst GTPase activating proteins 
(GAPs) promote GTP hydrolysis to deactivate the protein (Barr and Lambright, 
2010). Effector proteins only interact with the active form of the GTPase and 
therefore effector proteins can be recruited to membranes temporally by switching 
the GTPase to an active state. Membrane recruitment of OCRL1 5-phosphatase is 
thought to be mediated by interactions with Rab proteins (Hyvola et al., 2006), 
discussed in more detail below (Cellular roles of OCRL1). 
 
The spatiotemporal regulation of phosphoinositides and the Rab GTPases is critical 
for membrane trafficking and organelle maturation. The transport of cargo through 
successive membrane compartments either through vesicle fusion or membrane 
maturation requires the membrane to change identity by modifying its 
phosphoinositide and Rab GTPase composition. As one species of phosphoinositide 
is replaced by another during vesicle trafficking or membrane maturation, a 
different set of peripheral proteins is recruited to the membrane. To achieve such a 
transition, some phosphoinositides and Rab GTPases have been shown to recruit 
regulators that lead to production of the next phosphoinositide or activation of the 
downstream Rab (Jean and Kiger, 2012). In addition Rab and phosphoinositide 
activities can lead to the recruitment of enzymes that inactivate their own function, 
which ensures a sequential progression of membrane identity (Jean and Kiger, 
2012). For example, during endosome maturation, Rab5 on early endosomes 
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recruits a Rab7 GEF to contribute to Rab7 activation on late endosomes (Rink et al., 
2005). Similarly, phosphoinositide regulating enzymes can be recruited as 
phosphoinositide effectors. For example, PI(3)P on early endosomes facilitates its 
own down-regulation by recruiting a set of MTM proteins (myotubularins) with 3-
phosphatase activity (Jean et al., 2012). The MTM proteins are recruited to PI(3)P 
on membranes through FYVE domains (Jean et al., 2012).  
 
Some Rab GTPases and phosphoinositides have common effectors, strengthening 
membrane specificity further. Many of these effector proteins require both the Rab 
and phosphoinositide for membrane recruitment (Jean and Kiger, 2012). These 
effector proteins have only weak and transient interactions with phosphoinositides 
but the presence of another binding partner, such as a Rab GTPase, increases the 
binding strength of the effector protein to the membrane (Carlton et al., 2005). For 
example, recruitment of EEA1 (early endosome antigen 1) to endosomes requires 
both PI(3)P and Rab5 (Simonsen et al., 1998). In this way, Rab GTPases and 
phosphoinositides co-operate to maintain distinct identities of organelles and 
ensure the correct timing and location of a variety of events. Some examples of 
proteins regulated by phosphoinositides, as well as their cellular function are given 
next.  
 
 
Cellular roles of phosphoinositides 
 
The ability to rapidly turnover phosphoinositides makes them optimal mediators in 
signalling pathways. At the plasma membrane, PI(4,5)P2 and PI(3,4,5)P3 are involved 
in the intracellular transduction of extracellular signals. Upon stimulation of G-
protein coupled receptors, phospholipase C (PLC) hydrolyses PI(4,5)P2 into second 
messengers Inositol(1,4,5)P3 (IP3) and 1,2-Diacylglycerol (DAG) which activate 
downstream signalling pathways that promote transcription factor activation 
(Czech, 2000). PI(3,4,5)P3 is normally present at very low levels in cells at rest but 
upon growth factor stimulation the levels of this phosphoinositide rapidly rise 
where it recruits effectors of numerous signalling pathways (Cantley, 2002).  
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Phosphoinositides, particularly PI(4,5)P2 and PI(3,4,5)P3 are key regulators of the 
organisation and dynamics of the actin cytoskeleton (Czech, 2000). These 
phosphoinositides act as platforms to recruit regulators of the actin cytoskeleton as 
well as actin binding proteins to the membrane. Membrane associated actin 
dynamics contribute to the force required for events such as shape change, 
migration and endocytosis. One way phosphoinositides affect actin dynamics is 
through regulating the activities of Rho GTPases, which activate signalling cascades 
involved in actin organisation. For example, GEFs of Rac1 (Sos1 and Vav) are 
activated by interactions with PI(3,4,5)P3 through PH domains (Das et al., 2000). 
PI(3,4,5)P3 mediated Rac1 activation leads to the induction of actin filament 
assembly near membranes containing this phosphoinositide. In addition, most of 
the Rho family members contain a cluster of positively charged residues which may 
bind to acidic phospholipids, for example, Rho1 and Cdc42 become associated with 
the membrane in part through interactions of their polybasic sequence with 
PI(4,5)P2 (Johnson et al., 2012; Yoshida et al., 2009). As well as regulating the Rho 
family of GTPases, these phosphoinositides also regulate the actin nucleating 
Arp2/3 complex. In one mechanism, PI(4,5)P2 acts together with the GTPase Cdc42 
to recruit N-WASP to the plasma membrane, resulting in the activation of Arp2/3 
(Rohatgi et al., 2000). PI(4,5)P2 further contributes to actin filament assembly by 
directly interacting with numerous actin binding proteins, as well as negatively 
regulating proteins that inhibit actin filament assembly (Yin et al., 2003). As a 
consequence of these activities, membranes rich in PI(4,5)P2 are usually associated 
with actin filament assemblies and disrupting the levels of this phosphoinositide 
affects the organisation of these structures (Raucher et al., 2000).  
  
As well as cytoskeletal dynamics, phosphoinositides are involved in multiple stages 
of membrane trafficking including cargo selection, vesicle budding, tethering and 
fusion. At the plasma membrane, PI(4,5)P2 regulates both endocytosis and 
exocytosis (Czech, 2000). PI(4,5)P2 interacts with numerous components of the 
clathrin mediated endocytic machinery such as the adaptor protein AP-2 (Gaidarov 
and Keen, 1999), and epsin (Itoh et al., 2001). Similarly, PI(4)P recruits components 
of the clathrin machinery to the Golgi apparatus. Without PI(4)P, the clathrin 
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adaptor protein AP-1 dissociates from the TGN and all AP-1 dependent trafficking 
events are inhibited (Wang et al., 2003). Phosphoinositides can facilitate vesicle 
budding by recruiting effector proteins with BAR domains (Bin, Amphiphysin, Rvs-
homology) which dimerize and form a curved structure to drive membrane 
deformation (van Weering et al., 2010). In addition, PI(4,5)P2 mediated actin 
filament assembly (discussed above) contributes to the force required to induce 
membrane curvature and scission of endocytic vesicles (Sun et al., 2007). In 
addition, phosphoinositides can facilitate membrane trafficking specificity by 
recruiting tethering proteins to particular membrane compartments. PI(3)P recruits 
EEA1 which functions to dock incoming vesicles to the endosome and PI(4,5)P2 
interacts with several components of the exocyst complex to target vesicles to the 
plasma membrane (He et al., 2007; Zhang et al., 2008). 
 
 
OCRL1 domain organisation and binding partners 
 
OCRL1 is a member of the type II family of inositol polyphosphate 5-phosphatases 
which include synaptojanins 1 and 2, SHIP (SH2 containing inositol 5-phoshatase) 1 
and 2, SKIPP (Skeletal muscle and kidney enriched inositol polyphosphate 
phosphatase) and INPP5B (Inositol polyphosphate-5-phosphatase B) (Astle et al., 
2006). Members of this family share the central 5-phosphatase domain, but differ in 
additional domain structures.  
  
The N-terminus of OCRL1 contains a PH-like domain (figure 1.2), which lacks 
residues required for phosphoinositide recognition and therefore does not bind to 
membranes (Mao et al., 2009). Adjacent to the PH domain is the central 5-
phosphatase domain followed by a short helix connecting to a ASPM-SPD-2-Hydin 
(ASH) domain (Ponting, 2006) and a Rho GAP-like domain (Faucherre et al., 2003), 
indicated in figure 1.2. The ASH domain has an immunoglobulin-like fold similar to 
VAP (vesicle-associated membrane protein-associated protein) and is frequently 
associated with cilia and centrosomal proteins (Ponting et al., 2006). The RhoGAP 
domain lacks the catalytic arginine residue and is enzymatically inactive but is able 
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to interact with various small GTPases, such as Cdc42, Rac1 and Arf family members 
Arf1 and Arf6 (Lichter-Konecki et al., 2006). The Rho GAP-like domain and ASH 
domain is required for OCRL1 to associate with several members of the Rab GTPase 
family. OCRL1 has a broad specificity of Rab binding partners including Rab1, Rab5, 
Rab6, Rab8, Rab14 (Hyvola et al., 2006), as well as Rab3, Rab13, Rab22, Rab35 
(Fukuda et al., 2008) and Rab31 (Rodriguez-Gabin et al., 2010). Interactions of 
OCRL1 with Rab5, Rab6 and Rab35 have been confirmed by functional and co-
localisation studies (Dambournet et al., 2011; Hyvola et al., 2006) and OCRL1 has 
recently been crystallised in complex with Rab8a (Hou et al., 2011). Interactions 
with Rab8 require the complete ASH domain of OCRL1 and one α-helix from the 5-
phosphatase domain (Hou et al., 2011). This binding mode is unusual, whereas 
other known Rab effectors bind their Rab through α-helical structural elements, 
OCRL1 interacts with Rab8a through the β-sheets of the ASH domain as well as the 
one α-helix (Hou et al., 2011).  
 
As well as interacting with Rab GTPases, the ASH domain of OCRL1 is also required 
for interactions with the endocytic proteins APPL1 (adaptor protein, 
phosphotyrosine interaction, PH domain and leucine zipper containing 1) and 
IPIP27A/B (inositol polyphosphate phosphatase interacting protein of 27 kDa A/B), 
also known as Ses1/2, for sesquipedalian (Erdmann et al., 2007; Noakes et al, 2011; 
Swan et al, 2010). These proteins interact with OCRL1 through an F&H motif, a 
short amino acid sequence within a α-helix containing phenylalanine and histidine 
residues essential for binding to OCRL1 (Noakes et al, 2011; Swan et al, 2010). The 
ASH-RhoGAP-like domain of OCRL1 has been crystallised in complex with the F&H 
peptide of IPIP27A/Ses1 (Pirruccello et al., 2011). The binding site for IPIP27A/Ses1 
is distinct from the binding site for Rab proteins, with F&H proteins interacting with 
the RhoGAP-like domain and not the ASH domain of OCRL1. However, the 
requirement of the ASH domain for binding of OCRL1 to F&H proteins might be due 
to the ASH domain stabilising the RhoGAP-like domain fold (Hagemann et al., 2012). 
Interestingly the F&H binding surface in OCRL1 is evolutionary conserved in 
organisms that do not have homologues of IPIP/Ses proteins or APPL1 (Pirruccello 
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et al., 2011), indicating the presence of additional proteins containing the F&H 
motif. 
   
As well as the modular domains, OCRL1 also contains several short motifs that co-
ordinate interactions with additional binding partners. On either side of the central 
5-phosphatase domain are several clathrin box motifs: LIDLE and LIDIA which 
interact with clathrin heavy-chain. In the linker between the PH domain and 5-
phosphatase domain is a short motif (FEDNEF) that binds to the adaptor protein AP-
2. These interactions have been shown to facilitate the formation of clathrin cages 
in vitro (Choudhury et al., 2005). 
 
 
 
Figure 1.2: Schematic diagram showing domain structure of OCRL1. At the C-
terminus of the protein are a catalytically inactive Rho GAP-like domain and an ASH 
domain which facilitates Rab GTPase binding. At the N-terminus is a PH-like domain 
and in the centre is the catalytic 5-phosphatase domain. OCRL1 contains several 
short motifs: LIDLE and LIDIA interact with clathrin heavy chain and FEDNF binds to 
adaptor protein 2 (AP-2). 
 
 
OCRL1 and INPP5B are the only members of the type II 5-phosphatase family that 
contain the ASH domain and RhoGAP-like domain at the C-terminus. INPP5B has no 
clathrin or AP-2 binding sites (Jefferson and Majerus, 1995) but shares all other 
binding partners of OCRL1, suggesting the possibility that OCRL1 and INPP5B have 
partially overlapping functions. Lowe Syndrome cannot be reproduced in OCRL1-
knockout mice, probably due to compensation by INPP5B (Jänne et al., 1998). 
Evidence for INPP5B compensating for loss of OCRL1 in mice comes from the 
observation that loss of INPP5B and OCRL1 singularly produces only minor 
phenotypes but loss of both INPP5B and OCRL1 together is lethal (Jänne et al., 
PH 5-phosphatase ASH GAP
LIDLELIDIA
FEDNF
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1998). Splice site variation between species may explain the lack of compensation 
in humans (Bothwell et al., 2010). However, the potential for INPP5B to 
compensate for OCRL1 is a possible explanation for the tissue specificity of Lowe 
Syndrome. Variations in the level of expression of INPP5B in the relevant tissues 
may affect the severity of the OCRL1 loss of function phenotype.  
 
OCRL1 exists as two splice isoforms (a and b) that differ by the presence or absence 
of eight amino acids (EDSFLEKE) downstream of the LIDLE clathrin box motif 
(Nussbaum, 1999). The longest isoform (Isoform a) is only expressed in the brain, 
whilst both isoforms are present in all other tissues, with the shorter isoform 
usually the most abundant (Johnson et al., 2003). Alternative splicing of OCRL1 
modifies it’s interaction with clathrin; OCRL1 isoform a binds clathrin heavy chain 
with higher affinity than isoform b (Choudhury et al., 2009). 
 
 
Cellular roles of OCRL1 
 
Membrane localisation of OCRL1 is thought to be primarily mediated by 
interactions with Rab proteins, with Rab1 and Rab6 recruiting OCRL1 to the Golgi 
apparatus, Rab5 recruiting OCRL1 to endocytic membranes (Hyvola et al., 2006) and 
Rab8 recruiting OCRL1 to other trafficking intermediates (Coon et al., 2012). Point 
mutations of OCRL1 that render the protein defective in Rab binding fail to target 
intracellular membranes (Hyvola et al., 2006). Furthermore, binding to Rab GTPases 
has been reported to stimulate the 5-phosphatase activity of OCRL1 (Hyvola et al, 
2006), suggesting that OCRL1 is recruited to membrane compartments by Rab 
GTPases at least in part to regulate the levels of PI(4,5)P2. However, OCRL1 also 
localises to clathrin coated trafficking intermediates by directly interacting with 
components of the clathrin machinery (Choudhury et al., 2005; Ungewickell et al, 
2004) and has been found to translocate to plasma membrane ruffles after growth 
factor stimulation in a Rac-1 dependent manner (Faucherre et al, 2003; Hyvola et al, 
2006). OCRL1 has also been found to localise to the tight Junctions of epithelial cells 
(Grieve et al., 2011). However, the protein interactions that mediate junctional 
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recruitment of OCRL1 and its cellular function there are not currently known. These 
findings are explained in more detail in the second section of this introduction: 
Epithelial cell polarity. 
  
The subcellular localisations of OCRL1 and its confirmed binding partners indicate a 
role in regulating membrane trafficking. Furthermore, the interaction of OCRL1 with 
numerous Rab proteins suggests that OCRL1 may regulate multiple trafficking 
pathways. Numerous studies have defined roles for OCRL1 in the endocytic 
pathway. Firstly, OCRL1 has been implicated to regulate traffic from endosomes to 
the Golgi apparatus (Choudhury et al., 2005; Cui et al., 2010; Ungewickell et al., 
2004; van Rahden et al., 2012). For example, overexpression or depletion of OCRL1 
in HeLa cells results in the redistribution the cation-independent mannose 6-
phosphate receptor (CI-MPR) to enlarged endosomes that are defective in 
trafficking to the TGN (Choudhury et al., 2005). In agreement with OCRL1 binding to 
Rab5 and components of the clathrin machinery, OCRL1 also associates with 
endocytic clathrin coated pits and to peripheral early endosomes (Erdmann et al., 
2007). At early endosomes, OCRL1 interacts with the Rab5 effector APPL1, and 
IPIP27A/B through an F&H motif that binds the C-terminal ASH-RhoGAP domain of 
OCRL1 (Noakes et al, 2011; Swan et al, 2010), as explained in the previous section. 
These interactions are mutually exclusive; APPL1 and IPIP27A/B compete for 
binding to OCRL1 as vesicles progress along the endocytic pathway (Noakes et al, 
2011; Swan et al., 2010). As early endosomes acquire PI(3)P and mature, the 
OCRL1-APPL1 interaction is replaced by the OCRL1-IPIP interaction (Swan et al., 
2010), suggesting a regulatory mechanism whereby membrane maturation is 
coupled to the modification of OCRL1 binding partners.  
 
Given the localisation pattern and pathways regulated by binding partners of 
OCRL1, there may be additional roles for OCRL1 in the endocytic pathway. For 
example, as well as the TGN and early endosomes, the IPIPs also localise to Rab11 
positive recycling endosomes and participate in trafficking of the transferrin 
receptor from these compartments to the cell surface (Noakes et al., 2011). APPL1 
has been implicated in signalling and sorting of cell surface receptors such as the 
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nerve growth factor receptor TrkA and its binding partner GPIC (GAIP-interacting 
protein, C terminus) (Lin et al., 2006). OCRL1 may regulate this protein complex 
since pull downs of OCRL1 from rat brain extracts contain GIPC and APPL1 
(Erdmann et al., 2007). In addition, GIPC has been found to be a binding partner of 
megalin (Lou et al., 2002), a protein less abundant on the cell surface in Lowe 
Syndrome (Norden et al., 2000). Megalin is a multi-ligand receptor that mediates 
reabsorption of low molecular weight (LMW) proteins from the ultrafiltrate. The 
accumulation of LMW proteins in the ultrafiltrate of Lowe Syndrome patients is 
consistent with a recycling defect of megalin (Christensen et al., 2002). In addition, 
many of the Rab binding partners of OCRL1 are involved in recycling pathways, 
including Rab8 and Rab35 (Hutagalung and Novick, 2011), further suggesting a 
possible role for OCRL1 in regulating recycling routes to the plasma membrane.  
  
A recent study directly implicates OCRL1 in plasma membrane recycling pathways. 
In cells derived from Lowe Syndrome patients and OCRL1 depleted renal cell lines, 
trafficking of megalin and the transferrin receptor to the cell surface was reduced 
(Vicinanza et al., 2011). In addition to reduced plasma membrane recycling, this 
study also demonstrated a requirement for OCRL1 in trafficking of epidermal 
growth factor receptor (EGFR) to late endosomes and confirmed the previous 
finding that OCRL1 regulates recycling of CI-MPR to the Golgi apparatus (Vicinanza 
et al., 2011). Without OCRL1, these receptors accumulated in large early 
endosomes, suggesting OCRL1 regulates cargo exit from these compartments. The 
block in recycling appeared to be caused by elevated levels of PI(4,5)P2 on 
endosomes which in turn increased the levels of filamentous actin associated with 
endosomal membranes, as shown in figure 1.3.  
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Figure 1.3: Loss of OCRL1 alters trafficking from early endosomes. A: OCRL1 
removes PI(4,5)P2 on endocytosed vesicles and early endosomes. Removal of 
PI(4,5)P2 facilitates a phosphoinositide switch towards PI(3)P which is required for 
early endosome organelle identity. B: Without OCRL1, PI(4,5)P2 levels remain high 
on these compartments. PI(4,5)P2 activates N-WASP dependent F-actin 
polymerisation which compromises cargo exit and trafficking to the plasma 
membrane, late endosomes/multi-vesicular body (MVB) and lysosome is impaired. 
Adapted from Vicinanza et al., 2011.  
 
 
 
However, a subsequent study found trafficking of the transferrin receptor and EGFR 
was normal in Lowe Syndrome fibroblasts, but defects were observed in the 
intracellular sorting of MPRs (van Rahden et al., 2012). Interestingly, OCRL1 
depletion resulted in reduced levels of active Rac1 and increased levels of active 
RhoA, affecting the activities of downstream actin regulatory substrates cofilin and 
PAK3 (van Rahden et al., 2012), suggesting OCRL1 might similarly regulate 
trafficking of MPRs through modulating cellular actin dynamics.  
  
A specific trafficking pathway regulated by OCRL1 has been described involving cilia 
assembly. Primary cilia are cell surface projections that sense the extracellular 
environment and are involved in multiple signal transduction pathways (Goetz and 
Anderson, 2010). The primary cilium is composed of a basal body differentiated 
from the centrosome and a ciliary axoneme consisting of 9 microtubule doublets 
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(Sorokin, 1962). OCRL1 has been found to localise to the basal body by numerous 
studies (Coon et al., 2012; Luo et al., 2012; Rbaibi et al., 2012). However, different 
effects have been reported on cilia length in the absence of OCRL1, with no clear 
consensus as to whether they are shorter than normal (Coon et al., 2012; Luo et al., 
2012) or elongated (Rbaibi et al., 2012). OCRL1 appears to effect cilia length by 
regulating a trafficking pathway involving Rab8 that carries ciliary proteins from the 
TGN to the primary cilium. In addition, OCRL1 regulates trafficking to the primary 
cilium from recycling endosomes through interactions with the IPIPs (Coon et al., 
2012). Interestingly, INPP5E is a member of the 5-phosphatase family and is 
mutated in Joubert Syndrome and MORM Syndrome, characterised by structure 
and function defects of cilia (Bielas et al., 2009; Jacoby et al., 2009). INPP5E shares 
substrates with OCRL1, down regulating the levels of PI(4,5)P2 and PI(3,4,5)P3. The 
prevalence of human disease with mutations in INPP5E highlights the importance of 
phosphoinositide metabolism in the function of cilia. Although not a ciliopathy, 
Lowe Syndrome affects the same organs as ciliopathy syndromes (Adams et al., 
2008), suggesting disrupted ciliary trafficking may play a role in aspects of Lowe 
Syndrome pathogenesis. 
 
The substrates of OCRL1 are key regulators of the actin cytoskeleton, linking OCRL1 
to the regulation of cytoskeletal dynamics. In addition to regulating endosomal 
actin (figure 1.3), cells from Lowe Syndrome patients have fewer stress fibres and 
increased punctate actin staining that co-localises with actin binding proteins 
regulated by PI(4,5)P2 (Suchy and Nussbaum, 2002). Analysis of these cells also 
indicated that OCRL1 is involved in cell migration, although it is not clear whether 
this is a consequence of altered actin dynamics or membrane trafficking (Coon et 
al., 2009; Suchy and Nussbaum, 2002). Recently aberrant actin phenotypes have 
been observed in cells undergoing cytokinesis in the absence of OCRL1. When HeLa 
cells divide, OCRL1 localises to the abscission site formed during the late stages of 
cytokinesis (Dambournet et al., 2011). Recruitment of OCRL1 to the abscission site 
is dependent on interactions with Rab35 (Dambournet et al., 2011). At the 
abscission site, OCRL1 hydrolyses PI(4,5)P2, which is thought to contribute to the 
removal of F-actin required to complete cytokinesis (Dambournet et al., 2011). Cells 
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from Lowe Syndrome patients frequently fail to complete cytokinesis due to the 
ectopic accumulations of F-actin at abscission sites (Dambournet et al., 2011). In 
addition, depletion of an OCRL1 homologue in Drosophila results in a high rate of 
cytokinesis failure. In these cells, loss of dOCRL1 disrupts furrowing of the 
contractile ring (Ben El Kadhi et al., 2011), which occurs at an earlier stage of 
cytokinesis than abscission. The furrowing defect seen in the absence of OCRL1 is 
thought to be caused by mis-targeting of contractile ring components to 
intracellular membranes with aberrant accumulations of PI(4,5)P2 and F-actin (Ben 
El Kadhi et al., 2011). By regulating the levels of PI(4,5)P2, OCRL1 may be involved in 
numerous cellular events that require dynamic actin pools.  
 
These studies demonstrate that OCRL1 regulates similar pathways in multiple 
cellular processes. Although loss of OCRL1 affects a wide range of cellular events 
such as membrane trafficking, cytokinesis and cilia assembly, common mechanisms 
of disruption exist. OCRL1 is recruited to various different sites in the cell by 
interacting with organelle specific Rab GTPases and their effector proteins. At these 
locations, OCRL1 functions to couple dephosphorylation of PI(4,5)P2 with 
membrane identity or cytoskeletal dynamics. One function of OCRL1 may be to 
remove PI(4,5)P2 on intracellular membranes, allowing the plasma membrane to 
maintain the identity of being PI(4,5)P2 rich and therefore allowing intracellular 
membranes to acquire alternative phosphoinositides. Disrupting this basic function 
of OCRL1 can explain many of the trafficking defects as well as the cytokinesis 
defects seen in Drosophila. For example, the contractile ring formed during 
cytokinesis becomes enriched in PI(4,5)P2, which aids recruitment of furrowing 
proteins to the site. Such a local enrichment of PI(4,5)P2 requires proteins such as 
OCRL1 to remove PI(4,5)P2 elsewhere. Disrupting this balance by depletion of 
dOCRL1 resulted in accumulations of PI(4,5)P2 on endosomes and the recruitment 
of the cytokinetic machinery away from the furrow site (Ben El Kadhi et al., 2011). 
Similar functions of OCRL1 may be required to facilitate the directionality of 
membrane trafficking. Disrupted phosphoinositide switches may explain the many 
trafficking problems reported in the absence of OCRL1. In addition, the removal of 
PI(4,5)P2 by OCRL1 functions to down-regulate F-actin such as post endocytosis or 
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during abscission. The spatial and temporal down-regulation of PI(4,5)P2 by OCRL1 
allows for the progression of these cellular events and loss of OCRL1 tends to result 
in a blockage at a particular stage in one of these processes.  
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Epithelial cell polarity 
  
 
Overview 
 
Through the common mechanism of PI(4,5)P2 hydrolysis, OCRL1 has been 
implicated to regulate numerous cellular processes, however it is not currently 
known which of these contribute to the pathology of Lowe Syndrome. Most of the 
cell types affected by Lowe Syndrome are highly polarised, neurons in the central 
nervous system, lens epithelial cells in the eye and renal proximal tubule epithelial 
cells in the kidney. Epithelial cell polarity is essential for the morphological and 
functional asymmetries that underlie these tissues. Polarised cells maintain an 
asymmetric distribution of proteins and lipids within the plasma membrane, as well 
as distinct spatial organisations of the cytoskeleton and organelles (Rodriguez-
Boulan et al., 1989).  
 
The renal failure in Lowe Syndrome and Dents disease can often be fatal (Loi et al., 
2006). The epithelial cells of the kidney form tubules where single monolayers of 
tightly packed cells are arranged around a central lumen (Hogan et al., 2002). The 
cells within the proximal tubule develop a distinct apical surface that faces the 
lumen and a basal domain that contacts the underlying extracellular matrix. The 
apical and basolateral domains are morphologically and compositionally different. 
The apical domain is covered in microvilli and contains proteins involved in 
absorption and secretion, the basal domain is specialised to form interactions with 
the underlying tissue (O’Brien et al., 2002). Separating the apical and basal domains 
is the lateral membrane which is similar to the basal domain but contains junctions 
involved in cell-cell adhesions and the maintenance of cell polarity.  
 
Failure of epithelial cells to polarise appropriately leads to a variety of diseases 
including polycystic kidney disease, cystic fibrosis and some metastatic cancers 
(McConkey et al., 2009; Wilson, 1997). Polarisation has a large functional 
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importance in the renal proximal tubule. The loss of proteins and metabolites in the 
urine of Lowe Syndrome and Dents-2 disease patients indicate abnormal 
reabsorption in the kidney, suggesting a possible role for disordered polarisation in 
the pathology of the disease. In addition, many of the cellular processes implicated 
to involve OCRL1 in the previous section have specific functions in polarised cells. 
For example, membrane trafficking and cytoskeletal dynamics are critical for the 
establishment and maintenance of cell polarity, suggesting polarisation may be 
disrupted in Lowe Syndrome.  
 
 
Intercellular junctions  
 
As mentioned previously, OCRL1 has been found to localise to the intercellular 
junctions of several epithelial cell lines (Grieve et al., 2011). During epithelial 
development, adjacent cells form intercellular junctions to facilitate the structural 
integrity of the tissue and to enable apical-basolateral polarity. In addition, 
intercellular junctions act as dynamic signalling complexes regulating the expression 
of genes involved in proliferation, differentiation and apoptosis (Jamora et al., 
2002; Matter and Balda, 2003).  
 
Strong cell adhesion is mediated by adherens junctions, characterised by the 
cadherin family of transmembrane proteins (Hartsock et al., 2008). The adhesive 
strength of adherens junctions is provided by calcium dependent homotypical 
interactions between the extracellular domains of E-cadherin proteins (Hartsock et 
al., 2008). In addition, the cytoplasmic domain of E-cadherin forms complexes with 
catenins that link the adherens junction to the actin cytoskeleton (Yonemura, 
2011). The lateral domains of epithelial cells are also linked by desmosomes and 
gap junctions. Gap junctions form channels to connect the cytoplasm of adjacent 
cells, allowing molecules and ions to be exchanged between neighbours (Kumar et 
al., 1985). In contrast, tight junctions create a diffusion barrier for the movement of 
molecules between cells. Tight junctions are composed of multiple integral 
membrane proteins linked to a cytoplasmic network of adaptor proteins that link 
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the junction to the actin cytoskeleton (Green et al., 2010). As well as maintaining a 
paracellular barrier, tight junctions also prevent diffusion of proteins and lipids 
between membrane domains (Dragsten et al., 1981). This junction is formed at the 
boundary between the apical and basolateral surface domains, preventing mixing 
of apical and basolateral membrane components.  
 
Intercellular junction formation occurs in a strictly sequential manner (Knust and 
Bossinger, 2002). Initially a primordial junction is formed that contains components 
of both adherens junctions and tight junctions. As the epithelium matures, the cells 
change morphology, gain height and resolve separate adherens junctions and tight 
junctions (Matter and Balda, 2003). In mature polarised epithelial cells, the tight 
junction forms a ring beneath the apical domain and the adherens junction is 
usually found on the basolateral side of the tight junction. Maturation of junctions 
is mediated by reorganisation of the actin cytoskeleton and vesicular delivery of 
junctional components to the plasma membrane (Green et al., 2010). 
 
Once junctions have matured, the junctions remain highly dynamic and are 
continuously remodelled through vesicular trafficking (Green et al., 2010). The 
dynamic nature of junctions is essential for their role in signalling and is also 
required during morphological changes such as cell division or cell extrusion. The 
dynamic nature of tight junctions was visualised by Shen and colleagues by imaging 
GFP-tagged tight junction proteins in live cells (Shen et al., 2008). The movement of 
the GFP signal was monitored by using fluorescence recovery after photobleaching 
(FRAP) as well as photoactivatable GFP probes (Shen et al., 2008). This study 
revealed that the junctional proteins ZO-1 (Zonula occludens-1), occludin and 
claudin-1 each have different stabilities at the tight junction, the majority of 
claudin-1 was stably localised to the tight junction, occludin was motile within the 
region of the junction while ZO-1 continuously moved between plasma membrane 
and intracellular pools (Shen et al., 2008). Therefore multiple mechanisms must 
exist for regulating the dynamics of junctional components. 
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OCRL1 localises to the tight junctions of multiple polarised epithelial cell lines in 
culture (Grieve et al., 2011). Immunoprecipitations of OCRL1 suggest that it exists in 
the same complex as junctional components ZO-1 and α-catenin early in junction 
formation (Grieve et al., 2011). Depletion of OCRL1 in these cells inhibited 
maturation, the cells were flatter than normal and failed to reach a columnar 
shape. Depletion of OCRL1 in more physiologically relevant 3-dimensional cultures 
prevented proper lumen formation (Grieve et al., 2011), further suggesting OCRL1 
is necessary for epithelial morphology. Other studies of OCRL1 in epithelial cells 
have not found the protein at junctions (Cui et al., 2010; Dressman et al., 2000), 
however OCRL1 is thought to target junctions temporally during early development 
as junctional OCRL1 was not detected in fully mature cells (Grieve et al., 2011). At 
junctions OCRL1 might regulate actin organisation. Alternatively, through its 
recognised role in regulating endocytic recycling, OCRL1 might be involved in 
pathways that turnover junctional proteins.  
 
 
Polarised membrane trafficking 
 
The dynamic nature of intercellular junctions is supported in part by vesicular 
trafficking. In addition, the apical and basolateral domains of epithelial cells are 
continuously remodelled via multiple trafficking pathways. Newly synthesised 
proteins can be directly delivered to the plasma membrane from the TGN as they 
are produced in the biosynthetic pathway (Rodriguez-Boulan et al., 2005). However, 
the route to the cell surface from the TGN is not always direct; some newly 
synthesised apical proteins traffic through recycling endosomes positive for Rab8a 
and Rab11a GTPases before being delivered to the plasma membrane (Ang et al., 
2004; Cramm-Behrens et al., 2008). After surface delivery, proteins at the plasma 
membrane can be internalised for entry along multiple trafficking pathways. 
Internalised cargo first enters domain specific early endosomes: apical early 
endosomes and basolateral early endosomes. From early endosomes, some 
proteins are trafficked to the lysosome or TGN, while other proteins undergo rapid 
recycling to plasma membrane. Many proteins are delivered to the common 
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recycling endosome, a Rab8 and Rab10 positive compartment localised to the 
perinuclear region where apical and basolateral cargoes are sorted for delivery to 
their respective domain (Wang et al., 2000). In addition, proteins destined for the 
apical domain may be further routed through the Rab11a positive apical recycling 
endosome before delivery to the cell surface (Leung et al., 2000), although whether 
the apical recycling endosome and common recycling endosome are separate 
entities or subdomains of the same structure is controversial (Leung et al., 2000; 
Thompson et al., 2007). There is some evidence to suggest a subset of apical 
proteins may be delivered first to the basolateral domain before routing to the 
apical surface (Hua et al., 2006). This transcytosis route is particularly used by 
epithelial cells of the liver, intestine and the retinal pigment epithelium (Bonilha et 
al, 1997; Matter et al., 1990, Maurice et al., 1994). The multiple pathways involved 
in polarised membrane trafficking are summarised in figure 1.4. These pathways 
help to maintain the different compositions of apical and basolateral domains and 
also have functional roles such as receptor mediated uptake of nutrients from the 
extracellular environment and the regulation of signalling receptors at the plasma 
membrane.  
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Figure 1.4: Membrane trafficking pathways in polarised epithelial cells. Proteins 
and lipids internalised either from the basolateral (blue) or apical (red) surface (1A 
and 1B), are delivered to basolateral early endosomes (BEEs) and apical early 
endosomes (AEEs). At EE, cargo can recycle to the plasma membrane (2A and 2B), 
or be directed in the degradation pathway to the multi-vesicular body, MVB (3A 
and 3B). Alternatively, basolateral and apical proteins are sorted into a recycling 
route and meet in the common recycling endosome, CRE (4A and 4B). At the CRE, 
cargo is sorted directly to the apical membrane (5) or indirectly via the ARE (6 and 
7). Cargo can also be sorted to the basolateral membrane from the CRE (8). In the 
biosynthetic pathway, plasma membrane targeting can occur directly from the 
Golgi (9A and 9B) or indirectly via recycling endosomes (10 and 11). TJ: tight 
junctions, AJ: adherens junctions. Adapted from Apodaca et al., 2012 
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Proteins destined for the junction, apical or basal membrane must be trafficked in 
different carriers selectively to these sites. Sorting is driven by multiple mechanisms 
at the TGN and recycling endosomes. For example, some proteins contain short 
sequence motifs that interact with adaptor proteins that are involved in specific 
trafficking pathways to ensure a particular sorting route (Pandey, 2010). In addition, 
lipid rafts are thought to play a role in the sorting of apical cargo. Some apical 
proteins may have an affinity for cholesterol and sphingolipids which make up lipid 
rafts. The association of apical proteins with lipid rafts could mediate clustering and 
incorporation into apical carriers (Cao et al., 2012). During sorting of apical and 
basolateral proteins, the membrane of the sorting organelle is organised into 
tubules or buds that assist in the formation of carriers. Membrane curvature is 
supported by BAR domain containing proteins (Habermann, 2004). In addition, 
membrane bending can be facilitated by the insertion of protein regions into the 
lipid bilayer (McMahon and Gallop, 2005). The membrane associated actin network 
also contributes to membrane deformation and scission (Lanzetti et al., 2007), 
along with motor proteins such as the dynamin family (Ferguson et al., 2012).  
  
Most of the events at sorting organelles are regulated by Rab GTPases and 
phosphoinositides. For example, the Rab11 GTPase recruits FIP5 (family interacting 
protein 5) and its binding partner SNX18 (sorting nexin 18) to apical recycling 
endosomes (Willenborg et al., 2011). SNX18 Is a BAR domain containing protein and 
FIP5 is required for scission, both proteins interact with PI(4,5)P2 which acts 
together with Rab11 to recruit them to the membrane (Willenborg et al., 2011). As 
carrier formation progresses from cargo selection to tubule formation, budding and 
scission, the proteins recruited to the membrane change to allow one stage to be 
completed and the next to be initiated. The sequential stages of endocytosis have 
been studied using fluorescence-based real-time imaging in yeast (Kaksonen et al., 
2005). Clathrin and coat proteins arrive at the site of endocytosis within the first 
10 seconds which is followed by a burst of actin polymerisation and recruitment of 
proteins able to bind curved membranes (Kaksonen et al., 2005). Once a bud is 
formed of appropriate size (approximately 30 seconds), the F-actin is down-
regulated and the vesicle is released (Kaksonen et al., 2005). Similar results were 
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found for clathrin mediated endocytosis in mammalian cells (Taylor et al., 2011). In 
this study the 5-phosphatases synaptojanin-2β1 and OCRL1 were recruited 
transiently to budding and post scission vesicles, indicating down-regulation of 
phosphoinositides during late stage endocytosis (Taylor et al., 2011). Removal of 
PI(4,5)P2 from late stage endocytic buds might facilitate actin depolymerisation and 
separation of the bud from the membrane of origin. Although these studies were 
carried out in yeast and fibroblasts, similar molecular dynamics are likely to occur 
for cargo exit of sorting organelles in polarised epithelial cells.  
 
Fully formed cargo carrying vesicles are trafficked to the plasma membrane along 
the actin and microtubule cytoskeleton by motor proteins that are recruited to 
carriers by Rab proteins and phosphoinositides. Different motor proteins drive 
membrane traffic to the apical or basolateral domain. The actin binding motor 
protein myosin-5b is recruited to apical recycling endosomes by Rab11 and Rab8 
and is essential for exit of apical cargo from the recycling endosomes to the plasma 
membrane (Lapierre et al., 2001; Roland et al., 2011). Mutations of myosin-5b can 
cause microvillus inclusion disease, characterized by the accumulation of large 
intracellular vacuoles enriched in microvilli (Müller et al., 2008). A similar 
phenotype is observed in Rab8 knockout mice (Sato et al., 2007). Trafficking of 
vesicles across the cytosol also depends on microtubule driven transport by the 
kinesin family of motor proteins, for example, the kinesin KIFC3 delivers the apical 
protein annexin-13b to the apical domain (Noda et al., 2001), while basolateral 
targeting of cargo carrying vesicles is driven by different members of the family 
(Lafont et al., 1994). 
 
Further membrane specificity of cargo delivery is achieved by tethering proteins 
once the vesicle is in the vicinity of the target membrane. Tethering proteins ensure 
vesicles fuse with appropriate membrane domains. The exocyst is a complex of 
eight proteins some of which are localised to the target plasma membrane while 
others are localised to the transport vesicle (Oztan et al., 2007; Yeaman et al., 
2001). Assembly of the complex when the vesicle meets the plasma membrane 
drives vesicle fusion (TerBush et al., 1996). Loss of exocyst function blocks the 
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recycling of internalised cargos and results in their accumulation in recycling 
endosomes (Prigent et al., 2003). The exocyst complex localises to secretory 
vesicles by interacting with Rab GTPases (Zhang et al., 2001) and targets them to 
plasma membranes rich in PI(4,5)P2, which is recognised by exocyst subunits EXO70 
and Sec3 (He et al., 2007, Zhang et al., 2008). Another type of tethering complex 
involves annexins which are present on apical transport vesicles and the target 
apical membrane. Annexins have the capacity to aggregate in a PI(4,5)P2 and 
calcium dependent manner, which might facilitate fusion of apical vesicles in the 
vicinity of the PI(4,5)P2 rich apical membrane (Gerke et al., 2005). In addition, 
polarised cells have different distributions of t-SNARES on the apical and basolateral 
membrane that complement different v-SNARES on apical and basolateral vesicles.  
 
 
The actin and microtubule cytoskeleton in polarised cells 
 
Membrane polarity is highly influenced by the orientation and organisation of 
cytoskeletal actin and microtubule filaments. Apical and basolateral cargo carrying 
vesicles are trafficked to the plasma membrane by motor proteins that utilise the 
polarity of the cytoskeleton for directional information, therefore polarised 
trafficking is dependent on the polarised organisation of actin and microtubule 
arrays. Molecular motor proteins were discussed in the previous section (Polarised 
membrane trafficking). Briefly, myosins are motor proteins that interact with actin 
filaments whilst microtubule motors encompass the kinesin and dynein families. In 
addition to regulating polarised membrane trafficking, the cytoskeleton also has a 
structural role within the cell and is required to maintain the tall cuboidal shape of 
polarised epithelial cells.  
 
Fully polarised epithelial cells have a dense network of actin filaments throughout 
the cell cortex. In the lateral domain, short actin filaments are part of the spectrin 
network that maintains the columnar shape of epithelial cells (Kizhatil and Bennett, 
2004). In the apical domain, actin filaments are specially arranged to form microvilli 
that increase membrane surface area for absorption of nutrients from the 
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extracellular fluid. The actin filament organisation in microvilli may also help retain 
apical cargo in the apical membrane (Revenu et al., 2012). Epithelial cells also 
develop a circumferential actin belt associated with tight junctions and adherens 
junctions which is essential for junction stability (Cavey and Lecuit, 2009). Actin 
reorganisation plays an important role in initiating cell-cell contacts and in the 
expansion required for the cuboidal morphology. Actin polymerisation produces 
membrane protrusions to generate new sites of E-cadherin based contacts 
(Bershadsky, 2004). Following these initial contacts, acto-myosin tension near 
contacting membranes generates a pulling force to facilitate the lateral expansion 
(Yamada and Nelson, 2007). Actin dynamics are regulated by Rac, Rho and Cdc42 
GTPases (Ridley, 2006) as well as phosphoinositides (Yin et al., 2003).  
 
The microtubule cytoskeleton in un-polarised cells typically displays a centrosomal 
arrangement of dynamic microtubules with the plus ends directed towards the cell 
periphery (Müsch, 2004). In polarised cells the arrangement of the microtubules is 
dependent on the specific cell type. Epithelial cell lines derived from the kidney 
maintain a population of stable microtubules organised vertically along the polarity 
axis with the minus end facing apically and the plus end basolaterally in addition to 
more dynamic apical and basal networks (Bartolini and Gundersen, 2006; Müsch, 
2004). This rearrangement of microtubules is regulated by the polarity protein 
kinase Par1b (Partitioning protein-1b), also known as MARK2 (Cohen et al., 2004). 
Depletion of Par1b from the Madin Darby Canine Kidney (MDCK) epithelial cell line 
prevented the organisation of microtubules normally associated with polarisation, 
whilst over-expression of Par1b resulted in rearrangement of the microtubules of 
MDCK cells to a liver-like phenotype, with microtubule arrays emanating from bile 
canaliculi-like lumina at the lateral membrane (Cohen et al., 2004). Cells over-
expressing Par1b re-routed their apical membrane traffic in accordance with the 
microtubule cytoskeleton (Cohen et al., 2004). In addition, disruption of 
microtubules with nocodazole or colchicine prevents plasma membrane localisation 
of apical proteins, which instead accumulate intracellularly in large vacuolar apical 
compartments (Gilbert et al., 1991; van Zeijl and Matlin, 1990). These vacuoles are 
thought to form from frustrated apical carriers unable to traffic to the plasma 
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membrane (Vega-Salas et al., 1987), highlighting the importance of microtubules in 
routing apical traffic.  
 
 
Phosphoinositides and polarised membranes 
 
The apical-basal polarity of the plasma membrane in epithelial cells includes 
phosphoinositides as well as proteins. The asymmetric distribution of 
phosphoinositides is critical for maintaining apical-basal polarity since domain 
specific phosphoinositides regulate trafficking and cytoskeletal dynamics 
appropriate for the membrane. In polarised epithelial cells, PI(3,4,5)P3 localises to 
the basolateral membrane, whereas PI(4,5)P2 is enriched apically (Martín-Belmonte 
et al., 2007). The segregation of these two phosphoinositides occurs during the 
early stages of polarisation, although it is not clear whether basal enrichment of 
PI(3,4,5)P3 is maintained in mature cells. PI(3,4,5)P3 becomes enriched basally when 
β1-integrins activate PI(3)-kinase which phosphorylates PI(4,5)P2 at the third 
position to generate PI(3,4,5)P3 (King et al., 1997). In addition, a significant source 
of PI(3,4,5)P3 is produced in the basolateral domain when cell-cell contacts are 
made since PI(3)-kinase is activated downstream of E-cadherin signalling (Kovacs et 
al., 2002). PI(4,5)P2 is maintained in the apical domain by the 3-phosphatase PTEN 
which dephosphorylates PI(3,4,5)P3. PTEN is recruited to tight junctions by 
interacting with the tight junction proteins MAGI-2 (membrane-associated 
guanylate kinase inverted-2) and Par3, known as Bazooka in Drosophila (Von Stein 
et al., 2005; Wu et al., 2000).  
 
The separation of apical and basolateral phosphoinositides is crucial for polarity 
homeostasis. Ectopic delivery of PI(4,5)P2 to the basolateral membrane results in a 
rapid redistribution of apical proteins to this compartment (Martin-Belmonte et al., 
2007). In addition, depletion of the 3-phosphatase PTEN prevents proper apical 
lumen formation due to lack of apical PI(4,5)P2 (Martin-Belmonte et al., 2007), 
further suggesting polarisation of PI(4,5)P2 is critical for apical membrane identity. 
Similarly, proper polarisation of PI(3,4,5)P3 is required for basal membrane identity. 
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Insertion of PI(3,4,5)P3 apically results in transcytosis of basolateral proteins to the 
apical membrane (Gassama-Diagne et al., 2006). Blocking endocytosis in these cells 
by expression of a dominant negative dynamin prevented the apical accumulation 
of basolateral proteins, highlighting the ability of phosphoinositides to regulate 
polarised membrane traffic. In addition, treatment of epithelial cells with PI(3)-
kinase inhibitors to limit production of PI(3,4,5)P3 reduced cell height due to 
inhibition of basolateral membrane expansion (Jeanes et al., 2009).  
 
As well as regulating polarised membrane trafficking, phosphoinositides also 
regulate cytoskeleton organisation beneath the plasma membrane. In the 
basolateral domain PI(3,4,5)P3 regulates Rac1 activation (Kovacs et al., 2002) and 
the recruitment of WAVE (Wiskott-Aldrich Syndrome protein family verprolin-
homologous protein) actin nucleating proteins (Padrick and Rosen, 2010). In the 
apical domain PI(4,5)P2 recruits the Cdc42 binding protein annexin-2 (Rescher et al., 
2004) and the WASP (Wiscott-Aldrich Syndrome protein) family of proteins which 
activate Arp2/3 to promote nucleation of filamentous actin (Padrick and Rosen 
2010). In addition PI(4,5)P2 interacts with the ERM proteins, ezrin, radixin and 
moesin, promoting the association of actin fibres and bundles to PI(4,5)P2 rich 
regions of the plasma membrane (Pearson et al., 2000). OCRL1 may be involved in 
the maintenance of plasma membrane phosphoinositide asymmetries by down-
regulating the levels of 5-phosphoinositides on intracellular membranes. 
 
 
Polarity complexes and polarised membranes 
 
Phosphoinositides co-operate with a set of evolutionarily conserved polarity 
complexes to regulate apical-basal polarity (Margolis and Borg, 2005). In a similar 
manner to phosphoinositides, polarity complexes associate with particular 
membrane domains and promote expansion of the domain they associate with. 
Apical membrane development is regulated by two polarity complexes: the Crumbs 
complex and the Par complex. The apical Crumbs complex consists of three major 
proteins, crumbs, PALS1 (protein associated with Lin-7) and PATJ (PALS1-associated 
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tight junction protein). The mammalian Par complex is comprised of two scaffold 
proteins: Par-3 (partitioning defective-3) and Par-6 (partitioning defective-6) and an 
atypical protein kinase C (aPKC). In addition, the Par complex exists as two separate 
complexes: Cdc42-Par6-aPKC and Par3-aPKC. The basolateral Scribble complex is 
associated with the lateral membrane and contains discs large (Dlg), lethal giant 
larvae (Lgl) and scribble proteins (Assémat et al., 2008). 
 
The apical polarity complexes Crumbs and Par are involved in generating apical-
basal polarity as well as tight junction formation, while the lateral Scribble complex 
appears to be required for the formation of adherens junctions. Modulating the 
protein levels of the Crumbs complexes affects the balance between apical and 
basolateral membrane expansion and the formation of tight junctions, highlighting 
the essential role of the Crumbs complex in regulating these activities. For example, 
overexpression of crumbs leads to an expansion of the apical membrane and 
reduction of the basolateral membrane (Roh et al., 2003) while loss of PALS1 
expression delays the formation of tight junctions (Straight et al., 2004). Modulating 
the levels of the Par complex appears to particularly affect the apical membrane. 
Depletion of Par3 in monolayer cultures of MDCK cells resulted in the formation of 
the apical domain in the lateral membrane and a similar phenotype in 3D cultures 
(Horikoshi et al., 2009). In addition, deletion of the Par3 gene in C. elegans leads to 
the defective segregation of apical and basal proteins during the first cell division of 
the zygote (Kemphues et al., 1988). Depletion of scribble has little effect on 
apicobasal polarity but reduces the integrity of cell-cell adhesions and leads to 
increased cell motility (Qin et al., 2005).  
 
These polarity complexes initiate apicobasal polarity by recruiting functionally 
important proteins to the plasma membrane. In addition, some polarity proteins 
have enzymatic kinase activity and are involved in signalling cascades. The Crumbs 
complex acts as a scaffold to recruit and retain junctional proteins in the plasma 
membrane. The Crumbs component PATJ contains 10 PDZ domains that interact 
with tight junction proteins such as ZO-3 and claudin-1 (Roh et al., 2002). Further 
scaffolding activity is provided by the Crumbs component PALS1 which contains at 
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least six different domains that engage in protein interactions (Kamberov et al., 
2000). The GTPase Cdc42 is considered to play a central role in establishing cell 
polarity, regulating the orientation of the actin and microtubule cytoskeleton and 
organisation of membrane traffic (Etienne-Manneville, 2004). Cdc42 is recruited to 
the apical domain by interacting with Par6. In addition, the binding of Cdc42 to Par6 
induces a conformational change in Par6 that activates its binding partner aPKC 
(Garrard et al., 2003). Polarity proteins also regulate phosphoinositide turnover by 
recruiting phosphoinositide metabolising proteins to the plasma membrane. For 
example, a PDZ domain of Par3 has been shown to bind the PI-3-phosphatase PTEN 
(Von Stein et al., 2005), contributing to PI(4,5)P2 production in the apical domain. 
Although polarity proteins integrate a host of processes critical for apical-basal 
polarity, there is some evidence to suggest the asymmetric distribution of polarity 
complexes itself depends on phosphoinositide metabolism and polarised 
membrane trafficking, suggesting a feedback loop. For example, the exocyst 
complex, which regulates polarised membrane trafficking is required for Par3 
localisation (Lalli et al., 2009), suggesting that polarised membrane trafficking 
operates both upstream and downstream of polarity complexes. The earliest events 
known to initiate epithelial cell polarity are discussed in more detail next.  
 
 
Polarity orientation cues 
 
The segregation of apical and basolateral polarity complexes generates an axis of 
polarity that determines where on the membrane the apical and basolateral 
domains will form. Orientation of the polarity axis is influenced by positional 
information received from the surrounding micro-environment. Cells in culture are 
typically grown in an asymmetric environment with a plastic support on one side 
and growth media on the other. The presence of asymmetry in the environment is 
thought to assist in the formation of a polarity axis; the basal membrane is formed 
at the site of adhesion to the underlying support and the apical domain is formed 
where the plasma membrane contacts the growth media. When cells are immersed 
in a uniform environment surrounded by extra cellular matrix (ECM) they 
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proliferate and assemble into cysts of spherical monolayers with central lumens 
(O’Brien et al., 2002), more closely resembling epithelial organisation in vivo. Apical 
membrane formation in 3D culture is thought to be initiated at the two cell stage. A 
single cell fully immersed in ECM has no external polarity cues but asymmetry is 
introduced upon the first cell division, while the free plasma membrane remains in 
contact with the environment, a region of the plasma membrane can no longer 
sense the ECM due to the formation of cell-cell contacts. This suggests that cells 
initiate apical membrane formation during cell division, which is the topic of the 
section towards the end of this chapter entitled ‘Co-ordinating polarity and cell 
division’.  
 
Even after the first cell division, the apical membrane appears to be identified by 
the absence of adhesion. The apical membrane faces the inside of the lumen which 
forms no adhesive contacts, in contrast the basolateral membrane adheres to 
adjacent cells and the underlying matrix. One way in which cells might identify the 
absence of adhesion is through the activation state of integrin proteins. Cells 
distribute integrins in both the apical and basal membrane, however apical 
integrins remain inactive due to absence of collagen in the extracellular 
environment. When the apical membrane is covered with collagen, apical integrins 
become active and the cells re-assemble into tubules and develop the apical 
membrane in the new free surface (Schwimmer and Ojakian, 1995). These findings 
suggest the activation state of integrin receptors influences the orientation of the 
apical-basal polarity axis. 
 
Activated integrins initiate the formation of the basolateral membrane. Activated 
integrins promote deposition and re-modelling of a laminin rich basement 
membrane between the plasma membrane and the ECM. The basement membrane 
formed serves to enforce and further develop basal membrane identity. The 
serine/threonine kinase Par1b is activated downstream of integrin signalling and 
promotes laminin reorganisation by directly interacting with laminin receptors and 
inducing their aggregation at the basal surface (Masuda-Hirata et al., 2009; 
Yamashita et al., 2010). In addition, Par1b regulates the localisation of the 
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scaffolding protein IRSp53 (Insulin receptor substrate p53). IRSp53 links Rac1 and 
Cdc42 to their effector proteins in the basement membrane (Cohen et al., 2011, 
Scita et al., 2008). Active Rac1 and Cdc42 at the basal membrane further facilitate 
laminin remodelling by inducing sub-membranous cytoskeletal organisation. These 
signalling events downstream of integrin activation are required for proper 
positioning of the apical membrane. Depletion of β1-Integrin results in the 
abnormal localisation of the apical membrane to a region in-between neighbouring 
cells through inappropriate activation of a RhoA–ROCKI–myosin2 pathway (Yu et 
al., 2008), suggesting that ECM-derived signals influence polarity orientation by 
regulating cytoskeletal tension. In addition, lumen positioning in MDCK cells is 
regulated by Par1b mediated cytoskeletal organisation (Cohen et al., 2011). In these 
studies, impaired ECM signalling and basal cytoskeletal organisation triggered 
inappropriate positioning of the apical membrane but did not perturb polarity and 
intercellular junction formation, suggesting the orientation of cell polarity and 
apicobasal polarisation can be molecularly uncoupled.  
 
 
Early stages of apical membrane formation 
 
Once the orientation of apical-basal polarity has been established, the apical 
membrane is formed by polarised trafficking of apical components to the plasma 
membrane. When a single epithelial cell divides in 3D culture, the apical lumen is 
typically formed by exocytosis of apical cargo carrying vesicles to a specific site on 
the plasma membrane between the two cells (Martin-Belmonte et al., 2008). At the 
single cell stage, apical membrane components are distributed throughout the 
plasma membrane. The boundary that forms between daughter cells when the 
single cell divides acts as the precursor apical domain for the delivery of apical 
vesicles. The apical components that were uniformly distributed on the plasma 
membrane are endocytosed into Rab11a positive recycling endosomes and sorted 
for transport to this site (Bryant et al., 2010), see figure 1.5. The precursor apical 
domain or apical membrane initiation site (AMIS) is marked by Par3 and aPKC 
(Bryant et al., 2010). The mechanism of Par3 targeting to the AMIS is not clear, 
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however membrane recruitment may be mediated by interactions with the 
phosphoinositide PI(4,5)P2 (Horikoshi et al., 2011; Krahn et al., 2010; Wu et al., 
2007). Par3 is thought to recruit the lipid phosphatase PTEN to the AMIS (Feng et 
al., 2008; von Stein et al., 2005) which facilities enrichment of PI(4,5)P2 in the 
forming apical membrane by dephosporylation of PI(3,4,5)P3. Therefore Par3 
utilises PI(4,5)P2 for membrane recruitment and also facilitates the production of 
more PI(4,5)P2. This is another example of Par3 participating in a feedback loop to 
rapidly promote expansion of the apical membrane.  
 
Rab11a drives apical trafficking to the AMIS by recruiting Rabin8, a Rab8 GEF to 
apical vesicles (Bryant et al., 2010), which associates with motor proteins such as 
myosin-5b (Roland et al., 2011). In addition, trafficking of luminal vesicles also 
depends on microtubule driven transport. For example, the kinesin KIF3b is 
recruited to the membrane of apical vesicles through interactions with the Rab11 
binding protein FIP5 (Schonteich et al., 2008). Luminal targeting of apical vesicles 
requires the tethering exocyst complex. Rab11a on apical vesicles interacts with 
sec15a exocyst subunit (Wu et al., 2005) whilst sec8 and sec10 exocyst components 
are recruited to the AMIS (Bryant et al., 2010). In addition, enrichment of PI(4,5)P2 
at the AMIS is likely to facilitate membrane association of additional exocyst 
subunits (He et al., 2007; Zhang et al., 2008). Therefore a functional exocyst 
complex is formed when vesicle bound subunits interact with target apical 
membrane bound subunits, ensuring specificity of apical vesicles and apical 
membrane. Other tethering proteins such as SNAREs are likely to facilitate targeting 
of apical vesicles with the developing lumen; syntaxin-3 appears to play a key role 
in this process (Sharma et al., 2006).  
 
The Rab11a/Rab8 apical trafficking pathway functions upstream to deliver essential 
components required for lumen formation to the plasma membrane. One of the 
first proteins known to localise to lumens at the earliest visible stage is Gp135 
(glycosylated protein-135), also known as podocalyxin (Bryant et al., 2010). Gp135 
is a member of the CD34 family of anti-adhesins. Heavy sialylation of Gp135 gives 
the protein a negative charge which helps to repulse opposing membranes during 
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lumen expansion. In addition to Gp135, the Cdc42-Par6-aPKC polarity complex is 
also delivered to the AMIS via the Rab11a/Rab8a apical trafficking pathway (Bryant 
et al., 2010). Cdc42 is recruited to apical vesicles by its interaction with annexin-2, a 
PI(4,5)P2 binding protein (Martin-Belmonte et al., 2007) and is activated on apical 
vesicles via the GEF protein Tuba (Bryant et al., 2010). Par3 at the AMIS might act as 
an additional tethering factor by associating with Cdc42-Par6-aPKC on apical 
vesicles and completing the formation of the Par polarity complex (figure 1.5). 
However, association of Par3 and Par6 is thought to occur only temporally and is 
disrupted by delivery of the Crumbs polarity complex to the AMIS. This complex is 
also delivered to early forming lumens via the same Rab11a/Rab8a trafficking 
pathway (Walther and Pichaud, 2010). Arrival of the Crumbs complex at the AMIS is 
thought to dissociate Par3 from Cdc42-Par6-aPKC and facilitate relocation of Par3 
to apicolateral borders, where junctions form (Morais-de-Sá et al., 2010 and 
Walther and Pichaud, 2010), also shown in figure 1.5.  
 
Expansion of the AMIS into a lumen requires separation of opposing plasma 
membranes which is achieved by multiple mechanisms, as mentioned above, 
negatively charged sialic acids in apical glycoproteins such as Gp135 repel adjacent 
apical membranes (Strilić et al., 2010). Gp135 also contributes to the organisation 
of the sub-apical actin network by recruiting ERM proteins (Meder at al., 2005), 
which together with ROCK (Rho-associated protein kinase) generates the force 
required for lumen expansion through contraction of actin (Ferrari et al., 2008). In 
addition, delivery of ion pumps to the forming lumen creates an ionic gradient that 
encourages water to enter through the paracellular pathway. The exocytosis of fluid 
filled endocytic vesicles at the AMIS further contributes to lumen expansion 
(Martin-Belmonte et al., 2008). The formation of a lumen by exocytosis of luminal 
components occurs in developing mouse aorta (Strilić et al., 2009) and in MDCK 
cysts (Martin-Belmonte et al., 2008). However, other mechanisms for generating a 
luminal space exist. For example, some cells cluster and generate a lumen by 
apoptosis of cells not in contact with the ECM, generating luminal space. This 
occurs for example in mammary terminal end buds (Mailleux et al., 2008). Although 
multiple mechanisms exist for generating the space for a lumen, polarisation must 
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still occur as the membrane facing the luminal space is developed to specialise in 
apical membrane activities.  
 
 
 
 
Figure 1.5: Model for apical lumen formation in cysts. The apical membrane 
initiation site (AMIS) is marked by the Par3-aPKC polarity complex. Apical 
components such as Gp135/podocalyxin (red) are trafficked in Rab11a and Rab8a 
positive vesicles. Formation of the Par complex (Cdc42-Par6-aPKC) and the Exocyst 
complex (containing Sec subunits) drive trafficking of apical vesicles to the AMIS. 
Delivery of fluid filled vacuoles as well as heavily sialylated proteins such as Gp135 
to the AMIS induce membrane expansion of the forming lumen. Arrival of the 
Crumbs complex (Crumbs-Pals1-Patj) to the early forming lumen re-locates Par3-
aPKC to the periphery enabling tight junction formation (purple) to occur around 
the forming lumen. Adapted from Bryant et al., 2010. 
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Cytokinesis 
 
Overview 
 
Cytokinesis is the final stage of cell division that results in the separation of two 
cells after the completion of mitosis. Cytokinesis in mammalian cells is achieved 
through the formation of an actomyosin ring that contracts to divide the cell into 
two. The assembly of the actin ring is in turn regulated by the microtubule 
cytoskeleton which plays an important role in defining the cleavage plane. Vesicular 
trafficking is required for the final stages of cytokinesis when the two daughter cells 
become physically separated.  
 
A homologue of OCRL1 has been implicated to regulate contractile ring formation in 
Drosophila (Ben El Kadhi et al., 2011). In addition, OCRL1 is required for the final 
stage of cytokinesis in human non-polarised epithelial cell lines (Dambournet et al., 
2011). The final stage of cytokinesis is referred to as abscission, when the 
intercellular microtubule bridge is severed. Whether OCRL1 regulates cytokinesis in 
polarised epithelial cell lines is not currently known.  
 
 
Cytoskeletal dynamics during cytokinesis 
 
Cytokinesis in mammalian cells involves rearrangement of the mitotic spindle to 
define the plane of division and extensive actin polymerisation to facilitate 
abscission (figure 1.6). The mitotic spindle is organised by the centrosomes which 
replicate and separate at the beginning of mitosis. Each centrosome nucleates an 
array of microtubules such that a bipolar spindle is formed (Cassimeris and 
Skibbens, 2003). In metaphase, the positive ends of the spindle microtubules align 
the chromosomes whilst the negative ends of microtubules focus near the 
centrosome (Cassimeris and Skibbens, 2003).  
55 
  
Cytokinesis begins in anaphase when the mitotic spindle rearranges to separate the 
chromosomes and initiate division into two pronuclei. During this process the 
mitotic spindle reassembles to form the central spindle (figure 1.6), a dense array of 
antiparallel microtubules between the two spindle poles (Fededa and Gerlich, 
2012). Astral microtubules extend from spindle poles to the cell cortex which helps 
define the cleavage plane (Fededa and Gerlich, 2012). In symmetric division, this 
occurs midway between segregated chromosomes so that the cytoplasm is equally 
divided between daughter cells.  
 
Once the cleavage plane has been identified, the contractile ring is assembled. The 
small GTPase RhoA becomes activated at the boundary of the cleavage plane 
(Bement et al., 2005) and recruits effector proteins that organise contractile ring 
assembly (Watanabe et al., 2008). The contractile ring is composed of three 
structural components: actin, myosin-2 and septins. Activated RhoA stimulates 
actin polymerisation by activating formins (Watanabe et al., 2008). In addition, the 
production of PI(4,5)P2 at the cleavage furrow further stimulates actin 
polymerisation. The actin binding motor protein myosin-2 hydrolyses ATP to exert 
force on the actin filaments and promote constriction of the ring during the 
furrowing stage (Glotzer, 2005). The septins are GTP binding proteins that associate 
to form oligomeric filaments (Sirajuddin et al., 2007). In addition to these three 
components, the peripheral plasma membrane protein anillin appears to be critical 
for assembly of the contractile ring. Anillin is able to bind both myosin-2 and the 
septins, potentially functioning as a cross linker of the actomyosin and septin 
cytoskeletons (D'Avino, 2009). PI(4,5)P2 at the cleavage furrow may contribute to 
recruitment of key components of the contractile ring, for example both anillin and 
the septins interact with PI(4,5)P2 (Field et al., 2005). 
 
As cytokinesis progresses, the contractile ring constricts and compacts the midzone 
microtubule array until an intercellular cytoplasmic bridge is formed (figure 1.6). 
These microtubules overlap at the midbody, which also contains numerous proteins 
required for abscission (Skop et al., 2004). Abscission proceeds by disassembly of 
the actin contractile ring and plasma membrane fission. Actin filament disassembly 
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during abscission requires inactivation of RhoA at the midbody (Saurin et al., 2008). 
In addition, down-regulation of PI(4,5)P2 may be required to remove the actin 
filaments associated with the intercellular bridge. This process may involve OCRL1 
and is discussed in the section entitled ‘OCRL1 in cytokinesis’. 
 
 
 
 
 
Figure 1.6: Organisation of the cytoskeleton during the different stages of 
cytokinesis. Cytokinesis begins by assembly of the central spindle consisting of 
midzone microtubules and astral microtubules that contact the cell cortex. 
Interaction of the central spindle with the cell cortex defines the cleavage site 
(purple line) and initiates assembly of the actin contractile ring (green). Furrow 
ingression is mediated by contraction of the actin ring which condenses midzone 
microtubules to form the intercellular bridge. At the centre of the intercellular 
bridge is the midbody (yellow) that contains numerous proteins required for 
abscission. At the end of cytokinesis, the intercellular bridge is cleaved which occurs 
asymmetrically on one side of the midbody (not shown).  
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Membrane trafficking during cytokinesis 
 
As well as rearranging the actin and microtubule cytoskeleton, specific membrane 
trafficking pathways are altered during mitosis and cytokinesis to accommodate 
fluctuations in cell volume and plasma membrane surface area. In addition, the 
delivery of new membrane to the abscission site during the final stages of 
cytokinesis is essential for completing this process (Schweitzer et al., 2005).  
 
During interphase, the Golgi complex and endocytic compartments localise near the 
centrosome in the perinuclear region of the cell. At this stage in the cell cycle, the 
rate of recycling to and from the plasma membrane is balanced and a constant cell 
size is maintained. As cells enter prophase, clathrin mediated endocytosis (CME) is 
inhibited, though the mechanism underlying this inhibition is unclear (Fielding and 
Royle, 2013). However, recent evidence suggests the inhibition may be due to the 
unavailability of the actin machinery, which assembles into a stiff cortex in mitotic 
cells (Kaur et al., 2014). Furthermore, the increased membrane tension during 
mitosis would add to the requirement of actin to assist endocytosis and overcome 
the inhibition (Kaur et al., 2014). As cells enter late anaphase and telophase, CME 
resumes to normal levels (Fielding and Royle, 2013). In addition to altering the rate 
of endocytosis, the rate of recycling to the plasma membrane slows during 
metaphase and anaphase, resulting in an intracellular accumulation of endosomes 
(Boucrot and Kirchhausen, 2007). These endosomes accumulate into four clusters, 
two pools of endosomes localise around each centrosome, while additional clusters 
of endosomes accumulate at the furrow side of the two pronuclei formed during 
anaphase. These endosomes are positioned proximal to the minus end of the 
midzone microtubules (Dunster et al., 2002). As mitosis progresses to telophase, 
recycling resumes, with most of the traffic directed towards the furrow (Boucrot 
and Kirchhausen, 2007). In this study, the recovery of plasma membrane surface 
area did not require the Golgi apparatus, suggesting that modulation of plasma 
membrane surface area during mitosis is mostly achieved through regulating 
endosomal recycling and not the secretory pathway (Boucrot and Kirchhausen, 
2007). Therefore, endocytosis and recycling appear to be regulated spatially and 
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temporarily during mitosis, however the mechanism adjusting the rate of 
endosomal exit during early stages of mitosis remains to be elucidated. 
 
During cytokinesis, endocytic recycling is essential for the final separation of the 
two daughter cells. Disruption of clathrin mediated endocytosis results in significant 
defects in cytokinesis (Schweitzer et al., 2005; Smith and Chircop, 2012), suggesting 
the accumulation of intracellular membrane is critical for this process. During 
cytokinesis, Rab11 positive vesicles traffic from proximal clusters along midzone 
microtubules and accumulate in the midbody of the intercellular bridge (Simon and 
Prekeris, 2008). Vesicles in the intercellular bridge fuse with the plasma membrane 
before abscission (Schiel et al., 2011) and depletion of Rab11 or expression of a 
dominant-negative mutant induces significant abscission defects (Wilson et al., 
2005). In addition, secretory vesicles derived from the Golgi apparatus may also be 
required for abscission (Gromley et al., 2005). Although vesicle trafficking is 
involved in completing cytokinesis, the exact role of vesicles in the mechanism of 
abscission remain unclear. Fusion of vesicles with the plasma membrane of the 
intercellular bridge might cause thinning of the intercellular bridge, bringing 
opposing plasma membranes closer together (Neto and Gould, 2011). The final 
abscission step is thought to involve further constriction of the bridge by a helical 
arrangement of the ESCRT (endosomal sorting complexes required for transport) 
complex until direct fission of the opposing membranes occur (Guizetti et al., 2011).  
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OCRL1 in cytokinesis 
 
OCRL1 has been implicated via its phosphatase activity to be involved in cytokinesis. 
In Drosophila, a homologue of OCRL1 is required for furrowing of the contractile 
ring. Depletion of dOCRL1 causes increased intracellular levels of PI(4,5)P2 on giant 
endocytic vacuoles (Ben El Kadhi et al., 2011). Consequently, in dividing cells, 
components of the cleavage furrow including anillin were mis-localised to the 
PI(4,5)P2 rich vacuoles (Ben El Kadhi et al., 2011). Mis-localisation of the furrowing 
machinery led to unsuccessful furrowing and a high frequency of bi-nucleate cells 
(Ben El Kadhi et al., 2011). Therefore, OCRL1 in Drosophila is required to down-
regulate PI(4,5)P2 on intracellular membranes so that the contractile ring in dividing 
cells has the identity of being rich In PI(4,5)P2 which is important for correct 
targeting of contractile ring components.  
 
In HeLa cells, OCRL1 removes 5-phosphoinositides to facilitate abscission during the 
final stages of cytokinesis. In these cells, depletion of OCRL1 blocked abscission due 
to abnormal accumulations of PI(4,5)P2 and associated actin filaments in the 
intercellular bridge, highlighting the requirement for lipid and F-actin removal for 
the final physical separation of daughter cells (Dambournet et al., 2011). OCRL1 
localises to the intercellular bridge in a Rab35 dependent manner (Dambournet et 
al., 2011), therefore OCRL1 is likely delivered to the abscission site by direct 
interactions with Rab35, which regulates a fast recycling endocytic pathway that is 
essential for abscission (Kouranti et al., 2006).  
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Coordinating polarity and cell division 
 
 
Overview 
  
During epithelial development, cell division is co-ordinated with polarisation so that 
the morphology of the tissue and the integrity of the epithelial barrier are 
maintained as cells within the epithelium divide. Unsurprisingly, there appears to 
be significant cross-talk between cell division and polarisation mechanisms (Hehnly 
and Doxsey, 2012). In addition, many key regulatory proteins and complexes 
required for polarisation also have functional roles in cell division, particularly 
during cytokinesis (Hehnly and Doxsey, 2012). If OCRL1 regulates cytokinesis in 
polarised epithelial cells, this could have consequences for polarisation and the 
morphology of the epithelium.  
  
 
Apical membrane formation and cytokinesis 
 
In epithelial cysts, apical membrane formation occurs at the late stages of the first 
cell division. Daughter cells co-ordinate delivery of apical membrane vesicles to a 
common site that lies between the cell pair. The molecular landmark for apical 
membrane insertion at this particular site is not currently known but one possibility 
is for cells to utilise products of the cytokinesis machinery to initiate 
lumenogenesis. In yeast, a complex of proteins retained from the previous 
cytokinesis event provides the landmark for membrane delivery required for the 
formation of the next bud (Nelson, 2003). In mammalian cells, a number of 
observations support the idea that apical membrane insertion occurs at the site of 
cytokinesis. In epithelial cysts, apical cargo such as Gp135 and crumbs3a 
accumulate in Rab11a positive recycling endosomes at the onset of mitosis (Bryant 
et al., 2010; Schlüter et al., 2009). During metaphase, apical cargo carrying vesicles 
localise around the poles of the mitotic spindle and are subsequently partitioned 
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into each daughter cell during telophase (Hobdy-Henderson et al., 2003). At the 
latest stages of mitosis, Rab11 positive apical vesicles are trafficked to the site of 
abscission along the midzone microtubule bundle (Schlüter et al., 2009), suggesting 
that lumen formation is co-ordinated with mitosis and the abscission site localises 
the formation of the first apical membrane. Expression of dominant negative 
Rab11a in MDCK cells blocked the trafficking of apical cargo such as Crumbs3a and 
prevented early apical membrane formation (Schlüter et al., 2009). Therefore, 
polarised cells appear to have utilised a common Rab11 vesicular trafficking 
pathway during cytokinesis to co-ordinate cell division with apical-basal polarity.  
  
At the two cell stage of epithelial cysts, the orientation of the polarity axis is aligned 
with the spindle axis and the apical membrane forms in the plane of cell division 
(figure 1.7). In subsequent cell divisions, the apico-basal polarity axis is aligned 
perpendicular to the spindle axis so that apical membrane formation reinforces the 
lumen formed following the first cell division (figure 1.7). Therefore as epithelial 
cells develop from two cells to multicellular cysts, the orientation of polarisation 
changes relative to the plane of cell division. In 2D monolayer cultures of epithelial 
cells, the relative orientations of the polarity axis and the plane of cell division are 
similar to multicellular cysts, where cells divide in a horizontal plane and polarise in 
a vertical plane (figure 1.7).  
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Figure 1.7: Orientation of the apical-basal axis relative to the spindle axis in cyst 
and monolayer epithelial development. In the first cell division within a cyst the 
apical-basal axis (red line) and the spindle axis (blue line) are aligned so that 
formation of the apical lumen is co-ordinated with mitosis. In subsequent cell 
divisions within a cyst, the apical-basal axis is aligned perpendicular to the spindle 
axis so that apical membrane formation reinforces lumen formation. Similarly, in 2D 
monolayer cultures of epithelial cells the apical-basal axis and plane of cell division 
are aligned at right angles.  
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The mechanism of shifting the orientation of the apical-basal axis from a horizontal 
plane in two cells to a vertical place in multicellular cysts is not known. One 
possibility is that apical membrane formation might utilise mitotic machinery only 
in the first cell division but not in subsequent divisions, so that the mechanism of 
apical membrane formation becomes dissociated from cell division once an apical 
membrane has already been established. For example, in one study trafficking of 
crumbs3a to spindle poles was not observed in cell divisions occurring in cysts 
larger than two cells, instead crumbs3a remained in the plasma membrane and the 
apical domain established at the two cell stage was kept intact (Schlüter et al., 
2009). These findings suggest that apical membrane trafficking along the spindle 
and midzone microtubules to form the apical membrane is unique to the very first 
division only. However, disrupting spindle orientation of dividing cells in 
multicellular cysts leads to a multi-lumen phenotype; cells fail to traffic apical 
membrane to a common lumen and subsequently form multiple lumens in the 
lateral membranes between cells (Jaffe et al., 2008). This suggests that even at later 
stages of development, cell division influences the orientation of apicobasal polarity 
and that the mitotic apparatus directs apical membrane formation in all cell division 
events.  
 
Several polarity proteins have been implicated recently in spindle pole orientation 
during epithelial cell division. Silencing of Cdc42 causes spindle orientation defects 
in the MDCK cell line (Jaffe et al., 2008; Rodriguez-Fraticelli et al., 2010, Qin et al., 
2010) and in the developing neural tube of Xenopus laevis (Kieserman and 
Wallingford, 2009). In all cases, loss of Cdc42 and spindle mis-orientation severely 
disrupted morphogenesis of the epithelium. In MDCK cysts, depletion of the Cdc42 
GEFs Intersectin-2 and Tuba caused multiple lumen formation (Rodriguez-Fraticelli 
et al., 2010, Qin et al., 2010), suggesting that regulation of spindle orientation by 
Cdc42 is required for proper lumenogenesis. Tuba localises to intracellular 
membranes and is necessary for the apical localisation of Cdc42, while Intersectin-2 
localises to the centrosome, where it may activate Cdc42 in the pericentrosomal 
region during mitosis.  
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Spindle orientation is regulated by the G-alpha binding protein Pins (Siller and Doe, 
2009). When cells within a cyst or monolayer divide, the mitotic spindle is initially 
orientated parallel to the vertical apicobasal axis but subsequently rotates 90° 
aligning parallel to the ECM. Pins localises to the lateral membrane where it 
captures astral microtubules and anchors them to the plasma membrane (Zheng et 
al., 2010). Disruption or mis-localisation of Pins causes spindle mis-orientation and 
disrupts lumen formation (Hao et al., 2010). Pins segregation to the lateral 
membrane appears to be regulated by the Par6–Par3–aPKC Par polarity complex 
(Hao et al., 2010). Pins is phosphorylated by aPKC at the apical membrane, which 
causes it to be sequestered by 14-3-3, excluding Pins from the apical cortex and 
restricting its localisation to the lateral membrane (Clarke, 2009). Disruption of any 
of the components of the Par6–Par3–aPKC complex affects polarised localisation of 
Pins, induces abnormal spindle orientation and results in multiple lumen formation 
(Hao et al., 2010). Activated Cdc42 can bind to the Par6-aPKC complex and activates 
aPKC (Goldstein et al., 2007), therefore the role of Cdc42 in spindle orientation 
could involve apical activation of aPKC and sequestering of Pins.  
  
The orientation of the mitotic spindle during cell division may affect the positioning 
of the mid body during abscission, since the midbody and intercellular bridge is 
formed from spindles derived from the mitotic spindle apparatus. The midbody is 
thought to mark the site of apical membrane formation and therefore midbody 
localisation may affect apical membrane trafficking. For example, apical cargo such 
as aPKC and crumbs3a are trafficked along midzone microtubules (Schlüter et al., 
2009). In the intestinal cyst model (caco-2), depletion of Cdc42 caused the position 
of the midbody to be mis-localised due to random orientations of the mitotic 
spindle (Jaffe et al., 2008). Interestingly, the localisation of the midbody coincided 
with lumen development in both normal cysts and in Cdc42 depleted cysts which 
formed multiple lumens, suggesting the multiple lumen phenotype of Cdc42 
depletion could be due to mis-localised midbodies. The formation of multiple 
lateral lumens in multicellular cysts with mis-localised midbodies further suggests 
that apical trafficking along the midzone microtubules is not unique to the first cell 
division and on-going apical membrane trafficking is co-ordinated with abscission. 
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In epithelial cells growing as cysts and in two dimensional cultures, the midbody 
localises asymmetrically near the apical domain (Fleming et al., 2007; Reinsch and 
Karsenti, 1994). Apical localisation of the midbody ensures apical cargo is trafficked 
towards the apical membrane. The analysis of MDCK cells in two dimensional 
culture and mouse intestinal epithelial cells in vivo has revealed that cleavage 
furrowing is asymmetric (figure 1.8), proceeding from the basal side to the apical 
side. Asymmetric furrowing of the contractile ring positions the midbody apically 
and ensures abscission occurs near the surface of the monolayer (Fleming et al., 
2007; Reinsch and Karsenti, 1994). However, in the case of the first cell division of 
epithelial cysts, abscission appears to be symmetric and apical membrane 
formation is initiated in the middle of the cleavage plane.  
 
 
  
 
Figure 1.8: Asymmetric furrow ingression positions the midbody apically. During 
cytokinesis, furrowing of the contractile ring (green) occurs asymmetrically, from 
the basal membrane (brown) towards the apical surface (red). The directional 
movement of the contractile ring is indicated with an arrow. In cyst cultures of 
epithelial cells, the midbodies (yellow) are located beneath the developing lumen 
whilst in to two dimensional cultures the midbodies are positioned beneath the 
apical side of the monolayer (not shown). Asymmetric abscission ensures the 
structure of the tissue is not disrupted by cells undergoing division.  
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The mechanism regulating asymmetric furrow ingression is not clear. However, in 
the C. elegans embryo, depletion of anillin and the septins blocked asymmetric 
furrowing and cytokinesis subsequently occurred midway in the cleavage plane 
(Maddox et al., 2007). Anillin and the septins promote a differential distribution of 
contractile ring components around the circumference of the ring (Maddox et al., 
2007; Tse et al., 2011), thus strengthening constriction of the ring from one side. 
For example, myosin-2 is more concentrated on the side of the ring that ingresses 
the most and depletion of either anillin or the septins results in a loss of this 
asymmetric distribution (Maddox et al., 2007). Asymmetric abscission in polarised 
cells might function to limit disruption of apical junctional complexes and maintain 
the integrity of the epithelium.  
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Project aims and objectives 
  
The cell types most affected in Lowe Syndrome are highly polarised but whether 
OCRL1 is involved in establishing or maintaining polarity is not currently known. The 
overall aim of this project was to study the role of OCRL1 in polarisation which is 
critical for the function and architecture of the tissues affected by Lowe Syndrome. 
  
The reasoning behind this objective was that OCRL1 has been implicated by 
numerous studies to regulate processes important for cell polarity, such as 
membrane trafficking and cytoskeletal dynamics. Several groups have used the 
MDCK cell line or renal cells derived from Lowe Syndrome patients to examine the 
effects of OCRL1 loss on these processes. One study reported defects in the 
trafficking of receptors such as megalin and transferrin to the cell surface (Vicinanza 
et al., 2011), while another study found no effect on biosynthetic or endocytic 
pathways but instead reported changes in trafficking from the TGN to lysosomes 
(Cui et al., 2010). Therefore the role of OCRL1 in regulating polarised trafficking 
remains unclear. However, the multiple reports of OCRL1 function in ciliogenesis 
suggest a role for OCRL1 in apical trafficking. The formation of the primary cilium is 
a hallmark of apical membrane biogenesis. OCRL1 regulates trafficking of ciliary 
proteins in a Rab8 dependent pathway (Coon et al., 2012) and apical trafficking in 
renal cells also occurs through Rab8 dependent transport. Rab8 was shown to be 
one of the preferred in vitro binding partners of OCRL1 (Hyvola et al., 2006) and it 
has recently been crystallised in complex with Rab8 (Hagemann et al., 2012), 
therefore other Rab8 dependent apical trafficking pathways may be regulated by 
OCRL1 as well as the ciliary specific route. Lastly, OCRL1 facilitates cytokinesis in 
Drosophila and non-polarised cell lines (Ben El Kadhi et al., 2011; Dambournet et 
al., 2011). It is not known whether OCRL1 similarly functions in renal cell 
cytokinesis, but should OCRL1 affect cytokinesis in polarised epithelial cells, 
polarisation might in turn be affected.  
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In addition to a possible role of OCRL1 in regulating polarised trafficking pathways, 
several of its interaction partners play crucial roles in polarised epithelial cell 
development such as the Rho GTPases Rac1 and Cdc42. Additionally, 
phosphoinositides regulate multiple processes in polarised cell types, particularly 
the substrate of OCRL1; PI(4,5)P2, which is expected to be elevated in Lowe 
Syndrome. The strongest evidence suggesting a role for OCRL1 in cell polarity was 
the finding that OCRL1 depletion disrupted lumen formation in MDCK cysts (Grieve 
et al., 2011), although the mechanism behind this remains unclear.  
 
Given the previous findings with OCRL1 outlined above, it is possible that OCRL1 
has a role in polarisation and that polarisation may be disrupted when OCRL1 is 
absent. This project studies the role of OCRL1 in the polarisation of cell lines derived 
from the kidney, which is the organ most affected in Lowe Syndrome as well as 
Dents-2 disease. Firstly, we detail the effects of OCRL1 loss on the appearance of 
epithelial monolayers in Chapter 3. Whether OCRL1 plays a role in polarised 
trafficking pathways is examined in Chapter 4 and chapter 5. Chapter 4 focuses on 
the localisation of polarity markers in cells allowed to fully mature without OCRL1. 
The emphasis of Chapter 5 is on the role of OCRL1 in the earliest stages of 
polarisation when an apical-basal polarity axis is established. Lastly, Chapter 6 
examines a role for OCRL1 in renal cell cytokinesis which is intricately linked to 
polarisation in this cell type. One possibility is that these aspects of renal tubular 
cell function are disrupted in Lowe Syndrome and Dents-2 disease, where loss of 
OCR1 causes selective renal proximal tubulopathy and eventually renal failure. 
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Chapter Two 
 
Materials and Methods 
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DNA methods 
 
Bacterial strains 
 
BL21 Escherichia coli (E. coli) competent bacteria were used for GST fusion protein 
expression. E. coli strain MC1061 was used for plasmid DNA amplification. 
Competent bacteria were stored at -80 οC.  
 
DNA Constructs 
 
GFP tagged human OCRL1 (wild-type, isoform b, 893 amino acids) and GFP-
OCRL1Δphosphatase Δ237–539) were a gift from Prof. Martin Lowe (University of 
Manchester Faculty of Life Sciences, UK). Human GFP-AKT-PH (1–167), and GFP-
Grp1-PH were a kind gift from Dr. Tamas Balla (National Institute of Health, 
Bethesda, USA). GFP-PLCδ-PH was prepared previously in our lab (Dr. Tim Levine, 
Institute of Ophthalmology, University College London, UK). Cdc42-GFP was a gift 
from Prof. Catherine Rabouille (Hubrecht Institute, Utrecht, Netherlands). GST-
zebrafish-OCRL1 and GST-human-OCRL1 were also gifts from Prof. Martin Lowe. 
GFP/EGFP plasmids were Kanamycin resistant and GST plasmids were Ampicillin 
resistant.  
 
Bacterial transformation 
 
Competent bacteria were thawed on ice. 10 ng plasmid DNA was incubated with 15 
µl MC1061 or 500 ng plasmid DNA was incubated with 30 µl BL21 on ice for 5 
minutes. Bacteria were heat shocked at 42 οC for 45 seconds and immediately put 
back on ice. 5x volume (75 µl for BL21, 150 µl for MC1061) of LB medium without 
antibiotics was added and the bacteria were incubated at 37 οC for 30 minutes. 
After resting at 37 οC the bacteria were diluted into 4 ml LB containing appropriate 
antibiotic (100 μg/ml Ampicillin or Kanamycin) and grown shaking at 30 οC 
(MC1061) or 37 οC (BL21) overnight. 
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Bacterial glycerol stocks 
 
For long term storage of transformed bacteria, overnight cultures were diluted in 
glycerol and stored at -80 οC. 0.5 ml of overnight culture was diluted in 0.5 ml 
sterile 50% (v/v) glycerol solution in a sterile eppendorf tube. To recover the 
bacteria a small amount of frozen culture was extracted with a sterile inoculating 
needle and added to LB medium containing appropriate antibiotic. Inoculated 
cultures were grown at 30 οC (MC1061) or 37 οC (BL21) overnight before DNA 
extraction.  
 
Plasmid DNA extraction 
 
2 ml overnight transformed bacterial cultures were pelleted by centrifugation at 
3000-4000 x g for 10 minutes. Plasmid DNA was extracted using QUIAGEN Spin 
Miniprep Kit according to manufacturer’s instructions. Briefly, bacterial cells were 
lysed by alkali and the lysate was applied to a silica column that selectively binds 
plasmid DNA. Contaminants were removed with wash buffers and the plasmid DNA 
was eluted with 40 µl of ddH2O. Concentration and purity of plasmid DNA samples 
were obtained with a Nanodrop (Thermo Fisher Scientific).  
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Protein methods 
 
SDS-PAGE 
 
Cell lysates were prepared for SDS-PAGE analysis by washing cells twice with 
Dulbecco’s phosphate buffered saline (PBS, Invitrogen) and then adding directly to 
the cells 2x sample buffer (4% SDS, 20% glycerol, 0.003% bromophenol blue, 0.125 
M Tris pH 6.8, 10 % β-mercaptoethanol and 1% Sigma protease inhibitor cocktail). 
200 µL sample buffer was added per well of cells on a 6 well plate. Cell lysates were 
heated at 95 °C for 2 minutes before loading. Resolving gels were 0.375 M Tris pH 
8.8, 10% Acrylamide/Bis-acrylamide, 0.1% SDS. Stacking gels were 0.125 M Tris pH 
6.8, 4% Acrylamide/Bis-acrylamide, 0.1% SDS. Gels were polymerised with 0.05% 
ammonium persulphate and 0.1% TEMED (tetramethylethylenediamine). Gels were 
run in 1 x SDS-PAGE buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) for 90 minutes 
at 150 V. 
  
Coomassie staining  
 
Following electrophoresis the protein gels were stained with coomassie blue (0.1% 
(w/v) coomassie blue, 20% (v/v) methanol, and 10% (v/v) acetic acid) and resolved 
with de-stain solution (50% (v/v) methanol in water with 10% (v/v) acetic acid).  
 
Electrophoretic transfer 
  
PVDF membrane (GE Healthcare) was pre-soaked in 100% methanol for 10 seconds 
and immersed in ddH2O. After SDS-PAGE, polyacrylamide gels and Whatman filter 
paper was soaked in transfer buffer (25 mM Tris, 250 mM glycine pH 8.3, 0.1% SDS, 
20% MeOH) for 10 minutes. Gels were transferred using a wet transfer apparatus 
(BioRad) assembled according to manufactures instructions. Transfer was at 300 
mA for 45 minutes at 4 °C.  
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Immunoblotting 
 
After electrophoretic transfer, PVDF membranes were blocked in PBST (PBS 0.05% 
Tween-20) containing 5% skimmed milk for 60 minutes at room temperature (RT) 
with agitation. Primary antibody incubations were for 2 hours at RT or overnight at 
4 °C diluted in blocking solution. The membrane was washed five times for 10 
minutes with PBST and then incubated with an appropriate HRP conjugated 
secondary antibody in blocking solution for 1 hour. After secondary antibody 
incubations, the membrane was washed again five times for 10 minutes each with 
PBST and then washed once with PBS for an additional 10 minutes. Protein bands 
were detected with Pierce ECL Western Blotting Substrate and Fuji x-ray film. 
 
Immunoprecipitations 
   
A confluent 15 cm plate of cells were washed three times with cold PBS and lysates 
were harvested by direct addition on ice of 3 ml extraction buffer to the plate (10 
mM Hepes pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.5% Na-deoxycholate, 0.2% 
SDS, Sigma protease inhibitor cocktail). The cells were scraped at 4 °C. 1 ml extract 
was incubated with protein G sepharose beads rotating for 30 minutes at 4 °C. 
Previously the beads were washed three times in extraction buffer and centrifuged 
at 7,500 x g. The pre-cleared lysates were added to immunobeads (1.5 μg of 
antibody conjugated overnight to protein G sepharose beads). Lysate was 
incubated with immunobeads for 2 hours at 4 °C. Beads were washed once with 
PBS containing 0.5% Triton-X100 followed by an additional wash with just PBS. The 
beads were suspended in 2x sample buffer and boiled before loading onto SDS-
PAGE gels or storing at -80 °C.  
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Expression of GST fusion proteins 
  
BL21 E. coli was transformed with pGEX vectors coding for the amino-terminal 
fragment of OCRL1 (1-237) tagged to GST or zebrafish GST-OCRL1 (1-297). 5 ml of 
overnight cultures of BL21 were diluted into 500 ml LB medium and 100 mg/ml 
ampicillin. Cultures were incubated at 37 °C for approximately 2 hours at 250 rpm 
until A600 reached 0.8-1.0 at which point 0.2 mM IPTG was added to induce protein 
expression. Cultures were placed at 30 °C at 250 rpm for 5 hours to allow protein 
expression. Bacteria were centrifuged at 7,500 x g for 15 minutes at 4 °C to pellet 
the cells which were re-suspended in 30 ml of cold NETN (0.5% NP-40, 20 mM Tris 
pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1 mg/ml lysozyme and Sigma 
protease inhibitor cocktail) and incubated on ice for 30 minutes. The DNA was 
sheared by sonication with a microprobe 5 x 10 seconds on ice. Insoluble cell debris 
was pelleted by centrifugation at 12000 x g for 20 minutes at 4 °C. Protein 
expression was checked by running the clarified supernatant on 10% 
polyacrylamide gels and stained with coomassie blue. If successful the supernatant 
was stored at -80 °C or immediately processed for purification.   
 
GST and GST-fusion protein column preparation 
 
30 ml total soluble protein prepared from bacteria expressing GST fusion proteins 
was incubated with 1.5 ml of 50% slurry of glutathione-sepharose beads (1:1 
suspension in NETN) for 2 hours on a rotor at 4 °C. The glutathione-sepharose 
beads were pre-equilibrated with NETN. The beads were washed twice with 0.1 M 
borate buffer pH 8.0, once each with 0.1 M borate buffer pH 9.0, and once with 0.2 
M borate buffer pH 9.0. The GST and GST fusion protein was cross-linked to the 
beads using 40 mM dimethypimelimidate (DMP) for one hour at 4 °C. Beads were 
again washed in 0.1 M borate buffer pH 8.0 before incubation with 40 mM 
ethanolamine in 0.1 M borate buffer pH 8.0 for 45 min at 4 °C. Additional washes 
were carried out once each with PBS, 0.2 M glycine-HCl (pH 2.5), 1 M K2HPO4 and 2 
final washes in PBS.   
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Affinity purification of anti-OCRL1 antibodies 
 
10 ml sheep serum raised against human GST-OCRL1 (1-237) was diluted 1:1 in PBS 
containing 0.2% Tween-20. The anti-GST antibodies in the serum were first 
removed by affinity purification using a GST column. The glutathione-sepharose 
beads cross-linked to GST were incubated with the serum for 2 hours at 4 °C. The 
beads were spun and the remaining serum was incubated with glutathione-
sepharose beads cross-linked to zebrafish GST-OCRL1 (1-297) overnight at 4 °C. The 
beads were placed in a 2 ml Biorad column and the flow through was allowed to 
pass. The beads in the column were washed with 120 ml of PBS containing 0.2% 
Tween-20, followed by 10 ml of just PBS. After washing, the antibody was eluted 
with 0.2 M glycine-HCl (pH 2.5) into eppendorf tubes already containing 1 M 
K2HPO4. This was repeated so that 10 fractions were collected. The fractions were 
run on a 10% acrylamide gel and stained with coomassie blue to identify which 
fraction the antibody was eluted in.  
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Mammalian cell culture 
 
Cell lines 
  
Madin-Darby canine kidney epithelial cells (MDCK) clone 2 and Caco-2 (human 
caucasian colon adenocarcinoma epithelial cells) were gifts from Prof. Karl Matter 
(Institute of Ophthalmology, University College London, UK). MDCK clone 2 cells 
stably expressing GFP-Gp135 (Meder et al., 2005) was a kind gift from Prof. Joachim 
Fullekrug (Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, 
Germany). The renal tubular cell line RCC4 stably transfected with wild-type pVHL 
was kindly provided by Prof. Patrick Maxwell (Division of Medicine, Rayne Institute, 
University College London, UK). The hTERT immortalised human renal tubular cell 
line NHPTK (Herbert et al., 2013) was a kind gift from Prof. Robert Bacallao 
(Department of Medicine, Indiana University School of Medicine, Indianapolis, 
USA). The transformed trabecular meshwork human cell lines NTM5 and GTM3 
were kind gifts from Prof. Ian Grierson (Eye and Vision Science, University of 
Liverpool, UK). LoweB fibroblasts were a kind gift from Prof. William O'Brien 
(Department of Molecular and Human Genetics, Baylor College of Medicine, 
Houston, USA).  
  
Growth conditions 
 
All cell lines were grown at 37 °C with 5% CO2. MDCK, Caco-2, GTM3, NTM5, and 
VHL+ RCC4 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, 
Invitrogen) containing 10% heat inactivated foetal bovine serum (FBS, Invitrogen). 
LoweB fibroblasts were cultured in DMEM medium containing 20% FBS. NHPTK 
cells were cultured in Lonza's REBM medium containing Lonza’s supplements for 
renal cells (bullet kit) and 10% FBS. All cell culture media was supplemented with 
100 μg/ml streptomycin and 100 μg/ml penicillin. 
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Passaging cells 
 
Prior to passaging MDCK, Caco-2, LoweB, NTM5, GTM3 and VHL+ RCC4 cell lines, 
the cells were washed once in calcium and magnesium free PBS (Invitrogen). NHPTK 
cells were washed in HDF buffer (8 g NaCl, 0.4 g KCl, 1 g Glucose 
Dextrose/monohydrate, 0.35 g NaHCO3 in 992 ml endotoxin free H2O). All cells 
were detached from the tissue culture flask with 0.25% Trypsin (w/v) in 0.5 mM 
EDTA (disodium ethylenediaminetetraacetic acid). Detached MDCK, Caco-2, NTM5, 
GTM3, LoweB and VHL+ RCC4 cells were split directly into appropriate medium 
without additional washing and centrifugation steps at a ratio of 1:6. Detached 
NHPTK cells were suspended in growth medium, pelleted by centrifugation and re-
suspended in fresh medium prior to plating at a ratio of 1:5.  
 
Freezing cells 
 
For storage, cells were grown to approximately 70% confluence, washed and 
trypsinised according to the passaging protocol. Once detached, cells were 
suspended in appropriate growth medium and transferred to a 15 ml sterile 
centrifuge tube. Cells were pelleted at 1000 rpm for 4 minutes and re-suspended in 
cold freezing medium (20% (v/v) dimethylsulphoxide (DMSO) in FBS). Freezing 
medium was added to trypsinised cells at 6x volume and the cells in freezing 
medium were aliquoted into 1 ml storage vials. Cells were frozen slowly, initially at -
20 °C for an hour, followed by -80 °C overnight before permanent storage in liquid 
nitrogen at -80 °C. For short term storage (several months) cells were maintained at 
-80 °C. 
 
Thawing cells 
 
Recovery of cells from frozen stocks was carried out as quickly as possible. Growth 
medium was pre-warmed to 37 °C in advance.  Vials of cells were taken from 
storage and immediately placed in a 37 °C water bath until approximately 80% had 
thawed.  The thawed cells were washed in growth medium and pelleted at 1000 
78 
  
rpm for 4 minutes to remove the DMSO. The cell pellet was re-suspended in fresh 
growth medium appropriate for the cell line and plated into tissue culture flasks.  
 
Calcium switch assay 
 
Cells were grown in appropriate medium for the cell line (see growth conditions). At 
approximately 80% confluence the cells were washed and trypsinised according to 
the passaging cells protocol. Detached cells were diluted in pre-warmed calcium 
free DMEM (Invitrogen) containing 10% FBS in a 15 ml centrifuge tube. The cells 
were spun down at 1000 rpm for 5 minutes and washed for a second time by re-
suspending the cell pellet in calcium free DMEM and centrifuging again at 1000 rpm 
for 5 minutes. After washing, the cells were re-suspended in calcium free DMEM 
containing 10% FBS and re-plated in a 6 well plate containing glass coverslips and 
incubated at 37 οC 5% CO2 overnight. To carry out the switch, cells were washed 
twice in PBS and incubated with pre-warmed complete DMEM (containing normal 
high calcium content) and 10% FBS. Cells were fixed and observed at various time 
points after calcium recovery. 
 
Apoptosis assay 
 
Cells were grown on 13 mm coverslips in 24 well plates to approximately 60% 
confluence. As a positive contol for apoptosis, a control group of cells were treated 
with 1 μM staurosporine (Invitrogen) in the extracellular growth medium for 2 
hours before analysis. To detect apopotic bodies the cells were incubated with a 
number of fluorescent stains in the extracellular growth medium for 1 hour prior to 
analysis. The membrane permeable DNA marker Hoechst 33342 (final 
concentration of 1 μg/ml) labels live cells. Propidium iodide (final concentration of 2 
μg/ml) labels necrotic cells. YO-PRO-1 idodide dye (Molecular probes, Invitrogen) 
was used at 1/1000 and labels specifically apoptotic cells. Samples were fixed in 3% 
PFA but not permeabilised.  
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Plasmid DNA transfection with JetPEI 
 
This protocol was carried out for experiments in Chapter 3 (3.9-3.10) and Chapter 4 
(4.9-4.11) because cells were grown over the course of 5 days and therefore siRNA 
and DNA transfection could be carried out separately. Cells were transfected with 
DNA 24 hours after the second siRNA dose (section ‘siRNA transfection with 
Oligofectamine’) when they were approximately 70% confluent. For cells in figure 
3.1 which were wild type and untreated with siRNA, the cells were transfected with 
plasmid after 3 days growth at approximately 70% confluence. To prepare the 
transfection mix, 0.4 µg of plasmid DNA was add to 150 µl of sterile NaCl JetPEI 
buffer (polyplus transfection), vortexed and spun down. In a separate tube 4 µl of 
JetPEI reagent (polyplus transfection) was diluted in 150 µl of sterile NaCl JetPEI 
buffer, vortexed and spun down. After resting for 5 minutes, the JetPEI reagent 
solution was added to the DNA solution to give a final transfection mix of 300 µl. 
After 20 minutes of additional resting, the transfection mix was added drop wise to 
cells containing 1.5 ml of appropriate growth medium for the cell line containing 
antibiotic. 
 
siRNA transfection with Oligofectamine 
 
Cells in all experiments were grown on 22 mm square coverslips in 6-well plates in 
appropriate medium containing antibiotic (see growth conditions). The siRNA 
protocol used varied depending on the stage of cell growth when treating with 
siRNA.  
 
Cells growing as monolayers (Chapter 3 and Chapter 4) were treated twice with 
siRNA over the course of 4-5 days growth. In this protocol, cells were plated at 
approximately 20% confluence on day 1. On day 2 cells were treated with one dose 
of siRNA at approximately 40% confluence and again on day 3 at approximately 
60% confluence. Cells were allowed to rest until fixing on day 4 or 5, 48 hours or 72 
hours post the first siRNA treatment respectively. Whether cells were fixed at 48 
hours or 72 hours is indicated in the figure legends.  
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When cells were treated with siRNA and subsequently transfected with a plasmid, a 
modified version of this siRNA protocol was carried out to allow time for DNA 
transfection before becoming fully confluent. This protocol was performed in the 
experiments for Figures 3.10, 4.9, 4.10, 4.11. For this protocol, cells were plated on 
the morning of day 1 and treated to the first dose of siRNA 8 hours later on the 
same day, when they had reached approximately 30% confluence. The cells were 
treated again to a second dose of siRNA 24 hours later at approximately 50% 
confluence on day 2 and transfected with plasmid DNA separately 24 hours later on 
day 3. Cells were allowed to rest and fixed on day 4 or 5, 48 hours or 72 hours after 
the second dose of siRNA.   
 
For RNAi treatment of cells plated at very low confluence (Chapter 5 and 6), the 
cells were plated onto coverslips for just a few hours before treatment with one 
dose of siRNA. In this protocol, cells were trypsinised well and pipetted gently to 
discourage cell clumping prior to plating. Cells were plated for 4 hours, treated once 
with siRNA and analysed 17-24 hours later.  
 
In all protocols using MDCK cells, the cells were treated with a mix of 4 canine 
specific OCRL1 siRNA sequences. All protocols using human cell lines were treated 
with a mix of 2 human specific OCRL1 siRNA sequences and control cells were 
treated with non-targeting control siRNA. All siRNA was purchased from Invitrogen 
and the sequences are listed below in the section: siRNA sequences.  
 
For both single and double siRNA transfections, the following method was used to 
prepare the siRNA for transfection. The siRNA was diluted into 175 µl of serum free 
Opti-MEM (Invitrogen) in a 1.5 ml tube so that the final concentration of siRNA was 
120 nM (6 µl of a 20 µM stock). In a separate tube, 5 µl Oligofectamine transfection 
reagent (Invitrogen) was diluted into 15 µl serum free Opti-MEM. After 5 minutes 
incubating at room temperature the oligofectamine solution was gently mixed with 
the siRNA solution and incubated for an additional 20 minutes at room 
temperature. The cells were washed twice in PBS to remove antibiotics and plated 
in 800 µl of appropriate growth medium without antibiotics. The final siRNA: 
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Oligofectamine solution of 200 µl was added drop wise to a single well of a 6 well 
plate and mixed gently before returning to the incubator for 24 hours.   
 
siRNA transfection with INTERFERin 
   
INTERFERin transfection reagent was used for human cell lines, because 
Oligofectamine appeared toxic and resulted in cell death (data not shown). 
Therefore this protocol was used for Figures 3.11, 3.12, 3.13, 3.14, 5.24 and 5.24. 
Cells were plated on 22 mm glass coverslips in a 6 well plate and cultured to 
approximately 50% confluence, taking approximately 1-3 days depending on the 
cell line (indicated in figure legend). At 50% confluence, human siRNA was 
transfected with INTERFERin (Polyplus transfection). siRNA was diluted in 150 µl 
serum free Opti-MEM so that the final concentration was 40 nM (3 µl of a 20 µM 
stock) and incubated for 5 minutes. INTERFERin was vortexed and 2 µl was added to 
the siRNA solution and the mixture was left to rest for 10 minutes at room 
temperature. Cells were washed once in PBS and replaced with 1.35 ml appropriate 
medium containing antibiotics. The RNAi transfection mix was added drop wise to 
the cells, gently mixed and the cells were returned to the humidified chamber for a 
further 48 hours. The medium was replaced after 24 hours.  
  
Plasmid DNA and siRNA co-transfection 
 
This protocol was used in chapter 5 (Figures 5.18-5.23) where cells were only 
depleted of OCRL1 for less than 24 hours. Separate transfection of siRNA and 
plasmid in the course of 24 hours was toxic. For this protocol, cells were plated on 
22 mm glass coverslips in a 6 well plate and cultured to approximately 60% 
confluence. Co-transfection of siRNA with plasmid DNA was carried out using 
JetPRIME reagent (Polyplus transfection). The siRNA was diluted in 150 µl JetPRIME 
buffer so that the final concentration was 50 nM (2.5 µl of a 20 µM stock), 2 µg of 
plasmid DNA in ddH20 was added to the siRNA mix, vortexed, spun down and 
incubated for 5 minutes. After resting, 4 µl of JetPRIME reagent was added to the 
siRNA/DNA mix, vortexed, spun down and incubated for a further 15 minutes at 
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room temperature. The cells were washed once with PBS before adding 850 µl of 
appropriate growth medium for the cell line containing antibiotic. The transfection 
mix was added drop wise to the cells, 8 hours later it was washed off and the 
growth medium was replaced.  
  
siRNA sequences 
 
Canine OCRL1 
CUUUCCGAUACCUCCGUUCUU 
GCUUAUUAGUCUUCAUCACUU 
UUUGAUGAGACCCUCCCGCUU 
UUUGAUGAGACCCUCCCGCUU 
Human OCRL1 
UUUGAUGAGACCCUCCCGCUU 
CUUUCCGGUACCUUCGUUCUU 
 
 
Primary antibodies 
 
Mouse anti-Ezrin, rabbit anti-Par6β, mouse anti-aPKCζ, goat anti-scribble (Santa 
Cruz Biotechnology, Inc.), rabbit anti-Par3 (EMD Millipore) and rabbit anti–ZO-1 
(antigen: the peptide N-YTDQELDETLNDEVC-C) described previously (Benais-Pont et 
al., 2003) were all kind gifts from Prof. Karl Matter (Institute of Ophthalmology, 
University College London, UK). Polyclonal anti-OCRL1 antibody used for 
immunoblotting was a gift from Prof. Robert Nussbaum (Department of Medicine, 
UCSF, San Francisco, USA), described previously (Olivos-Glander et al. 1995). 
Affinity-purified rabbit antibodies to annexin-2 (Gerke and Weber, 1984) and 
mouse monoclonal anti-α-tubulin (Sigma) were gifts from Prof. Stephen Moss 
(Institute of Ophthalmology, University College London, UK). Rabbit polyclonal anti-
Rab11a (Zymed) was a gift from Prof. Clare Futter (Institute of Ophthalmology, 
University College London, UK). Mouse anti-Gp135 secreted from hybridoma cell 
line 3F2 (Ojakian and Schwimmer, 1988) was a kind gift from Prof. George Ojakian 
(State University of New York Downstate Medical Center, Brooklyn, NY). Rat anti-
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(CI)-M6PR (Reaves et al., 1996) and rabbit anti-Rab8a (Sigma) were kind gifts from 
Prof. Paul Luzio (Cambridge Institute for Medical Research, University of 
Cambridge, UK).  Primary antibodies were diluted in PBS to a concentration of 1–5.0 
µg/ml. 
 
Immunostaining 
  
For immunostaining the cells were either fixed with PFA or methanol. Methanol 
was only used when staining the microtubules, to better preserve the structures. 
Therefore methanol fixation was used in all microscopy figures in Chapter 6 and 
Figure 4.12. For PFA fixation, cells were washed once in PBS and fixed in 3% PFA 
(w/v) in PBS at room temperature for 30 minutes. Cells were permeabilised with 
0.5% Triton X-100 in PBS for 2 minutes. For methanol fixation, cells were washed 
quickly in PBS and incubated with cold methanol on ice for 2 minutes. After fixation 
with both PFA and methanol, the cells were washed 5 times in PBS for 5 minutes. 
Primary antibodies were incubated with the cells in PBS either overnight at 4 °C or 
at room temperature for 2 hours. Primary antibodies were washed off the cells 5 x 
5 minutes each with PBS. Secondary antibodies conjugated to FITC, TRITC or Cy3 
(Molecular probes Alexafluor, Invitrogen) were incubated with the cells in PBS 
(1/2000) for 45 minutes. When DAPI or phalloidin was used, they were diluted 
according to manufacturers protocols (1/2000 for phalloidin and 1/5000 for DAPI) 
into the secondary antibody mix and incubated with cells at the same time. The 
cells were washed 5 x 5 minutes in PBS before mounting in vectashield (Vector 
Laboratories, Inc) on glass cover slides for imaging. Confocal images were acquired 
with an SP2 confocal microscope (Leica) using Apochromat 63×/1.4 immersion oil 
objectives. Immersion oil (Carl Zeiss) was used for all objectives.  
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Live cell imaging  
 
Cells from Figures 5.6 and 5.18 were imaged live on a Leica confocal microscopy 
system pre-warmed to 37 °C. Cells were plated on 35 mm glass bottom MaTek 
dishes and imaged directly from the dish. Prior to imaging the cells were replaced 
with phenol free medium (Leibniz) containing 10% FBS and antibiotics.  
 
Fluorescence recovery after photobleaching (FRAP) 
 
FRAP experiments (Figure 5.6) were performed on transfected cells plated into 35 
mm glass bottom MaTek dishes in phenol free medium. The Leica confocal 
microscopy system was pre-warmed to 37 °C prior to analysis. The pinhole size was 
set to maximum AU units to allow for large confocal sections to be imaged. Laser 
light was set to a low intensity for image recording to minimise background 
bleaching and high intensity for bleaching the flourophore. Specific regions of 
interested were selected for bleaching using the Leica software. Images were 
recorded pre-beaching, immediately post bleaching and every 2.5 minutes from 
then on. The images were aligned in ImageJ to account for movements in the plane 
using the StackReg plugin. Signal Intensity values for the regions of interest was 
calculated in ImageJ. Values were normalised against background fluorescence 
intensity.  
 
Image editing 
 
Microscopy images were adjusted for brightness and contrast with Adobe 
Photoshop. Stacks were compressed and XZ images were reconstructed using 
ImageJ. 3D reconstructions of stacks were created using ImageJ 3D Viewer. 
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Statistical analysis 
 
T-test  
 
T-tests on group means were carried out in Excel. Each group of data was first 
plotted in S+ (TIBCO) to check for normal distribution. The equality of the variances 
between compared groups was tested with a Fisher test in S+. Where variances 
were statistically different a Welch modified T-test was done in Excel. T-tests were 
carried out in S+ on linear regressions to confirm the gradients were statistically 
different from 0.  
 
ANOVA  
  
One-way ANOVA was performed to test whether multiple means were equal. This 
test was carried out in S+.  
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Chapter Three 
 
OCRL1 is involved in the maturation 
of epithelial cells 
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Overview 
  
Some of the symptoms of Lowe Syndrome manifest in polarised cells of the lens 
and kidney epithelium. Cells in an epithelium grow as a single layer and adhere to 
each other strongly through multiple junctions including adherens junctions, tight 
junctions and desmosomes. Another feature of the epithelium is the uniformity of 
cell size and shape, for example the simple epithelium of the kidney consists of 
sheets of cells which are tall and columnar in shape. Isolated epithelial cells are 
relatively flat, but upon initiating cell-cell contacts the sheet grows in height by 
extension of the lateral domain. Spatial control of the actin cytoskeleton in these 
cells is crucial for proper morphogenesis of the epithelium. In addition, formation of 
apical and basolateral domains relies on vesicular transport of domain specific 
cargo to the plasma membrane. Given the cell types most affected in Lowe 
Syndrome and the potential for OCRL1 to regulate actin dynamics or trafficking in 
polarised epithelial cells, OCRL1 could be involved in some aspect of epithelial 
maturation.  
 
This chapter is a continuation of a previous doctoral project investigating the 
localisation and function of OCRL1 in polarised epithelial cell lines (Grieve et al., 
2011). Most of the previous work was carried out in intestinal epithelial cells (Caco-
2), derived from a human colonic adenocarcinoma. In addition, some results were 
reproduced in the renal MDCK cell line. In both Caco-2 and MDCK cells, OCRL1 was 
shown to target intercellular junctions, co-localising with the tight junction protein 
ZO-1 (Grieve et al., 2011). In addition, this work implicated OCRL1 to function in 
some aspect of epithelial maturation since monolayers of Caco-2 and MDCK cells 
depleted of the protein were flatter than normal (Grieve et al., 2011).  
 
Firstly, this chapter reproduces the finding that OCRL1 targets intercellular 
junctions and then confirms that OCRL1 is required for maturation in a similar 
manner shown previously, in addition to accurately measuring the effect. In this 
chapter, we also investigate possible explanations for these findings and reveal the 
role of OCRL1 in epithelial development may extend to human renal cells and cells 
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derived from the trabecular meshwork of the lens, which is also affected by Lowe 
Syndrome. 
 
 
OCRL1 targets intercellular junctions in MDCK cells 
  
OCRL1 has been shown by numerous studies to localise to the Golgi apparatus and 
endosomes in non-polarised cells (Choudhury et al., 2005; Noakes et al., 2011; 
Swan et al., 2010; Vicinanza et al., 2011). Previous work in several polarised 
epithelial cell lines found a small pool of OCRL1 targeted primordial junctions 
(Grieve et al., 2011). Here, expression of OCRL1 tagged with green fluorescent 
protein (GFP) in MDCK cells showed OCRL1 to localise to the Golgi apparatus, 
numerous intracellular vesicles and the plasma membrane, marked by the tight 
junction marker ZO-1 (figure 3.1). XZ images suggested OCRL1 localised to the 
region of the plasma membrane engaged in intercellular junctions (data not 
shown).  
 
The localisation of overexpressed recombinant OCRL1 might not reflect the 
localisation of the endogenous protein. To detect endogenous OCRL1, sheep 
antibodies raised against human-OCRL1 antibodies were purified with zebrafish-
OCRL1 to reduce affinity of binding and enable efficient elution of the most useful 
antibodies from the column. These antibodies also detected a population of OCRL1 
at intercellular junctions (figure 3.2), as shown with other antibodies previously 
which were no longer available (Grieve et al., 2011). The specificity of the antibody 
was confirmed in cells depleted of OCRL1 with silencing oligonucleotides (siRNA), 
which showed that both the junctional staining and the Golgi apparatus staining 
were dependent on the presence of the protein (figure 3.2). There was also a small 
amount of nuclear staining with the OCRL1 antibody which was likely to be non-
specific as it was not lost when OCRL1 was depleted.  
 
Previously, OCRL1 depletion did not affect the appearance of the tight junction 
(Grieve et al., 2011). However, when we repeated the RNAi experiment, the 
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localisation of ZO-1 no longer appeared normal. Here, the junctional bands of ZO-1 
appeared to be thinner than controls and non-continuous in the absence of OCRL1 
(figure 3.2). In addition, the broken appearance of the junctions in OCRL1 depleted 
cells was accompanied by a larger vesicular pool of ZO-1 (figure 3.2), which was not 
reported previously (Grieve et al., 2011). These differences may be explained by the 
use of different antibodies and optimisation of the levels of OCRL1 depletion in 
recent studies compared to previous studies.  
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Figure 3.1: GFP-OCRL1 partially localises to junctions in MDCK cells. MDCK cells 
were grown for 3 days and were transfected with GFP-OCRL1 DNA at 60% 
confluence. 24 hours after transfection the cells were fixed and permeabilised for 
immunostaining with antibodies to the tight junction protein ZO-1. Representative 
images are shown from 3 experiments. White arrows indicate sites where GFP-
OCRL1 (green) co-localised with ZO-1 (red). Single confocal sections are shown. 
Scale bar 10 μM.  
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Figure 3.2: Endogenous OCRL1 partially localises to the tight junction. MDCK cells 
were grown overnight. At 40% and 60% confluence cells were transfected with non‐
targeting control or a pool of canine specific OCRL1 siRNA. After 48 hours, the cells 
were fixed and permeabilised for immunostaining with antibodies to the tight 
junction protein ZO-1 (red) and OCRL1 (green). Representative images are shown 
from 1 of 3 experiments. White arrows indicate sites where ZO-1 and OCRL1 co-
localise which is absent from OCRL1 depleted cells. Single confocal sections are 
shown. Scale bar 10 μM.  
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OCRL1 forms a complex with tight junction protein ZO-1  
 
The apparent co-localisation of OCRL1 with ZO-1 by immunofluorescence indicates 
a potential interaction. Supporting this possibility, it was previously shown that 
immunoprecipitates of OCRL1 complexes were positive for ZO-1 (Grieve et al., 
2011). To confirm this interaction, we repeated the immunoprecipitation 
experiments in reverse, not carried out previously. Immunoprecipitated complexes 
of ZO-1 contained OCRL1 (figure 3.3), further suggesting that they exist in the same 
complex at the tight junction. 
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Figure 3.3: OCRL1 interacts with the tight junction ZO-1 complex. MDCK cells were 
grown on 10 cm dishes. LoweB fibroblasts were grown in a 6 well plate. Cell lysates 
were collected at 70% confluence. MDCK lysate was pre-cleared with negative 
beads before incubating overnight with protein G-sepharose beads linked to either 
ZO-1 or normal rabbit immunoglobulin (rIg). The precipitated proteins (Lanes 3, 4, 
5) and MDCK input lysate (Lane 1) were run on SDS-PAGE gels and probed for 
OCRL1 (Lanes 1, 3, 4) and ZO-1 (Lane 5). LoweB fibroblasts from a patient with Lowe 
Syndrome lacking OCRL1 provided a negative control for OCRL1 immunoblotting 
(Lane 2). Arrows indicate OCRL1 (105kDa) and ZO-1 (220kDa). 
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OCRL1 is required for maturation of MDCK monolayers  
 
Having reproduced the junctional localisation of OCRL1 in MDCK cells, we next 
investigated a role for OCRL1 in maturation. By using the filamentous actin (F-actin) 
stain phalloidin as a peripheral marker, MDCK cell monolayers were shown to be 
flatter when depleted of OCRL1 by RNA interference than control cell monolayers 
(figure 3.4A). In addition, we used the position of the tight junctions, normally 
localised apically, as a measure of cell height (figure 3.4B). The height of the tight 
Junction marker ZO-1 above the basal domain was reduced in OCRL1 depleted cells 
compared to control cells (figure 3.4B), further indicating inhibition of epithelial 
maturation in the absence of OCRL1. As well as appearing flatter, cells depleted of 
OCRL1 had a larger cross-sectional area compared to control cells (x1.67 ± 0.11 
SEM), suggesting overall cell volume might be unaffected by loss of OCRL1 because 
a loss in cell height vertically was accompanied by an increased growth laterally 
(figure 3.5). MDCK cells grow as densely packed sheets, therefore in agreement 
with OCRL1 depleted cells having a larger cross-sectional area, there were less of 
these cells on the coverslip (figure 3.6). These findings suggest that OCRL1 
depletion results in fewer cells that are flatter than controls.  
 
OCRL1 depletion appears to reduce cell number, which could be due to increased 
levels of cell death or reduced proliferation rates, which was not investigated 
previously. To check for increased levels of cell death during OCRL1 RNAi 
experiments, OCRL1 depleted cells were stained with a combination of Hoechst 
33342 (live cells), propidium iodide (necrotic cells) and YO-PRO-1 (apoptotic cells) at 
a number of time points after RNAi treatment. For comparison, some cells were 
treated with staurosporine instead of siRNA. The kinase inhibitor staurosporine 
induces apoptosis and was therefore used as a positive control. No excessive 
apoptosis was observed for up to 72 hours post RNAi compared to cells treated 
with staurosporine. The highest level of apoptosis was observed 48 hours post RNAi 
where 0.04% ± 0.0005 SEM of total cells treated with OCRL1 siRNA were apoptotic 
compared to 0.02% ± 0.001 SEM of cells treated with non-targeting control siRNA. 
Although significant (p=0.004, n=3, students T-test), the slightly elevated level of 
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apoptosis in OCRL1 depleted cells does not explain the 48% average reduction of 
cell number upon OCRL1 depletion compared to controls (figure 3.6). The reduced 
number of OCRL1 depleted cells appeared to be due to less cell division events 
(figure 3.8). Total cell number was counted regularly over the course of the RNAi 
assay. OCRL1 depleted cells continued to grow more slowly than control cells even 
when the cell number was normalised to control levels by re-plating both at a lower 
cell density (figure 3.8). Therefore MDCK cells continued to grow more slowly 
without OCRL1.  
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Figure 3.4: Depletion of OCRL1 reduces the height of MDCK monolayers. MDCK 
cells were grown overnight and treated with siRNA as in figure 3.2. After 48 hours, 
the cells were fixed and permeabilised for staining. A: Cells were stained with Cy5-
phalloidin to identify filamentous actin (blue). B: Cells were immunostained with 
antibodies to the tight junction protein ZO-1 (red). Panels from A and B do not 
represent the same cells. XZ sections were reconstructed from Z-stacks containing 
30 confocal sections spanning from the bottom to the top of the cell layer. 
Experiment was repeated twice and multiple XZ reconstructions were taken from 
each experiment (n=3). Scale bar 10 μM. 
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Figure 3.5: Depletion of OCRL1 increases cross sectional cell area. MDCK cells were 
grown overnight and treated with siRNA as in figure 3.2. After 48 hours, the cells 
were fixed, permeabilised and stained for the actin stain phalloidin as a peripheral 
cell marker and the DNA stain DAPI. Single confocal sections of the middle of the 
cell layer were taken across 6 different RNAi experiments. Approximate cell cross 
sectional area in each confocal section was calculated using the cell number and 
known dimensions of the frame. Using these two paramters it is posssible to 
estimate average cross sectional area per cell due to the intercellular contacts 
formed between MDCK cells and therefore tight packing of MDCK monolayers.  
Plotted is the mean and SEM. P=0.001 (students T-test). 
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Figure 3.6: Depletion of OCRL1 reduces cell number. MDCK cells were grown 
overnight and treated with siRNA as in figure 3.2. After 48 hours, the cells were 
fixed, permeabilised and stained for the DNA stain DAPI. Single confocal sections of 
the middle of the cell layer were taken across 5 different RNAi experiments. 
Representative images are shown. The cell number in each frame was determined 
by the number of nuclei. There was an average of 187 ± 8 SEM cells in each frame 
treated with control siRNA compared to 97 ± 6 SEM in each frame of cells treated 
with OCRL1 siRNA (p=8x10-9, students T-test). Scale bar 20 μM. 
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Figure 3.7: Depletion of OCRL1 does not induce significant apoptosis. MDCK cells 
were grown overnight and treated with siRNA as in figure 3.2. Cells were fixed at 0, 
8, 24, 48 and 72 hours post RNAi treatment. For 1 hour before fixing the cells were 
incubated with a combination of Hoechst 33342 (live cells), propidium iodide 
(necrotic cells) and YO-PRO-1 (apoptotic cells) in the medium. Only Hoechst 33342 
(blue) and YO-PRO-1 (green) are shown. In addition some MDCK cells were treated 
with 1 μM staurosporine for 2 hours as a positive control for apoptosis. 
Representative single confocal sections are shown of cells treated with siRNA for 48 
hours from one set of three experiments. White arrows point to apoptotic cells. 
Scale bar 40 μM. 
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Figure 3.8: Depletion of OCRL1 reduces proliferation rate. Equal numbers of MDCK 
cells were plated at low density into the wells of a 24 well plate. At 48 and 72 hours 
the cells were treated with either non‐targeting control siRNA or a pool of OCRL1 
siRNA. Every 24 hours the cells were trypsinised and counted in a haemocytometer. 
Cell viability was confirmed by staining with trypan blue. At 96 hours in culture the 
cells were trypsinised and re-plated at a lower cell density. In this experiment the 
same number of cells from each sample was re-plated at low density and the 
proliferation rate was followed as before (inset graph). Results plotted are from a 
representative of 3 experiments.  
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The enzymatic activity of OCRL1 is required for maturation of MDCK 
monolayers 
 
The results above suggest OCRL1 depletion may limit cell height, therefore we 
tested the effect of excess OCRL1 on cell height by expression of GFP-OCRL1 in 
untreated MDCK cells that still had endogenous OCRL1 (figure 3.9). Untreated 
MDCK cells over-expressing GFP-OCRL1 were slightly taller than cells expressing 
GFP alone (11.8 µm ± 0.32 SEM compared to 10.53 µm ± 0.17 SEM, n=50, p=0.001), 
suggesting OCRL1 has the capacity to induce expansion. The specificity of the effect 
on cell height with modulation of OCRL1 levels was further assessed by a series of 
rescue experiments. To carry out these experiments, the endogenous protein was 
first depleted with canine specific siRNA followed by reintroduction of OCRL1 by 
expression of human GFP-OCRL1. OCRL1 depleted cells re-expressing OCRL1 had 
cell heights comparable to normal levels (11.0 µm ± 0.27 SEM compared to 10.9 µm 
± 0.16 SEM, n=50, p=0.88), suggesting re-expression of OCRL1 can rescue the loss of 
cell height caused by depletion of the endogenous protein. However a human GFP-
OCRL1 construct lacking the 5-phosphatase domain caused no gain of cell height 
when re-expressed in OCRL1 depleted cells (8.8 µm ± 0.2 SEM compared to 10.93 
µm ± 0.16 SEM, p<0.001). In addition, OCRL1 depleted cells re-expressing 
phosphatase null OCRL1 had cell heights comparable to OCRL1 depleted cells 
without re-expression (figure 3.4), further suggesting this construct was unable to 
induce any gain of height. These results suggest the enzyme activity of OCRL1 is 
required for maturation of MDCK cell monolayers. 
 
The results of the rescue experiment can be seen in XZ sections taken of cells on the 
coverslips (figure 3.10). These images show OCRL1 depleted cells neighbouring cells 
re-expressing the full length protein or the null phosphatase mutant. The GFP 
positive cells re-expressing full length OCRL1 extend several microns above the 
height of the surrounding OCRL1 depleted monolayer (figure 3.10). In contrast, the 
GFP positive cells re-expressing the null phosphatase mutant have heights 
comparable to their OCRL1 depleted neighbours (figure 3.10). Additionally, when 
two neighbouring cells both re-expressed full length OCRL1, the tight junction 
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marker ZO-1 appeared several microns higher than in un-transfected neighbours, 
however this was not seen in cells expressing phosphatase null OCRL1 (figure 3.10). 
Similar observations were made previously (Grieve PhD, 2009), but the results here 
carry them further with accurate measurement of the effect in a large number of 
cells (250 cells per experiment, n=3). In addition, an effect of excess OCRL1 in wild-
type MDCK cells was also observed (figure 3.9), which was not assessed previously.  
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Figure 3.9: Quantification of the recovery of cell height when full length OCRL1 
was expressed in OCRL1 depleted cells. MDCK cells were grown overnight. At 30% 
and 50% confluence, cells were treated with either non‐targeting control siRNA or a 
pool of OCRL1 siRNA. Some samples were left untreated with siRNA (column 1, 5). 
At 70% confluence the cells were transfected with either empty vector (GFP), GFP-
Δphosphatase-OCRL1 DNA (GFP-Δpase), or GFP-OCRL1 and grown for a further 24 
hours. Cells were fixed and stained for F-actin as in figure 3.4. Z-stacks of 50 
transfected cells per treatment were used to measure cell height. Plotted are the 
means (black line), upper and lower quartiles (white) and the range (dashed line). 
Results shown are from a representative of 3 data sets. * indicates p<0.01 and ** 
indicates p<0.001 (students T-test). 
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Figure 3.10: The cell height lost in OCRL1 depleted cells can be recovered by 
expression of full length OCRL1. MDCK cells were grown, transfected with siRNA 
and plasmid DNA as in figure 3.9. Cells were transfected with either GFP-OCRL1 
DNA or GFP-∆phosphatase-OCRL1 DNA. After 24 hours the cells were fixed and 
permeabilised for staining. A: Cells were immunostained with antibodies to the 
tight junction protein ZO-1 (red). B: Cells were stained for F-actin with Cy5-
phalloidin (blue). Panels in A and B do not represent the same cells. XZ sections 
were reconstructed from Z-stacks containing 40 confocal sections spanning from 
the bottom to the top of the cell layer. Experiment was repeated twice. Scale bar 10 
μM. 
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OCRL1 is required for the development of other cell lines 
 
The canine origin of MDCK cells limits any extension of the findings to human 
disease. Therefore, the affect of OCRL1 loss on cell shape was assessed in a hTERT 
immortalised human renal cell line NHPTK (Herbert et al., 2012), obtained from 
Prof. Robert Bacallao (Department of Medicine, Indiana University School of 
Medicine, Indianapolis, USA). These cells have not been used to study OCRL1 
previously, so we first carried out immunofluorescence staining of OCRL1 to assess 
the localisation pattern. In human renal cells, OCRL1 localised to the Golgi 
apparatus and intracellular vesicles but no peripheral localisation of OCRL1 was 
apparent (figure 3.11), suggesting junctional recruitment of OCRL1 is specific to 
MDCK and Caco-2 cells. We used the same RNAi protocol for the human renal cell 
line as we used previously for the MDCK cell line, however the human cells took 
longer to mature and reach full confluence in culture compared to MDCK cells. 
Therefore, at the time of analysis, after 5 days of growth, the human renal cells 
were still sub-confluent and may not have completed junction formation. However, 
by immunofluorescence, we were able to confirm that OCRL1 could be depleted 
from the human renal cell line, the Golgi apparatus and vesicular staining seen with 
OCRL1 antibodies was lost when cells were treated with human specific OCRL1 
siRNA (figure 3.11). 
  
The human renal cells formed a tightly packed monolayer of columnar shaped cells 
after 8 days in culture, cell boundaries were visualised using the F-actin stain 
phalloidin (figure 3.12). We next tested whether OCRL1 depletion affected cell 
shape in a similar manner to MDCK cells. Monolayers of human renal cells treated 
with OCRL1 siRNA appeared less mature and failed to columnarise (figure 3.12). 
However, staining for F-actin revealed severe disruptions to monolayers of human 
renal cells not seen in MDCK cells. Instead of forming tight cell-cell and cell-ECM 
contacts, these interactions appeared perturbed (figure 3.12). Human renal cells 
depleted of OCRL1 formed large plasma membrane folds rich in F-actin where tight 
lateral contacts are normally made (figure 3.12), suggesting that OCRL1 might 
facilitate adhesive interactions in this cell line. 
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We next carried out similar experiments on a transformed human trabecular 
meshwork cell line. The trabecular meshwork is responsible for draining the 
aqueous humor from the eye, which may be disrupted in Glaucoma (Tektas and 
Lutjen-Drecoll, 2009). We obtained non-glaucomatous trabecular meshwork cells 
(NTM5) and glaucomatous (GTM3) cells from Prof. Ian Grierson (Eye and Vision 
Science, University of Liverpool, UK). In NTM5 cells, OCRL1 localised to the Golgi 
apparatus and vesicular pools (figure 3.13) and similar results were found for the 
GTM3 cell line (data not shown). OCRL1 could be depleted from this cell line, as 
shown by the loss of immunofluorescence staining with OCRL1 antibodies when 
cells were treated with a pool of human specific siRNA (figure 3.13). Staining with F-
actin revealed that loss of OCRL1 appeared to have an effect on NTM5 cells, there 
were fewer cells that were not columnar-shaped like controls (figure 3.13). These 
results suggest that OCRL1 functions in multiple cell lines to promote shape change 
during columnar maturation.  
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Figure 3.11: OCRL1 can be depleted from a human renal cell line. NHPTK cells were 
grown overnight. Cells were transfected with non‐targeting control or a pool of 
human specific OCRL1 siRNA on the second and third day in culture and fixed 48 
hours later. Cells were fixed and permeabilised for immunostaining with antibodies 
to OCRL1 (red) and stained with the DNA stain DAPI (blue). Single confocal sections 
are shown. Images shown are from a single experiment. White arrows indicate 
Golgi apparatus localisation of OCRL1. Scale bar 10 μM. 
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Figure 3.12: OCRL1 depletion disrupted the morphology of human renal cell 
monolayers. On the third and fourth day of culture, NHPTK cells were transfected 
with non‐targeting control or a pool of human specific OCRL1 siRNA. After a total of 
8 days in culture, the cells were fixed and permeabilised to stain for F-actin with 
phalloidin (green) the DNA stain DAPI (blue). XZ sections were reconstructed from Z-
stacks containing 30 confocal sections spanning from the bottom to the top of the 
cell layer. Two XZ images from different regions on the coverslip are shown per 
treatment (panels A and B) from 2 experiments. White arrows indicate abnormal 
adhesions. Scale bar 10 μM. 
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Figure 3.13: OCRL1 can be depleted from cells derived from the trabecular 
meshwork. Human NTM5 cells were grown overnight. At 40% and 60% confluence 
cells were transfected with non‐targeting control or a pool of human specific OCRL1 
siRNA. After 48 hours, the cells were fixed and permeabilised for immunostaining 
with antibodies to OCRL1 (red) and stained with the DNA stain DAPI (blue). Single 
confocal sections are shown. Images shown are from a single experiment. White 
arrows indicate Golgi apparatus localisation of OCRL1. Scale bar 10 μM. 
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Figure 3.14: OCRL1 is required for the maturation of trabecular meshwork cells. 
NTM5 cells were grown overnight. At 40% and 60% confluence cells were 
transfected with non‐targeting control or a pool of human specific OCRL1 siRNA. 
After 48 hours, cells were fixed and permeabilised for staining F-actin with 
phalloidin (green). XZ sections were reconstructed from Z-stacks containing 30 
confocal sections spanning from the bottom to the top of the cell layer. Two XZ 
images are shown per RNAi treatment from two experiments (Panels A and B). Scale 
bar 10 μM. 
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Summary 
 
This chapter aimed to investigate the localisation and function of OCRL1 in 
maturation of polarised epithelial cell lines derived from cell types that are affected 
by Lowe Syndrome. We confirmed the previous finding that a small pool of OCRL1 
targeted apical tight junctions, existing in a complex with the tight junction protein 
ZO-1 (Grieve et al., 2011). OCRL1 appeared to be required to maintain the normal 
morphology of the tight junction which was thinner, partially broken and more 
punctate when OCRL1 was depleted. The disrupted appearance of the tight junction 
seen here when OCRL1 was depleted suggests OCRL1 may play a role in pathways 
that regulate junction integrity.   
 
In addition to highlighting a potential role for OCRL1 at tight junctions, the results in 
this chapter support the previous work that suggested OCRL1 may be required for 
epithelial maturation. In MDCK cells, OCRL1 depletion inhibited the maturation of 
monolayers from flat to columnar shape. In addition, these affects were 
reproducible in a cell line derived from the trabecular meshwork of the lens 
(NTM5). More extensive disruptions of the monolayer were observed in a human 
kidney cell line (NHPTK). As well as reducing cell height, OCRL1 loss affected the 
ability of cells to form adhesive contacts with each other and the underlying matrix. 
These results indicate OCRL1 may be involved in the formation of intercellular 
contacts and is required for the shape change that normally accompanies epithelial 
development. In the MDCK cell line, extension of cell height during maturation 
required 5-phosphase activity, an intact enzyme domain in OCRL1 was necessary to 
rescue the phenotype, suggesting down-regulation of PI(4,5)P2 mediates 
columnisation of cells in the monolayer. Growth of the monolayer in the vertical 
plane occurs by a combination of vesicular trafficking, intercellular junction 
formation and rearrangements of the actin cytoskeleton. OCRL1 has previously 
been implicated to regulate numerous processes in non-polarised cells which 
contribute to the maturation of polarised cell types, and these are discussed below.  
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Discussion 
 
The results in this chapter confirm that OCRL1 targets apical junctions in MDCK cells 
(Grieve et al., 2011). Although OCRL1 has been reported to localise to peripheral 
membranes (Erdmann et al., 2007; Faucherre et al., 2005), several studies of OCRL1 
in polarised epithelial cells failed to detect the protein at junctions (Cui et al., 2010; 
Dressman et al., 2010; Vicinanza et al., 2011). Similarly, in this chapter, endogenous 
OCRL1 was not observed at junctions in a human renal cell line (NHPTK) or a lens 
epithelial cell line (NTM5), suggesting the localisation pattern of OCRL1 is cell type 
specific and may not be relevant to Lowe Syndrome. An alternative possibility is 
that OCRL1 targets intercellular junctions only temporarily. Supporting this 
possibility is the previous finding that junctional localisation of OCRL1 was lost once 
monolayers reach maturity (Grieve et al., 2011). In addition, OCRL1 was absent 
from co-immunoprecipitated ZO-1 complexes when cells were grown to a higher 
density (Grieve et al., 2011). These findings suggest that OCRL1 may only function 
at tight junctions temporally during epithelial development.  
  
Intercellular junction formation occurs early during development by vesicular 
trafficking of junctional components to the lateral membrane. OCRL1 regulates 
numerous trafficking pathways including biosynthetic and recycling routes 
(Choudhury et al., 2005; Erdmann et al., 2007; Vicinanza et al., 2011) and both of 
these pathways are involved in the formation of intercellular junctions. The finding 
in this chapter that OCRL1 depletion increases punctate intracellular staining of ZO-
1 is consistent with OCRL1 regulating trafficking of vesicles carrying junctional 
proteins. If OCRL1 regulates membrane traffic of junctional components, the pool 
of OCRL1 at junctions may be delivered along with peripheral vesicular carriers 
originating from the Golgi apparatus or recycling endosomes.  
  
Alternatively, OCRL1 might be recruited to junctions to maintain a balance in 
phosphoinositide composition or regulate functional pools of 5-phosphoinositides. 
The PI(4,5)P2 synthesising enzyme PIP5Kγ has been found to target intercellular 
junctions in multiple cell lines, generating the  PI(4,5)P2 required for actin assembly 
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and adhesive strength (Akiyama et al., 2005; El Sayegh et al., 2007). By regulating 
the levels of PI(4,5)P2, OCRL1 could have an important local role at intercellular 
junctions because of the ability of PI(4,5)P2 to regulate actin binding proteins and 
therefore the organisation of actin filaments. 
  
Although OCRL1 was found to complex with the tight junction protein ZO-1, the 
interaction may not be direct since ZO-1 exists in large complexes containing many 
proteins. Several confirmed binding partners of OCRL1 localise to the tight junction 
which could mediate OCRL1 recruitment. Several GTPases that interact with OCRL1 
are known to target intercellular junctions, such Cdc42 and Rab8 (Rojas et al., 2001; 
Yamamura et al., 2008). Interestingly, Rab8 is involved in vesicular trafficking of 
tight junction proteins (Marzesco et al., 2002; Yamamura et al., 2008). Supporting 
the possibility that OCRL1 is recruited to junctions through interactions with 
junctional GTPases is the finding that the ASH-GAP domain of OCRL1 is required for 
OCRL1 to localise to junctions; expression of the C-terminal domain of OCRL1 
showed junctional localisation, while the N-terminal portion of the protein was 
unable to target junctions (Grieve et al., 2011).  
 
Alternatively, if OCRL1 localises to junctions to modulate the actin cytoskeleton, it 
may be interacting with actin binding proteins in the perijunctional actin pool. 
OCRL1 has been reported to interact with the GEF Frabin (also known as FGD4) 
which displays actin-bundling activity (Nakanishi and Takai, 2008). Frabin was 
identified as a potential OCRL1 binding partner due to the presence of an F&H motif 
in the amino acid sequence, resembling the interaction motif of the IPIPs/Ses 
proteins and APPL1 with OCRL1 (Daniels and Levine, unpublished observation). 
Frabin has since been confirmed as an OCRL1 binding protein (Laura E Swan, 
personal communication, 2012). Similarly, using an online bioinformatics tool 
(PROSI TE), we identified δ-catenin as another candidate protein containing a motif 
resembling the F&H motif found in OCRL1 binding proteins. Although this 
interaction remains unconfirmed, δ-catenin acts as a prominent adhesive protein 
and could potentially recruit OCRL1 to intercellular contacts. While the results of 
this chapter indicate OCRL1 localises to the vicinity of tight junctions in some cell 
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types, the relevance of junctional OCRL1 and its interactions with junctional 
proteins remains unclear, addressing these questions would require a molecular 
dissection of the interactions involved.  
  
Although junctional localisation of OCRL1 has been inconsistent between cell types, 
we noticed that depletion of OCRL1 consistently reduced cell number and affected 
cell shape. One possible mechanism of delayed proliferation in OCRL1 depleted 
cells could involve cytokinesis, since OCRL1 has been implicated to regulate this 
stage of cell division (Ben El Kadhi et al., 2011; Dambournet et al., 2011). The role of 
OCRL1 in cytokinesis of MDCK cells is explored in chapter 6. The flattened 
appearance of OCRL1 depleted epithelial monolayers could be due to an indirect 
effect of slower proliferation rates. For example if OCRL1 delays proliferation and 
results in fewer cells on the coverslip, it is unsurprising that monolayers appear less 
mature than controls. However, rescue experiments demonstrated that OCRL1 had 
the ability to induce height gain in individual OCRL1 depleted cells. For example, 
OCRL1 depleted cells re-expressing OCRL1 as a GFP fusion protein extended several 
planes above the height of the monolayer. In addition, over-expression of OCRL1 in 
untreated cells also increased the height of cells above the rest of the monolayer 
indicating OCRL1 can directly induce shape change independently of affecting cell 
division. These rescue experiments also revealed that the 5-phosphatase activity of 
OCRL1 was required to induce cell height, suggesting down-regulation of 5-
phosphoinositides by OCRL1 is involved in epithelial maturation. Similarly, inhibition 
of a phosphatidylinositol 3-kinase which is likely to cause elevated levels of its 
preferred substrate PI(4,5)P2 also inhibited maturation of MDCK cells (Gassama-
Diagne et al., 2006), further suggesting phosphoinositide metabolism is critical in 
the process by which epithelial cells develop.  
 
The mechanism of OCRL1 regulation of cell shape change could involve a number of 
pathways. Expansion of lateral and apical membranes can facilitate shape change as 
new membrane is delivered by vesicular trafficking. The role of OCRL1 in regulating 
polarised trafficking pathways is explored in the next few chapters. It is also likely 
that OCRL1 affects maturation through regulation of the actin cytoskeleton. Loss of 
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OCRL1 has previously been shown to produce aberrant actin phenotypes in un-
polarised cell types (Hayes et al., 2006; Suchy et al., 2002), and might therefore be 
involved in regulating cytoskeletal dynamics in polarised cells. OCRL1 may regulate 
the structural pool of perijunctional actin or regulate cytoskeletal dynamics at other 
sites in the cell to facilitate the mechanical tension necessary for columnarisation. 
Supporting the idea that OCRL1 acts via the cytoskeleton to induce cell height is the 
finding that depletion of the actin regulatory protein Tmod3 phenocopies OCRL1 
loss, similarly inhibiting epithelial maturation (Weber et al., 2007). Through 
regulating the levels of PI(4,5)P2, OCRL1 could potentially be involved in numerous 
processes important for cytoskeletal re-arrangements, PI(4,5)P2 alters the function 
of a wide number of actin modulating proteins in addition to regulating actin 
nucleation through the Arp2/3 complex (Hilpelä et al., 2004). Given the large 
number of possible pathways downstream of OCRL1, further work would be 
required to determine the role of OCRL1 in the shape change that accompanies 
epithelial maturation. The next chapter focuses on another aspect of epithelial 
maturation, as cells columnarise they polarise and form distinct membrane 
domains. A potential role for OCRL1 in cell polarity is explored next in Chapter 4.  
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Chapter Four 
MDCK cells without OCRL1 form 
lateral apical lumens 
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Overview   
 
In the previous section, OCRL1 was implicated in epithelial cell maturation. Cells 
without OCRL1 were flatter than normal and pools of vesicular ZO-1 accumulated 
intracellularly, suggesting junctional remodelling and maturation may require 
turnover of 5-phosphoinositides. Columnar maturation occurs after cells make 
contacts and form junctions. In addition, columnar maturation occurs 
synonymously with polarisation. The loss of cell height that occurs without OCRL1 
suggested the possibility that polarisation may also be affected. Therefore we 
examined the distribution of polarised lipids and proteins in sheets of MDCK cells 
depleted of OCRL1. MDCK cells were chosen as a model to study polarisation in the 
kidney epithelium as they express many polarity markers and polarise well in cell 
culture. In this chapter, OCRL1 was depleted to a greater extent than previously, 
and the results obtained with this level of depletion suggested OCRL1 may be 
required for correct orientation of apical-basal polarity.  
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Optimising OCRL1 RNAi 
 
When MDCK cells were depleted of OCRL1 with a fresh batch of siRNA, we 
observed a different phenotype than in the previous chapter. Depleting OCRL1 with 
this siRNA inhibited maturation of MDCK monolayers as in Chapter 3 but in 
addition, cells accumulated large intracellular vacuoles and the ZO-1 pattern 
appeared to be more extensively broken (bottom panel figure 4.2). While 
disruptions to the ZO-1 pattern with OCRL1 depletion was observed previously 
(figure 3.2), the vacuoles were only observed with the siRNA used in this chapter. 
The differences in phenotype could be due to differing levels of OCRL1 depletion 
between batches of oligonucleotides. The siRNA used in this chapter efficiently 
depleted OCRL1, with approximately 75% of OCRL1 protein depleted 24 hours post 
RNAi and 90% of protein depleted 48 hours post RNAi (figure 4.1). Since the siRNA 
used in the previous chapter was no longer available to test depletion efficiency, it 
was not possible to directly compare protein levels between siRNA batches. 
However, halving the concentration of fresh siRNA reproduced the maturation 
defect seen in Chapter 3 but not the vacuole phenotype seen with higher 
concentrations of the same siRNA (figure 4.2), suggesting maximum OCRL1 
depletion may be required for cells to form vacuoles. All four siRNAs produced the 
vacuole phenotype when used in isolation at maximum concentration, indicating 
the vacuoles did not arrive from off-target effects (figure 4.3). Therefore cells with 
very low levels of OCRL1 were flatter than controls and accumulated intracellular 
vacuoles (figure 4.2 blue arrows). In addition, we noticed intercellular spaces 
between the lateral borders of some OCRL1 depleted cells. These spaces appeared 
to disrupt the tight junction, with bands of ZO-1 absent from regions where lateral 
vacuoles localised (figure 4.2 white arrows). Both sets of vacuole structures, 
intracellular and lateral, (indicated with blue and white arrows respectively) were 
lined heavily with filamentous actin (F-actin).  
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Figure 4.1: Endogenous OCRL1 can be depleted with siRNA. MDCK cells were 
grown on a 6 well plate overnight. At 40% and 60% confluence cells were 
transfected with non‐targeting control or a pool of canine specific OCRL1 siRNA. 
Cell lysates were collected after 24 and 48 hours and loaded onto a 10% SDS-PAGE 
gel and processed for immunoblotting with anti-OCRL1 and anti-α-tubulin 
antibodies. Since OCRL1 depletion reduces cell proliferation rate (see figure 3.8), 
the amount of cell lysate loaded was normalised according to expected cell density. 
Arrows indicate OCRL1 (105kDa) and α-tubulin (50kDa). The relative protein levels 
were quantified using ImageJ gel analyzer and normalised against the loading 
control. Briefly, the relative amount of protein was estimated by density of the 
band. Compared to the control at 24 hours after RNAi, OCRL1 protein was reduced 
by 75% and at 48 hours after RNAi, OCRL1 was reduced by 90% compared to the 48 
hour control.  
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Figure 4.2: Maximum OCRL1 depletion is required for vacuole formation.  MDCK 
cells were grown overnight. At 40% and 60% confluence the cells were transfected 
with non‐targeting control or a pool of OCRL1 siRNA at a final concentration of 60 
nM and 120 nM. After 48 hours with siRNA, the cells were fixed and permeabilised 
for immunostaining with antibodies to the tight junction marker ZO-1 (red) and the 
actin stain phalloidin (green). Single confocal sections and XZ sections are shown. XZ 
sections were constructed from Z-stacks of 30 confocal sections spanning from the 
bottom to the top of the cell layer. Blue arrows indicate intracellular vacuoles and 
white arrows indicate vacuoles between cells. Images shown are from a single 
experiment. Scale bar 20 µM. 
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Figure 4.3: Confirmation of siRNA specificity. MDCK cells were grown overnight. At 
40% and 60% confluence the cells were transfected with non‐targeting control or 
with four individual OCRL1 siRNAs at a final concentration of 120 nM. The cells 
were fixed and permeabilised for visualising F-actin with phalloidin (green) and the 
DNA with DAPI (blue). White arrows indicate actin vacuoles, both intracellular and 
lateral. Single confocal sections are shown. Images shown are from a single 
experiment. Scale bar 20 µM 
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OCRL1 depletion results in redistribution of the apical membrane to 
vacuoles  
 
Vacuoles in MDCK cells have been observed previously under certain conditions. 
Intracellular vacuoles appear in cells prevented from forming cell-cell contacts by 
removal of calcium from the extracellular media (Vega-Salas et al., 1988). These 
vacuoles contain microvilli and apical plasma membrane proteins but exclude 
basolateral proteins, and are therefore termed vacuolar apical compartments 
(VACs). Upon re-establishment of cell-cell contacts by re-addition of calcium, VACs 
are rapidly exocytosed towards intercellular spaces, after which the apical plasma 
membrane is re-formed (Vega-Salas et al., 1988). VACs are also formed when the 
microtubule cytoskeleton is disrupted and apical trafficking to the plasma 
membrane is perturbed (Gilbert et al., 1991; van Zeijl and Matlin, 1990). The 
structures seen upon depletion of OCRL1 have some properties of the VACs 
observed in these experiments, appearing similar in size and heavily enriched in F-
actin. Therefore we tested to see whether apical cargo also localised to the 
vacuoles formed when OCRL1 was depleted, indicative of disrupted apical 
trafficking pathways.   
 
To check the polarity status of OCRL1 depleted cells, we tested the localisation of a 
variety of apical and basolateral protein markers. Ezrin is a peripheral membrane 
protein that links the plasma membrane, where it interacts with PI(4,5)P2, to the 
actin cytoskeleton (Janke et al., 2008). Normally ezrin is enriched in the apical 
domain of MDCK cells. XZ images of MDCK cells treated with control siRNA showed 
the expected apical distribution of ezrin, lining the cell surface of monolayers 
(figure 4.4). However, ezrin was not localised to any peripheral domain in cells 
depleted of OCRL1 (figure 4.4). Higher magnification images of OCRL1 depleted cells 
revealed ezrin to be mostly cytosolic or present on large vacuoles intracellularly and 
between cells (figure 4.4 bottom panel). The aberrant pattern of ezrin staining 
resembled the pattern of F-actin staining shown above (figure 4.2), with ezrin 
localising to intracellular vacuoles or to the periphery of intercellular spaces in the 
lateral borders between cells (figure 4.4).  
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We found similar results with another apical marker frequently used when studying 
polarisation in MDCK cells. Gp135/podocalyxin is a heavily sialylated 
transmembrane protein that interacts with the actin cytoskeleton and is thought to 
be involved in expansion of the apical lumen (Ojakian and Schwimmer, 1988). 
OCRL1 depleted cells formed vacuoles rich in Gp135 and F-actin with the 
concomitant loss of these two components from the cell surface (figure 4.5).  
 
For staining with Gp135, cells were grown in culture for 4 or 5 days and depleted of 
OCRL1 for 48 or 72 hours to assess the effect of OCRL1 depletion at different stages 
of polarisation. Monolayers of MDCK cells mature and polarise with time and 
therefore control cells grown for 5 days were taller and more compact than control 
cells grown for 4 days (figure 4.5 panel 1 compared to panel 2). Depleting cells of 
OCRL1 for different lengths of time revealed differences in vacuole localisation, cells 
grown for 4 days and depleted of OCRL1 for 48 hours mostly formed vacuoles that 
were intracellular (figure 4.5 blue arrows), whereas cells grown for 5 days and 
depleted of OCRL1 for 72 hours mostly formed lateral vacuoles between cells 
(figure 4.5 white arrows). The abundance the two types of vacuole with time can be 
seen in single XY sections of OCRL1 depleted cells (figure 4.5 panels 3 and 4). The 
intracellular vacuoles formed after 48 hours without OCRL1 appeared smaller and 
predominately localised to a perinuclear region (figure 4.5). The intercellular 
vacuoles formed after 72 hours without OCRL1 were larger and localised along the 
lateral borders between two or more cells (figure 4.5). Wild type MDCK cells that 
are fully polarised form a dense network of F-actin beneath the apical membrane. 
In addition, the formation of F-actin rich microvilli adds to the density of F-actin 
near the apical membrane which stains strongly with phalloidin. OCRL1 depleted 
cells lost this enrichment of F-actin in the cell apex, further indicating a loss of 
apical membrane development on the cell surface (figure 4.5).  
 
To check whether the vacuoles observed in OCRL1 depleted cells were similar to 
the VACs formed in calcium switch experiments, we performed a calcium switch on 
untreated MDCK cells. The intracellular VACs formed upon loss of extracellular 
calcium were similar in appearance to the VACs formed when OCRL1 was depleted, 
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being of similar size and enriched in F-actin and Gp135 (figure 4.6). However in 
contrast to OCRL1 depletion, lateral vacuoles were not observed upon calcium 
depletion. In calcium switch experiments, the intracellular VACs are thought to fuse 
with the plasma membrane and re-form the apical surface when calcium is restored 
(Vega-Salas et al., 1988). Therefore in calcium switch experiments, lateral vacuoles 
are only observed temporarily, indicated with a blue arrow in figure 4.6.  
  
The localisation of several apical components to the vacuoles formed in OCRL1 
depleted cells suggested the membrane composition of vacuoles resembled the 
apical membrane normally found at the cell surface. To confirm this, an additional 
apical marker and a basolateral marker were tested for localisation to these 
structures. Annexin-2 is a sub-apical protein that also interacts with PI(4,5)P2 
(Lizarbe et al., 2011). Annexin-2 was strongly enriched on the vacuoles induced by 
loss of OCRL1 (figure 4.7). Conversely the basolateral marker Na+/K+ ATPase was not 
localised to these compartments (figure 4.8), further suggesting the apical nature of 
vacuole membranes. In summary, OCRL1 depleted MDCK cells formed intracellular 
and intercellular vacuoles. The vacuoles accumulated apical markers and excluded 
basolateral markers, resembling the VACs formed in calcium switch experiments 
and suggest OCRL1 is required for proper formation of the apical membrane.  
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Figure 4.4: Ezrin localises to vacuoles in OCRL1 depleted cells. MDCK cells were 
grown overnight. At 40% and 60% confluence the cells were transfected with non‐
targeting control or a pool of OCRL1 siRNA. After 48 hours with siRNA, the cells 
were fixed and permeabilised for immunostaining with antibodies to the apical 
marker ezrin (red) and the DNA stain DAPI (blue). Single confocal sections and XZ 
images are shown. XZ sections were constructed from Z-stacks of 20 confocal 
sections spanning from the bottom to the top of the cell layer. The bottom panel 
shows higher magnification images of intracellular and intercellular ezrin (white 
arrows) taken from confocal sections in the same stack as the images above. 
Images shown are representative from two experiments. Scale bar 20 µM. 
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Figure 4.5: Gp135 localises to vacuoles in OCRL1 depleted cells. MDCK cells were 
grown overnight and transfected with siRNA as in figure 4.4. After 48 or 72 hours 
without siRNA, the cells were fixed and permeabilised for immunostaining with the 
apical marker Gp135 (red) and stained with phalloidin to label F-actin (green). XZ 
sections were constructed from Z-stacks of 40 confocal sections spanning from the 
bottom to the top of the cell layer. Single confocal sections from the top of the cell 
layer are shown. Blue arrows indicate intracellular vacuoles and white arrows 
indicate vacuoles in the lateral membrane between cells. Images shown are from a 
single experiment. Scale bar 20 µM. 
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Figure 4.6: The VACs formed upon OCRL1 depletion resemble VACs in calcium 
switch experiments. Wild type MDCK cells were grown overnight in calcium free 
DMEM or calcium containing DMEM as a control. After 24 hours the cells were 
switched to calcium containing DMEM and fixed at various time points after 
recovery with calcium (0, 8 or 24 hours). The cells were permeabilised and stained 
for F-actin using phalloidin (green) and immunostained with antibodies to Gp135 
(red). Single confocal sections are shown. White arrows indicate intracellular VACs 
and blue arrow indicates an exocytosed VAC in the lateral membrane. Images 
shown are from a single experiment. Scale bar 20 µM. 
128 
  
 
Figure 4.7: OCRL1 depletion redistributes Annexin-2 to intracellular vacuoles. 
MDCK cells were grown and treated with control or pooled OCRL1 siRNA as in figure 
4.4. The cells were fixed and permeabilised for immunostaining with antibodies to 
Annexin-2 (red) and F-actin was labelled with FITC-phalloidin (green). Single 
confocal sections are shown. White arrows indicate the presence of Annexin-2 on 
actin rich intracellular vacuoles. Intercellular vacuoles showed the same properties. 
Images shown are representative from two experiments. Scale bar 10 µM. 
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Figure 4.8: The vacuoles formed upon OCRL1 depletion exclude Na+/K+ ATPase. 
MDCK cells were grown and treated with pooled OCRL1 siRNA for 72 hours as in 
figure 4.5. The cells were fixed and permeabilised for immunostaining with 
antibodies to the basolateral marker Na+/K+ ATPase (red) and F-actin was labelled 
with FITC-phalloidin (green). Single confocal sections of OCRL1 depleted cells are 
shown. White arrows indicate the absence of Na+/K+ ATPase on actin rich lateral 
vacuoles, but intracellular vacuoles showed the same properties. Scale bar 10 µM. 
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Phosphoinositides polarise to vacuoles formed upon OCRL1 depletion 
 
In addition to asymmetrically distributing proteins, polarised cell types also 
distribute phosphoinositides differentially on cell membranes. This is achieved by 
delivering specific lipids to target membranes and by localising lipid modifying 
enzymes spatially in the cell so that the production of a particular phosphoinositide 
is favoured on membranes where it is required. The asymmetric distribution of 
phosphoinositides in polarised cell types is a key aspect of maintaining domain 
identity. In MDCK cells PI(4,5)P2 is apically localised while PI(3,4)P2 and PI(3,4,5)P3 
are enriched basolaterally (Martín-Belmonte et al., 2007). To visualise where these 
lipids accumulate in the cell, a variety of phosphoinositide binding domains have 
been isolated, characterised for their phosphoinositide specificity and fused to 
green fluorescent protein (GFP) for expression in cells. The PH domain of 
phospholipase C delta (PLCδ-PH) is used to visualise  PI(4,5)P2 (Fujii et al., 1999), the 
PH domain of Grp1 is used to identify pools of PI(3,4,5)P3 (Klarlund et al., 2000) and 
the PH domain of AKT recognises both PI(3,4,5)P3 and PI(3,4)P2 (Gassama-Diagne et 
al., 2006).  
 
To assess whether OCRL1 depletion affects the distribution of apical and basolateral 
phosphoinositides, MDCK monolayers growing on glass coverslips were depleted of 
OCRL1 and transfected with GFP chimeras of the PH domains from AKT and PLCδ. 
XZ sections of OCRL1 depleted cells expressing the AKT-PH-GFP construct displayed 
an enrichment of PI(3,4,5)P3 and PI(3,4)P2 in the lateral compartment similar to 
controls (figure 4.9B), as well as nuclear localisation of AKT-PH-GFP. However XZ 
sections of OCRL1 depleted cells expressing PLCδ-PH-GFP revealed a loss of 
PI(4,5)P2 from the apical surface (figure 4.9A). Instead, OCRL1 depleted cells 
displayed PI(4,5)P2 enrichment exclusively in the lateral membrane (figure 4.9A). In 
control cells the reverse was true, PI(4,5)P2 localised exclusively to the apical 
domain and was not apparent in the lateral compartment (figure 4.9A). Therefore 
loss of OCRL1 resulted in the redistribution of PI(4,5)P2 from the apical membrane 
to the lateral membrane.  
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As well as the lateral localisation of PI(4,5)P2, the vacuoles formed in OCRL1 
depleted cells were also enriched in PI(4,5)P2 (figure 4.10). Expression of Grp1-PH-
GFP revealed the exclusion of the normally basolateral phosphoinositide PI(3,4,5)P3 
from these structures (figure 4.10). In OCRL1 depleted cells, the levels of PI(4,5)P2 
remaining on the apical surface were similar to the levels of PI(4,5)P2 in the basal 
domain (figures 4.9 and 4.10), suggesting the normal apical-basal polarisation of 
PI(4,5)P2 had been lost and polarisation of PI(4,5)P2 had shifted towards vacuoles in 
these cells. The localisation of apical PI(4,5)P2 to vacuoles and exclusion of 
basolateral phosphoinositides occurred whether the vacuole was formed 
intracellularly or localised between cells laterally (figure 4.11). Therefore loss of 
OCRL1 in MDCK cells promoted the formation of intracellular and intercellular 
compartments, not seen in control cells, with the phosphoinositide composition of 
the apical domain. 
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Figure 4.9: OCRL1 depletion redistributes PI(4,5)P2 to the lateral membrane. 
MDCK cells were grown overnight. At 30% and 50% confluence the cells were 
transfected with non‐targeting control or a pool of OCRL1 siRNA. 48 hours after the 
initial RNAi, the cells were transfected with PLCδ-PH-GFP DNA (PI(4,5)P2 binding 
domain) or AKT-PH-GFP DNA (PI(3,4)P2 and PI(3,4,5)P3 binding domain) and left for 
a further 17 hours. Cells were fixed and permeabilised to stain F-actin with 
phalloidin (red). XZ sections were constructed from Z-stacks of 40 confocal sections 
spanning from the bottom to the top of the cell layer. Images shown are 
representative images from n=6 cells per treatment across 2 experiments. White 
arrows point to peripheral enrichment of phosphoinositides. Scale bar 10 µM. 
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Figure 4.10: Intracellular vacuoles are enriched in apical phosphoinositides. MDCK 
cells were grown overnight and subjected to OCRL1 siRNA as in figure 4.9. After 48 
hours with siRNA, the cells were transfected with PLCδ-PH-GFP DNA (PI(4,5)P2 
binding domain) or Grp-PH-GFP DNA (PI(3,4,5)P3 binding domain) and left for a 
further 17 hours. Cells were fixed and permeabilised to stain F-actin with phalloidin 
(red). Single confocal sections and XZ images are shown. XZ images were created 
from Z-stacks containing 40 confocal sections. Arrows indicate the enrichment of 
PLCδ-PH-GFP and absence of Grp-PH-GFP on large intracellular vacuoles. Images 
shown are representative of all transfected cells in 2 experiments (n=20). Scale bar 
10 µM. 
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Figure 4.11: Lateral vacuoles are enriched in apical phosphoinositides. MDCK cells 
were grown and treated with OCRL1 siRNA as in figure 4.9. After 72 hours without 
siRNA, the cells were transfected with PLCδ-PH-GFP DNA (PI(4,5)P2 binding domain) 
or Grp-PH-GFP DNA (PI(3,4,5)P3 binding domain) and left for an additional 17 hours. 
Cells were fixed and permeabilised to stain F-actin with phalloidin (red). Single 
confocal sections from the middle of the cell layer are shown. Arrows indicate the 
enrichment of PLCδ-PH-GFP and absence of Grp-PH-GFP on large intercellular 
vacuoles. Images shown are representative of all transfected cells that had formed 
lumens in 2 experiments (n=10). Scale bar 10 µM. 
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Lateral lumens rearrange tight junctions and the microtubule cytoskeleton 
 
The tight junction normally acts as a diffusion barrier to proteins and lipids, 
separating the apical and basolateral domains. In OCRL1 depleted cells PI(3,4,5)P3 
was found to be excluded from lateral vacuoles but present on the rest of the 
membrane, whilst PI(4,5)P2 was abundant on lateral vacuoles and only weak 
detection of PI(4,5)P2 was seen on the remaining plasma membrane (figure 4.11). In 
addition, the phalloidin and PI(4,5)P2 staining of lateral vacuoles was relatively 
dense (figure 4.11), suggesting possible folding of the plasma membrane indicative 
of apical microvilli, as seen in microvillus inclusion disease (Müller et al., 2008). The 
effective segregation of apical and basal phosphoinositides suggested the integrity 
of the tight junction remained in OCRL1 depleted cells that had formed lateral 
lumens. However, previously we observed the tight junction to be disrupted by 
lateral lumens (figure 4.2). Therefore we looked more closely at the organisation of 
the tight junction in OCRL1 depleted cells with lateral lumens.  
 
To visualise the tight junction, OCRL1 depleted cells were stained with the tight 
junction marker ZO-1. The tight junction was extensively reorganised in cells that 
had formed lateral vacuoles (figure 4.12). As shown previously (figure 4.2), lateral 
vacuoles appeared to form between tight junctions and ZO-1 was enriched at sites 
where the vacuole membrane contacted the lateral membrane (figure 4.12 panel 
2). To study this further, a 3D reconstruction was created from a Z-stack of confocal 
images (figure 4.12 panel 3). The 3D image provided a complete view of the cell 
layer and revealed the entire structure of the tight junction in OCRL1 depleted cells. 
Bands of ZO-1 encompassed lateral vacuoles bordering the cell-cell contact (figure 
4.12 panel 3), suggesting the tight junction maintains a distinct apical membrane 
within the vacuole and separates this membrane from the basolateral domain.  
 
In addition to the tight junction, spatial organisation of the cytoskeleton is required 
for cells to maintain polarity. Cargo varying vesicles are trafficked along the 
microtubule cytoskeleton as a means of targeted transport. Normally MDCK cells 
polarise vertically with the apical domain formed at the top of the cell and the basal 
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domain facing the substratum. This arrangement of polarised membrane domains is 
supported by the underlying asymmetry of the microtubule network, with minus 
ends of microtubules facing the apical membrane and the plus ends facing the basal 
domain (Müsch, 2004). MDCK cells display a peripheral enrichment of vertical 
microtubules with this orientation and a dense network of microtubules beneath 
the apical surface.  
 
Since OCRL1 depleted cells display an abnormal organisation of polarised 
membrane domains, we looked at the arrangement of the microtubule network in 
cells that had formed lateral lumens. The microtubules were visualised with 
antibodies to α-tubulin. In OCRL1 depleted cells, some of the microtubules were 
resolved in a single confocal image due to their horizontal alignment with the plane 
of the section (figure 4.13). However due to the vertical arrangement of the 
microtubules in control cells, the confocal section cut through the microtubules 
perpendicularly, appearing as punctate dots (figure 4.13). Therefore the 
microtubules appeared to be vertically arranged in control cells but were seen 
emanating more horizontally from the lateral lumens in OCRL1 depleted cells. This 
is further demonstrated in 3D reconstructions of Z-stacks taken of OCRL1 depleted 
cells. The 3D images revealed the entire arrangement of microtubules which were 
extensively organised around lateral lumens (figure 4.13 bottom 2 panels). The 
enrichment of microtubules near lateral lumens further supports the apical nature 
of these compartments.  
 
In addition to the arrangement of tight junctions and microtubules, the positioning 
of the nuclei in OCRL1 depleted cells also supported a change in orientation. 
Normally MDCK cells gown in monolayer sheets position the nuclei centrally 
towards the bottom of the cell. However, in OCRL1 depleted cells, the nuclei were 
positioned at the maximum distance from the lateral vacuole near the opposite 
lateral membrane. Therefore the position of the apical membrane relative to the 
nuclei suggested OCRL1 depleted cells polarised horizontally. A  similar orientation 
of polarity is observed in normal hepatocytes, these cells form lateral apical lumens 
(bile canaliculi) which are maintained by rings of tight junction and a dense network 
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of microtubules proximal to the lumen (Treyer and Müsch, 2013).  One possibility is 
that MDCK cells depleted of OCRL1 adopt a hepatic mode of polarity. Similar results 
were shown for MDCK cells overexpressing Par1b, where cells appeared to convert 
from a normal columnar epithelial polarity to a hepatic mode of polarity (Cohen et 
al., 2004a, 2004b, 2007 and 2011). A schematic of polarity and junction 
organisation in cells depleted of OCRL1 is shown in figure 4.14. 
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Figure 4.12: Tight junctions support lateral lumens. MDCK cells were grown 
overnight. Cells were treated with siRNA as in Figure 4.5. Cells were fixed after 72 
hours and permeabilised for immunostaining with antibodies to the tight junction 
marker ZO-1 (red) and labelled F-actin with FITC-phalloidin (changed from green to 
blue). Single confocal sections are shown in the top 2 panels along with XZ sections. 
XZ sections were constructed from Z-stacks of 30 confocal sections spanning from 
the bottom to the top of the cell layer which were also used to create 3D 
reconstructions in ImageJ. The bottom panel shows a section of the 3D 
reconstruction at higher magnification. White arrows indicate regions of tight 
junction near lateral vacuoles. Experiment repeated twice. Scale bar 20 µM. 
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Figure 4.13: Microtubules reorganise around lateral lumens. MDCK cells were 
grown overnight and treated with siRNA as in figure 4.12. Cells were fixed 72 hours 
after initial RNAi and permeabilised for immunostaining with the microtubule 
marker α-tubulin (red), and the DNA was stained with DAPI (blue). Single confocal 
sections are shown through the middle of the cell layer.  3D reconstructions were 
made from Z-stacks containing 30 confocal sections in imageJ (bottom 2 panels). 
Experiment repeated twice. Scale bar 10 µM. 
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Figure 4.14 Schematic diagram of apical membrane formation in the absence of 
OCRL1. A: MDCK cells normally form an apical membrane enriched in PI(4,5)P2 
(green surface) at the apex of the monolayer, which is kept intact by junctional 
bands of ZO-1 (shown in red). B: Without OCRL1, MDCK cells form an apical 
membrane between neighbouring cells in the lateral membrane with encompassing 
rings of ZO-1.  
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Lateral lumens are formed from intracellular vacuoles   
 
OCRL1 depletion induces the formation of intracellular apical vacuoles, however 
these vacuoles can also form between cells, resembling lateral lumens. The relative 
abundance of intracellular vacuoles compared to lateral lumens appeared to 
depend on the length of time spent without OCRL1 (figure 4.5), suggesting a 
possible time dependant relationship between the two species of vacuole.  
 
To test whether the appearance of intracellular vacuoles preceded the appearance 
of lateral lumens, MDCK cells were depleted of OCRL1 and the position and size of 
vacuoles were measured at various time points after siRNA treatment. Over 300 
vacuoles were counted and categorised according to cellular position at each time 
point after RNAi over a 6 day period (figure 4.15). Early after OCRL1 depletion, 
vacuoles were entirely intracellular, 57% of vacuoles counted at 24 hours post RNAi 
appeared to be budding from the plasma membrane and 37% were near the 
plasma membrane. Later after OCRL1 depletion, 44 hours post RNAi, vacuoles were 
almost completely lateral with only 9% intracellular vacuoles remaining. At this late 
stage, lateral vacuoles shared by three or more cells were also observed. At an 
intermediate stage of 72 hours post RNAi, vacuoles were largely perinuclear (30%) 
or between two cells (33%). Therefore looking in detail at position alone, these 
results were consistent with a series of gradual changes taking place over the 6 
days. The first structures to appear were small vacuoles near the plasma 
membrane. These subsequently disappeared, with the appearance of perinuclear 
vacuoles. The fact that larger vacuoles appeared as the smaller ones disappeared 
suggested a precursor-product relationship, with the possibility that perinuclear 
vacuoles were formed by the fusion of smaller ones. Similarly perinuclear vacuoles 
declined as lateral lumens were formed, suggesting lateral lumens were formed 
from this perinuclear material. 
   
To obtain supporting evidence for the idea that intracellular vacuoles develop into 
lateral lumens, the size of vacuoles were measured over the course of the RNAi 
experiment. The intracellular vacuoles formed early after OCRL1 depletion were 
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smaller than the lateral lumens formed at a later stage (figure 4.16). Vacuoles 
budding from the membrane were the smallest (2.5 µM ± 0.06 SEM), perinuclear 
vacuoles were of an intermediate size (5.8 µM ± 0.15 SEM), and lumens formed 
between two cells were larger (8.1 µM ± 0.2 SEM) and larger still when between 
three or more cells (12.9 µM ± 0.4 SEM). The relative size of these vacuoles 
supported the possibility that lateral lumens were formed from perinuclear 
vacuoles.  
 
Furthermore it was also apparent that vacuoles at each cellular position increased 
in size over time; indicated in colour in figure 4.16 and plotted in figure 4.17. The 
lateral lumens first observed at 72 hours post RNAi were larger when observed at 
96 hours and larger still at 144 hours (figure 4.17). The same was true of small 
intracellular vacuoles, however most of these vacuoles had diminished in number 
by 48 hours, therefore the plotted increase in size was only true of the small 
population of intracellular vacuoles remaining at later time points (9%). In 
summary, these results indicate that OCRL1 depletion resulted in the formation of 
small vacuoles which fused at a perinuclear site before being exocytosed at cell-cell 
contacts where they formed lumens between cells. However, these results only 
considered population changes of vacuoles over time. To confirm these findings it 
would be necessary to follow individual vacuoles over time by live cell imaging.  
 
 
 
 
 
 
 
 
143 
  
 
Figure 4.15: Vacuoles are internalised before becoming lateralised. MDCK cells 
were grown overnight and subjected to RNAi as in 4.5. The cells were fixed at 
various time points after RNAi. The cells were permeabilised and stained for F-actin 
using FITC-phalloidin. Over 300 vacuoles were categorised according to cellular 
position from Z-stacks taken across the coverslip. A: Plotted at each time point is 
the percentage of vacuoles found at each position within the cell or between cells. 
Highlighted in red are vacuoles found between neighbouring cells, highlighted in 
blue are vacuoles found intracellularly. B: High magnification images are shown of 
vacuoles (indicated by red arrows) in each category. Scale bar 5 µM. 
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Figure 4.16: Vacuoles grow in size as they are internalised and lateralised. MDCK 
cells were grown overnight and subjected to RNAi as in figure 4.5. Cells were fixed 
at various time points post RNAi and permeabilised for staining F-actin with 
phalloidin. Confocal sections were taken from across the coverslip. Vacuole 
diameter was measured using Leica software and categorised according to cellular 
position. Plotted is the size of vacuoles at various cellular positions. Colours indicate 
the time of fixing after RNAi. One-way ANOVA analysis confirmed the mean 
diameter for each position was not equal, p<0.001. 
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Figure 4.17: Vacuoles increase in size over time. MDCK cells were grown overnight 
and subjected to RNAi as in Figure 4.5. The data was collected as in figure 4.16. 
Plotted is the mean diameter of the vacuoles found at various cellular positions 
over time and line of best fits. The colours indicate different cellular positions. A 
student’s T-test confirmed the gradients of all line of best fits plotted were not 
equal to zero, p<0.05. 
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Summary 
 
A role for OCRL1 in polarisation has not previously been investigated although Lowe 
Syndrome affects cell types in which polarisation is critical to cellular function. In 
Chapter 3, loss of OCRL1 hindered the maturation of epithelial cells. Maturation 
was studied in terms of cell shape, however as cells mature they also polarise to 
form distinct apical and basolateral membranes. The finding that loss of OCRL1 
hindered maturation suggested polarisation may also be affected. This chapter 
investigated whether OCRL1 was required for polarisation in the MDCK cell line, 
which was also used in Chapter 3 to show OCRL1 was involved in epithelial 
maturation.       
 
The effects on maturation shown previously were observed in monolayers of MDCK 
cells grown without OCRL1 for several days. Therefore, we studied polarisation at 
the point where OCRL1 loss affected maturation by repeating previous experiments 
in addition to looking at the distribution of a number of polarity markers. However, 
repeating experiments from the previous chapter yielded different results. In 
addition to affecting epithelial maturation, OCRL1 loss induced the appearance of 
vacuolar apical compartments (VACs). These VACs resembled the apical membrane 
in composition; rich in apical proteins and lipids and associated actin filaments. 
Although polarity markers were not used previously, the distribution of F-actin was 
used in the previous chapter to assess cell shape and vacuoles were not observed. 
The experimental protocol remained the same in both chapters, however a 
different batch of siRNA used in this chapter may explain the new finding. 
Maximum OCRL1 depletion with new siRNA appeared to be required for vacuole 
formation to accompany loss of maturation, suggesting sub-maximal OCRL1 
depletion hindered maturation while a greater loss of OCRL1 also induced polarity 
defects. Alternatively, vacuoles may have been missed in the previous chapter due 
to poor resolution and grainy appearance of F-actin with Cy5-phalloidin compared 
to the phalloidin stains used in this chapter which produced clearer and more 
detailed results.  
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Studying the location and size of vacuoles over time suggested intracellular apical 
vacuoles fused with the plasma membrane to form lateral apical lumens. The lateral 
apical lumens were accompanied by a loss of apical membrane from the cell 
surface, resembling the organisation of membrane domains in hepatic cell lines 
with bile canaliculi. The organisation of membrane domains in cells without OCRL1 
suggested polarisation along a horizontal rather than vertical plane. In addition, the 
horizontal arrangement of the microtubule cytoskeleton and the re-positioning of 
nuclei to ensure maximal distance from the lateral lumen further suggested 
horizontal orientation. Polarisation appeared unaffected by loss of OCRL1; cells 
formed distinct apical and basolateral membrane domains kept separate by 
reorganised bands of tight junction. However, OCRL1 depletion affected the gross 
organisation of membrane domains, suggesting OCRL1 may be required for the 
correct orientation of the apical-basal polarity axis.  
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Discussion 
 
The results of this chapter demonstrate a requirement of OCRL1 for the correct 
positioning of the apical membrane. OCRL1 depleted cells first formed their apical 
membrane intracellularly in the form of large vacuoles which appeared to be used 
at later stages of development to form lateral apical lumens. Intracellular apical 
domains are frequently observed when apical trafficking pathways are perturbed, 
whilst lateral apical lumens are less common but may indicate mis-localisation of 
key polarity proteins responsible for positioning of the apical membrane.  
  
The intracellular apical domains formed when OCRL1 was depleted resemble the 
vacuolar apical compartments (VACs) formed in calcium switch experiments or 
when the microtubule cytoskeleton is disrupted (Gilbert et al., 1991; van Zeijl and 
Matlin, 1990). VACs are large vacuoles which contain microvilli and apical plasma 
membrane but exclude basolateral membrane markers. Removal of calcium from 
the extracellular environment blocks calcium dependent adhesive intercellular 
contacts which in turn prevents polarisation. VACs are thought to accumulate by 
the fusion of frustrated apical vesicles unable to traffic to the plasma membrane in 
the absence of cell-cell adhesion. Similarly, disruption of microtubules with 
nocodazole or colchicine blocks apical trafficking to the cell surface and results in 
the formation of VACs (Gilbert et al., 1991; van Zeijl and Matlin, 1990). The 
appearance of VACs in the absence of OCRL1 hints at the possibility that apical 
trafficking to the plasma membrane may be affected. In addition, OCRL1 has 
previously been implicated to regulate recycling of megalin and other receptors to 
the cell surface (Vicinanza et al., 2011). Megalin is normally expressed on the apical 
plasma membrane of polarised epithelial cells but accumulates in recycling 
endosomes when OCRL1 is depleted (Vicinanza et al., 2011), suggesting OCRL1 
regulates the trafficking of this receptor from recycling endosomes to the plasma 
membrane. The vacuoles which form in the absence of OCRL1 could potentially be 
explained if OCRL1 similarly blocks the trafficking of other apical cargo. In the next 
chapter, the trafficking of apical carriers is studied in OCRL1 depleted cells pre-
vacuole formation by looking earlier after OCRL1 depletion.  
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Although disrupted apical trafficking may explain VAC formation, it was not clear 
why OCRL1 depleted cells subsequently form lateral lumens. VACs in calcium switch 
experiments persist only for as long as calcium is absent, when calcium is restored 
intercellular contacts re-form and VACs are rapidly exocytosed towards the lateral 
membrane (Vega-Salas et al., 1988). After VAC exocytosis, the apical membrane 
from the vacuole diffuses towards its final destination at the cell surface (Vega-
Salas et al., 1988). Lateral vacuoles are therefore transiently observed in calcium 
switch experiments as VACs undergo fusion with the lateral membrane. In OCRL1 
depleted cells, VACs appeared to similarly fuse with the lateral membrane, though 
exocytosis of VACs did not lead to reformation of the apical surface. Instead, the 
vacuoles were maintained in the lateral membrane and subsequently developed 
into a lateral lumen, however the reason for these differences are not clear. 
  
The formation of lateral lumens is often seen in MDCK cysts grown in 3D culture 
when it is referred to as the multi-lumen phenotype since insertion of apical 
membrane into the lateral region between cells of cysts disrupts the formation of a 
single central lumen. Multiple lumens are formed in MDCK cysts with loss of 
function of proteins involved in membrane domain segregation or tight junction 
formation such as Cdc42, Annexin-2, PTEN, aPKC and the apical polarity complex 
Crumbs (Jaffe et al., 2008; Martín-Belmonte et al., 2007; Schluter et al., 2009), 
highlighting their role in positioning rather than forming the apical membrane. In 
addition multiple lumens are also observed in MDCK cysts with defective apical 
trafficking pathways (Roland et al., 2011). The lateral lumen phenotype is less 
common when MDCK cells are grown in 2D culture as sheets, likely due to less 
stringent polarity requirements under these conditions. However, lateral lumens 
have been reported in epithelial monolayers over-expressing the serine/threonine 
kinase Par1b, also known as MARK2 and emk1 (Cohen et al., 2003, 2004a, 200b and 
2011). Monolayers of MDCK cells over-expressing Par1b convert from a normal 
columnar epithelial organisation to a hepatic-like appearance, discussed below.  
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Columnar epithelia, for example in the kidney and intestine, normally position the 
lumen or apical membrane at the apex of the cell. Other epithelia such as liver 
hepatocytes position the lumen (bile canaliculi) at sites of intercellular contact in 
the lateral domain. In addition, the microtubule cytoskeleton in hepatocytes is 
organised horizontally towards the bile canaliculi, supporting the heavy trafficking 
demands of the apical membrane (Cohen et al., 2004a). Par1b promotes the 
transformation of MDCK cells from a normal columnar epithelial polarity to hepatic-
like polarity through effects on the microtubule and actin cytoskeleton (Cohen et 
al., 2994a and 2011). Par1b regulates the microtubule binding activity of several 
microtubule associated proteins (Drewes and Ebneth, 1998, Illenberger et al., 
1996). In addition Par1b regulates the function of insulin receptor tyrosine kinase 
substrate p53; IRSp53 (Cohen et al., 2011). IRSp53 acts as a scaffold to link the Rho 
GTPases Cdc42 and Rac1 to their downstream effector molecules involved in actin 
organisation (Scita et al., 2008). At the basal side of the cell, IRSp53 stimulates the 
formation of a sub-membraneous actin network to facilitate receptor clustering and 
signalling from the extracellular matrix (Cohen et al., 2011). The mechanism of 
Par1b regulation of apical membrane positioning is thought to involve this pathway, 
although how ECM derived signalling affects positioning of the apical pole is not 
fully understood.   
 
How OCRL1 depletion might affect events at the basal side of the cell to affect 
positioning of the apical membrane is not clear. However, both Par1b and IRSp53 
interact with lipids; Par1b interacts with acidic lipids via a kinase associated-1 
domain (Moravcevic et al., 2010) and IRSp53 binds lipids through an inverted BAR 
domain (Levtsova et al., 2011). Work carried out in Drosophila indicates a potential 
role for PI(4,5)P2 in mediating membrane recruitment of Par1b; association of Par1b 
with the plasma membrane required PI(4,5)P2 generation by the PIP5K skittles 
(Gervais et al., 2008). In this study, depletion of skittles disrupted cytoskeletal 
organisation and asymmetric transport, suggesting a model where PI(4,5)P2 could 
mediate interactions between the plasma membrane, Par1b and the cytoskeleton 
(Gervais et al., 2008). Whether OCRL1 loss affects Par1b localisation through 
regulation of PI(4,5)P2 is studied in the next chapter. Over-expression of Par1b 
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appears to convert MDCK monolayers to a hepatic-like epithelium. Although the 
phenotype of OCRL1 depletion resembles the phenotype of Par1b over-expression, 
OCRL1 depleted cells do not fully take on the appearance of hepatic cells, 
suggesting a different underlying mechanism of lumen formation. These differences 
become apparent when the nature of the intracellular compartments are 
compared, discussed below.  
  
Calcium switch experiments can be performed on hepatic cells in a similar manner 
to columnar epithelia. When hepatic cells are grown in low calcium, luminal 
markers accumulate in an intracellular compartment that re-forms the bile 
canaliculi when calcium is restored (Tuma et al., 2002). However the hepatic 
intracellular apical compartment differs from the VACs observed in calcium switch 
assays performed on columnar epithelial cells. Columnar epithelia form VACs that 
stain heavily with phalloidin due to the presence of microvilli and exclusively 
accumulate apical markers. In contrast, the hepatic intracellular apical 
compartment is devoid of F-actin and the apical markers delivered to this 
compartment constitutively recycle to the plasma membrane (Tuma et al., 2002). 
Columnar epithelia and hepatic epithelia have different apical trafficking pathways 
which might explain the different characteristics of the intracellular apical 
compartments. For example, unlike columnar epithelia, hepatic cells consistently 
traffic their apical cargo via the basolateral domain (Maurice et al., 1994).   
 
When MDCK cells over-expressing Par1b are depleted of calcium, they form an 
intracellular apical compartment that resembles the intracellular compartment 
formed in hepatic cells (Cohen et al., 2004b). However, the intracellular apical 
compartments formed in OCRL1 depleted cells were more characteristic of the 
VACs formed in contact naive MDCK cells; they stained strongly with phalloidin and 
appeared to completely internalise apical proteins from the cell surface, indicating 
the absence of recycling through this compartment. Therefore unlike par1b over-
expression, MDCK cells depleted of OCRL1 retained kidney epithelial characteristics, 
suggesting OCRL1 depletion does not induce cells to become hepatic-like, and 
OCRL1 depleted cells form lumens through a different underlying mechanism. One 
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possibility is that lumen formation in OCRL1 depleted cells more closely resembles 
lumenogenesis in MDCK cyst cultures than bile canaliculi formation in hepatic 
epithelia. 
 
Lumen formation in epithelial cysts occurs when cells are immersed in a uniform 
environment of extra cellular matrix (O’Brien et al., 2002). In contrast, epithelial 
cells grown in an asymmetric environment with a plastic support on one side and 
growth media on the opposing side divide and assemble into sheets with an apical 
surface in place of a lumen. Therefore detection of asymmetry in the environment 
appears to be critical in determining the organisation of cells grown in culture. One 
possibility is that OCRL1 depleted cells lose the ability to detect external polarity 
cues and grow in 2D culture as though they were growing in 3D culture. This would 
explain why OCRL1 depleted cells appeared to maintain kidney epithelial cell 
characteristics.  
 
The position of the apical membrane or lumen is thought to be determined by the 
absence of cell adhesion, followed by targeting of apical polarity complexes to this 
region. PI(4,5)P2 has numerous roles in establishing apical membrane identity, 
recruiting several proteins that regulate expansion of the apical domain. For 
example, PI(4,5)P2 on the apical surface recruits Annexin-2, which in turn recruits 
Cdc42 and aPKC to the apical surface. Loss of PI(4,5)P2 from the apical domain 
prevents normal development of the apical surface and lumen (Martín-Belmonte et 
al., 2007), indicating the importance of PI(4,5)P2 in regulating apical membrane 
formation. In addition, there is some evidence to suggest PI(4,5)P2 may regulate 
membrane recruitment of key polarity proteins such as Par3 (Horikoshi et al., 2011; 
Krahn et al., 2010; Wu et al., 2007) as well as the exocyst complex (He et al., 2007; 
Zhang et al., 2008), which is critical for cargo trafficking to the apical membrane. 
The multiple roles of PI(4,5)P2 in recruitment of apical determinates suggests 
PI(4,5)P2 is likely to accumulate in the apical membrane early during development. 
 
The accumulation of PI(4,5)P2 in the apical domain requires a low level of PI(4,5)P2 
to be maintained on other membranes, so that the apical domain can be identified 
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as being rich in PI(4,5)P2. If depletion of OCRL1 leads to ectopic accumulation of 
PI(4,5)P2 in areas other than the apical membrane, one possibility is that key apical 
membrane determinates become mis-localised, over-riding external polarity cues 
that normally function to correctly position these complexes. Supporting this 
possibility is the finding in this chapter that PI(4,5)P2 was unusually enriched in the 
lateral membrane, a region that normally contains low levels of PI(4,5)P2. A similar 
function of OCRL1 has been identified in Drosophila during cytokinesis. Depletion of 
dOCRL1 induces ectopic accumulation of PI(4,5)P2 on intracellular membranes, 
subsequently key components of the cytokinesis machinery are mis-targeted away 
from the site of cytokinesis towards intracellular compartments (Ben El Kadhi et al., 
2011). The function of dOCRL1 during cytokinesis is to down-regulate PI(4,5)P2 on 
intracellular membranes, allowing the site of cytokinesis to appear comparatively 
rich in PI(4,5)P2 which recruits multiple contractile ring components to the furrow 
(Ben El Kadhi et al., 2011). OCRL1 may similarly function in polarisation to enable 
the correct localisation of multiple apical determinants that interact with PI(4,5)P2. 
The next chapter examines whether mis-targeting of key apical membrane 
determinants in OCRL1 depleted cells can explain the lateral lumen phenotype 
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Chapter Five 
 
OCRL1 regulates apical recycling 
pathways in MDCK cells 
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Overview 
 
In the previous chapter, the effect of OCRL1 depletion on cell polarity was studied 
in mature monolayers of MDCK cells grown in culture for up to 5 days. After 48 
hours without OCRL1, MDCK cells incorrectly formed the apical domain 
intracellularly, resembling the VACs (vacuolar apical compartments) formed in 
calcium switch experiments (Gilbert et al., 1991; van Zeijl and Matlin, 1990; Vega-
Salas et al., 1987). After 72 hours without OCRL1, MDCK cells lost the intracellular 
apical domain and instead positoned the apical domain between cells, resembling 
lateral apical lumens.  
 
The formation of VACs in calcium switch experiments is thought to occur by the 
fusion of frustrated transport vesicles unable to traffic to the plasma membrane 
(Vega-Salas et al., 1987), suggesting OCRL1 depletion might block apical trafficking 
to the cell surface. In addition, the eventual formation of the apical domain in the 
lateral region of the cell suggests OCRL1 may be required for early events in the 
polarisation process when cells establish an axis of polarity and first mark the sites 
of apical and basal membrane expasion. Both of these events, forming an axis of 
polarity and expanding polarised membrane domains, heavily depend on polarised 
trafficking pathways.  
     
Firstly, this chapter examines the role of apical trafficking in the phenotype of 
OCRL1 depletion by looking early after RNAi treatment, before intracellular vacuole 
formation. Secondly, this chapter studies the localisation of some of the key protein 
polarity complexes involved in apical-basal axis orientation in cells without OCRL1. 
The aim of these experiments was to find out whether elevated levels of PI(4,5)P2, 
after OCRL1 depletion, causes re-localisation of any of the polarity complexes that 
regulate positioning of the apical membrane. 
 
 
 
156 
  
Apical trafficking pathways are disrupted within 24 hours of RNAi 
treatment 
 
In the previous chapter, OCRL1 was depleted in monolayers of MDCK cells for 48-72 
hours. After 72 hours in culture without OCRL1, the cells had undergone extensive 
rearrangements of the cell cytoskeleton, membrane domains and intercellular 
junctions. To better understand the events that precede these rearrangements, the 
RNAi protocol was adapted so that OCRL1 was depleted for shorter amounts of 
time. Instead of depleting OCRL1 for 48-72 hours, monolayers of MDCK cells were 
depleted of OCRL1 for 24-48 hours. As in the previous chapter, monolayers 
depleted of OCRL1 for 48 hours formed perinuclear vacuoles enriched in Gp135 
(figure 5.1 second panel). However looking earlier (24 hours following the initiation 
of RNAi) revealed perinuclear accumulations of vesicular pools of Gp135 not seen 
previously (figure 5.1 top panel). The timings of these events suggests that the 
vacuoles predominantly seen at 48 hours after RNAi are formed from the fusion of 
the smaller vesiclular carriers seen 24 hours earlier. The perinuclear region of the 
cell houses numerous organelles and compartments involved in trafficking, the 
accumulation of vesicles carrying apical cargo in such a perinuclear region suggests 
that apical trafficking pathways are disrupted by loss of OCRL1. 
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Figure 5.1: OCRL1 depletion disrupts apical trafficking from a perinuclear region. 
MDCK cells were grown overnight. Cells were transfected with non‐targeting 
control or a pool of OCRL1 siRNA and fixed 24 or 48 hours later. Cells were 
permeabilised for immunostaining with antibodies to Gp135 (red) and the DNA 
stain DAPI (blue). Representative single confocal sections are shown from the 
middle of the monolayers from 2 experiments. Higher magnification images of the 
merged panels are shown in the last column. White arrows indicate vesicular pools 
of apical vesicles at 24 hours after OCRL1 RNAi and the vacuoles formed at 48 hours 
after OCRL1 RNAi. Scale bar 20 µM. 
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The role of OCRL1 prior to the development of polarity 
 
In the last experiment (figure 5.1) and in the previous chapter, polarisation was 
studied in monolayers of MDCK cells depleted of OCRL1. These cells had been 
growing in culture for 24 hours before RNAi and therefore the cells would have 
already begun polarising normally along a vertical axis before depletion of OCRL1. 
The process of switching from a vertical to a horizontal axis when OCRL1 is depleted 
takes approximately 72 hours; lateral apical lumens are fully formed by this time. 
During the course of approximately 72 hours without OCRL1, cells growing in 
monolayers initially seem to accumulate apical cargo in a vesicular perinuclear pool 
before forming perinuclear VACs which appear to be exocytosed in the lateral 
membrane. For the remainder of this chapter, OCRL1 was depleted in cells which 
had a limited amount of time to polarise before RNAi. In this new protocol, MDCK 
cells were plated at a very low density, usually as single cells for just a few hours 
before OCRL1 depletion. These cells would therefore undergo the earliest stages of 
polarisation without OCRL1. In addition, fixation and analysis took place 17-24 
hours post RNAi, even earlier than above (figure 5.1). These changes made to the 
protocol limit the oportunity for cells to begin polarising without OCRL1 so that the 
role of OCRL1 in this process can be better studied.  
   
Due to the short time-frame of the RNAi protocol, some cells on the coverslip 
remained as single cells at the time of analysis. These single cells had not 
undergone a cell division during the course of the experiment. Other cells on the 
coverslip were growing in pairs which may have divided and some cells were 
growing in small groups. Un-polarised MDCK cells treated with control or silencing 
oligonucleotides were stained for the apical marker Gp135. In single cells treated 
with non-targetting control siRNA, Gp135 was enriched on the cell surface, but also 
intracellularly in a perinuclear pool (figure 5.2A). This perinuclear pool was not seen 
in polarised monolayers of control cells (figure 5.1) and is likely to be a 
characteristic of cells early in polarisation (Meder et al.,2005). An XZ reconstruction 
of a single control cell revealed exclusion of Gp135 from the basal domain where 
the membrane contacts the underlying support (figure 5.3A). This agrees with 
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previous findings for Gp135 in single MDCK cells, indicating some level of polarity 
even at the single cell stage (Meder et al., 2005). In contrast to control cells, OCRL1 
depleted cells accumulated Gp135 entirely intracellularly and had no detectable 
Gp135 on the cell surface (figure 5.2B and figure 5.3B).  
 
In pairs of cells treated with non-targeting control siRNA, Gp135 had polarised to 
the early apical membrane, and was mostly excluded from the cell-cell contact as 
well as the basal surface (figure 5.3A). However, in control cells, a faint vesicular 
pool of Gp135 was seen near the cell-cell contact (figure 5.2A), suggesting some 
apical cargo is trafficked to this site normally. In paired cells polarising without 
OCRL1, Gp135 was entirely trafficked to a specific site in the lateral membrane 
(figure 5.2B). Since lateral lumens are formed in similar regions of OCRL1 depleted 
cells, it is likely that this pair of cells was undergiong early lumen formation, 
resembling trafficking of apical carriers to the AMIS (apical membrane insertion 
site) during early lumen formation (Bryant et al., 2010). Some OCRL1 depleted cells 
on the coverslip had formed resolvable lumens during the course of the experiment 
(figure 5.2B and figure 5.3B). Therefore depletion of OCRL1 in un-polarised MDCK 
cells growing at very low density induced the formation of lateral lumens similar to 
those seen in the previous chapter, where OCRL1 was depleted in MDCK cells 
growing as monolayers. Similar results were found in MDCK cells  stably expressing 
GFP-Gp135 (figure 5.4). Plating these cells for just a few hours before RNAi 
treatment and observing them 17 hours after RNAi resulted in perinuclear 
accumulations of GFP-Gp135 in single cells and the formation of vacuoles between 
neighbouring cells treated with OCRL1 siRNA (figure 5.4).  
  
These results indicate that depletion of OCRL1 first results in an accumulation of 
vesicular Gp135 intracellularly which appears to be trafficked to the site of apical 
membrane formation on the lateral membrane between paired cells. However, in 
contrast to cells growing in monolayers (Chapter 4), un-polarised cells depleted of 
OCRL1 almost always formed lateral lumens without an intermediary VAC stage. 
Instead, lateral lumens appeared to be formed directly from the vesicular pool of 
apical material (figure 5.2B). In addition, the process of lumen formation occurred a 
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lot quicker in un-polarised cells compared to monolayers, with the whole process of 
repolarisation complete in 24 hours compared to 72 hours. This difference could be 
due to the requirement for MDCK monolayers to reorient themselves as they 
switch from a vertical to horizontal plane of polarity. In addition their extensive 
contacts with neighbouring cells require cells growing in monolayers to coordinate 
the switch in polarity more so than a lone pair of cells. Therefore, with these 
additional requirements, lateral lumen formation is likely to take longer in cells 
growing as monolayers compared to cells growing in isolation. One possibility is 
that a delay in trafficking of the vesicular pool of Gp135 to the lateral membrane in 
cells growing as monolayers results in the fusion of these vesicles to form an 
intermediary VAC-like structure.  
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Figure 5.2: Lumen formation in cells plated at low confluence and depleted of 
OCRL1 for 17 hours. MDCK cells were plated as single cells and grown for 4 hours 
before treatment with either non‐targeting control (A) or a pool of OCRL1 siRNA 
(B). After 17 hours the cells were fixed and permeabilised for immunostaining with 
antibodies to Gp135 (red) and F-actin stain phalloidin (green) and the DNA stain 
DAPI (blue). Representative single confocal sections are shown of single cells, paired 
cells and cells growing in groups. Experiment repeated twice (n=20 cells observed 
per treatment). White arrows indicate peripheral membrane localisation of Gp135 
in control cells (A) and perinuclear or lateral lumen localisation of Gp135 in OCRL1 
depleted cells (B). Scale bar 10 µM. 
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Figure 5.3: XZ constructions of lumen formation in OCRL1 depleted cells. These 
cells were on the same coverslips as cells in figure 5.2. XZ sections were 
reconstructed from stacks of 40 single confocal sections. White arrows indicate 
peripheral membrane localisation of Gp135 in control cells (A) and perinuclear or 
lateral lumen localisation of Gp135 in OCRL1 depleted cells (B). Experiment 
repeated twice (n=20 cells observed per treatment). Scale bar 10 µM. 
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Figure 5.4: GFP tagging of Gp135 has no effect on its trafficking after OCRL1 
depletion. MDCK cells stably expressing GFP-Gp135 were grown and subjected to 
RNAi as in figure 5.2. Cells were fixed and permeabilised for staining with the DNA 
stain DAPI. Representative confocal sections are shown of a single cell, paired cells 
and cells growing in small groups expressing GFP-Gp135 (n=20 cells observed for 
each treatment in a single experiment). Cells not expressing GFP-Gp135 are 
indicated (*). Scale bar 10 µM. 
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OCRL1 depletion blocks apical recycling  
 
Without OCRL1, MDCK cells accumulate apical membrane in a perinuclear 
compartment. This material could be biosynthetic; newly produced Gp135 exiting 
the TGN, or endocytic from recycling pathways. OCRL1 depletion appears to result 
in a block in exiting of Gp135 from one of these compartments to the plasma 
membrane. To determine whether the perinulear Gp135 in OCRL1 depleted cells 
was endocytic, cells were plated at low density and depleted of OCRL1 in the 
presence of 10kDa rhodamine dextran in the media. Single cells lacking OCRL1 
accumulated rhodamine dextran intracellularly (figure 5.5), and lateral vacuoles 
formed between cells were also filled with endocytosed fluid (figure 5.5), indicating 
that MDCK cells depleted of OCRL1 form apical lumens from endocytosed material.  
 
Since a small pool of Gp135 localised to a perinuclear region in control cells (see 
figure 5.2A), it was possible to carry out FRAP (fluorescence recovery after 
photobleaching) analysis on live untreated cells  stably expressing GFP-Gp135. In 
this experiment, the perinuclear pool of GFP-Gp135 in one cell was photobleached, 
but left intact in a neighbouring control cell. The bleached perinuclear region 
quickly recovered in approximately 15 minutes (figure 5.6). These results indicate 
that in wild type MDCK cells, Gp135 recycles from a perinuclear region to the 
plasma membrane, and together with the results above suggest OCRL1 depletion 
might disrupt this pathway.  
 
To confirm the intracellular pool of Gp135 was endocytic, we tested for localisation 
of Rab11 to these compartments. In MDCK cells, Rab11A marks the apical recycling 
endosome (Casanova et al., 1999). In both control cells (figure 5.7A) and OCRL1 
depleted cells (figure 5.7B), the intracellular pool of GFP-Gp135 co-localised with 
Rab11A, agreeing with the previous finding that intracellular Gp135 localises to 
Rab11 positive compartments (Meder et al., 2005). However, the accumulation of 
Rab11 in the perinuclear region appeared denser in OCRL1 depleted cells compared 
to controls (figure 5.7B compared to figure 5.7A). In addition to the co-localisation 
of GFP-Gp135 with Rab11A in the perinuclear region, more peripheral puncta also 
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co-localised, indicated in higher magnification images (figure 5.7A/B). Another 
characteristic marker of apical trafficking pathways in MDCK cells is Rab8, which 
cooperates with Rab11 to target apical vesicles to the apical membrane (Bryant et 
al., 2010). Since Rab11 distribution was affected by OCRL1 depletion, we looked to 
see if Rab8 distribution was also affected. In a similar manner to Rab11, Rab8 
accumulated in a perinuclear region and was denser than controls (figure 5.8). 
Gp135 co-localised with the Rab8 compartment in the perinuclear region of OCRL1 
depleted cells (figure 5.8). In addition, double positive vesicles outside the main 
peri-nuclear region were also observed, indicated in higher magnification images 
(figure 5.8). These results suggest OCRL1 depletion causes the retention of apical 
cargo in exaggerated Rab11/Rab8 positive compartments in the perinuclear region 
of the cell.  
 
In addition to altering the disribution of apical markers, OCRL1 depletion markedly 
affected the distribution of the cation-independent mannose-6-phosphate receptor 
(CI-MPR) which normally traffics between the TGN and endosomes. OCRL1 
depleted cells lost the central Golgi apparatus pool of MPR which was clearly visible 
in control cells (figure 5.9). Instead of the Golgi apparatus pool, OCRL1 depleted 
cells showed an increase in peripheral MPR containing vesicles (figure 5.9), likely to 
be endosomes, also shown previously (Choudhury et al., 2005; Vicinanza et al., 
2011). Therefore OCRL1 depletion appears to affect multiple apical trafficking 
pathways through a variety of endosome populations.  
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Figure 5.5: Lateral lumens are connected to fluid-phase endocytic pathways. 
MDCK cells were grown and treated with siRNA as in figure 5.2 in the presence of 
10Kda rhodamine dextran for 17 hours and the DNA stain Hoechst 34233 for 30 
minutes before fixation. Cells were left un-permeabilised. Representative single 
confocal sections are shown of a single cell and paired cells on the coverslip. White 
arrows indicate the perinuclear accumulation of rhodamine dextran in a single cell, 
and a lateral vacuole formed between paired OCRL1 depleted cells. Representative 
images are shown from 3 experiments. Scale bar 10 µM. 
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Figure 5.6: GFP-Gp135 recycles rapidly in wild-type MDCK cells. MDCK cells stably 
expressing GFP-Gp135 were plated on a MaTek dish and grown for 5 hours.  Cells 
were imaged live in phenol free media at 37 οC with maximum pinhole diameter. 
One region of interest (ROI) shown in blue was bleached using Leica FRAP software, 
while the other was left unaffected (red). Images were taken every 2.5 minutes for 
17.5 minutes, some of these are shown in black and white. The images were aligned 
to account for movements in the plane using the StackReg plugin in image J and 
intensity over time values for the ROI were calculated in image J. Values were 
normalised against background fluorescence intensity. Representative images are 
shown from 3 experiments. Scale bar 10 µM. 
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Figure 5.7A: Gp135 traffics through Rab11 positive compartments in control cells. 
MDCK cells stably expressing GFP-Gp135 were grown and treated with non-
targeting control siRNA as in figure 5.2. Cells were fixed and permeabilised for 
staining with antibodies to Rab11A (red) and the DNA stain DAPI (blue). 
Representative confocal sections are shown of a single control cell and paired 
control cells (n=10 cells observed per treatment across 2 experiments). Higher 
magnification images are shown in the bottom panel. White arrows indicate regions 
where GFP-Gp135 and Rab11A co-localise. Continued on the next page. Scale bar 
10 µM. 
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Figure 5.7B: Gp135 accumulates in Rab11 positive compartments without OCRL1. 
MDCK cells stably expressing GFP-Gp135 were grown and treated with pooled 
OCRL1 siRNA as in figure 5.2. Cells were fixed and permeabilised for staining with 
antibodies to Rab11A (red) and the DNA stain DAPI (blue). Representative confocal 
sections are shown of a single OCRL1 depleted cell and paired OCRL1 depleted cells 
(n=10 cells observed per treatment across 2 experiments). Higher magnification 
images are shown in the bottom panel. White arrows indicate regions where GFP-
Gp135 and Rab11A co-localise. Scale bar 10 µM. 
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Figure 5.8: Gp135 accumulates in Rab8 positive compartments upon OCRL1 
depletion. MDCK cells were grown and subjected to RNAi as in figure 5.2. Cells 
were fixed and permeabilised for staining with Gp135 (red), Rab8 (green) and the 
DNA stain DAPI (blue). Representative confocal sections are shown of single OCRL1 
depleted cells (n=10 cells observed per treatment across 2 experiments). Higher 
magnification images are shown of the OCRL1 depleted cell. White arrows indicate 
punctate regions where Gp135 and Rab8 co-localise. Scale bar 10 µM. 
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Figure 5.9: OCRL1 depletion redistributes the mannose-6-phosphate receptor. 
MDCK cells were grown and subjected to RNAi as in figure 5.2. Cells were fixed and 
permeabilised for staining with phalloidin (red), CI-M6PR (green) and the DNA stain 
DAPI (blue). Representative confocal sections are shown from the middle of the 
monolayer. White arrows indicate the perinuclear region of M6PR localisation in 
control cells which is missing from OCRL1 depleted cells. Scale bar 10 µM. 
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OCRL1 depletion redistributes apical polarity proteins during early 
polarisation 
 
Apical–basolateral polarity is initiated by the asymmetric distribution of a number 
of conserved polarity protein complexes which direct downstream events such as 
polarised membrane traffic and cytoskeleton organisation. However, the polarised 
distribution of these protein complexes in turn depends on membrane trafficking 
(Lalli et al., 2009), highlighting the role that membrane trafficking plays in both 
initiating and reinforcing cell polarity. A Rab11/Rab8-dependent trafficking pathway 
has been shown to localise the Par complex to the nascent apical membrane 
(Bryant et al., 2010). The Par complex is responsible for regulating apical membrane 
expansion and junction assembly and is composed of aPKC, Par3 and Par6, as well 
as the Rho family GTPase Cdc42. In addition the Par complex can exist as two 
separate complexes; Cdc42–Par6–aPKC is associated with the apical surface 
whereas Par3–aPKC is associated with the tight junction.  
 
Upon depletion of OCRL1, a dense cluster of Rab11/Rab8 positive vesicles 
accumulate intracellularly and appear to be linked to lateral apical lumen 
formation. Given the role of the Par complex in apical membrane formation, we 
decided to investigate whether the abnormal vesicles observed upon depletion of 
OCRL1 result in a redistribution of Par complex components. This complex is 
particularly relevant as several of them could be recruited to aberrant pools of 
internal PI(4,5)P2 directly, such as Par3 (Horikoshi et al., 2011; Krahn et al., 2010; 
Wu et al., 2007) or indirectly, such as Cdc42, via Annexin-2 (Martín-Belmonte et al., 
2007).  
  
Firstly, we looked at the localisation of Par6 in control and OCRL1 depleted cells 
that had internalised vesicular pools of Gp135. In control cells, Par6 mostly localised 
to the plasma membrane, with some cytosolic vesicles (figure 5.10). In OCRL1 
depleted cells, Par6 was lost from the plasma membrane and accumulated in a 
perinuclear cluster of vesicles (figure 5.10). The Par6 positive vesicles co-localised 
with the perinuclear pool of Gp135 in OCRL1 depleted cells, suggesting that Par6 
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may be trafficked in the same Rab11/Rab8 pathway previously characterised for 
Gp135 (figure 5.7 and figure 5.8). Higher magnification images of the OCRL1 
depleted cell revealed double positive dots (Par6 and Gp135) outside the main 
perinuclear region and near the plasma membrane  (figure 5.10 bottom panel), 
further suggesting they are trafficked in the same pathway (figure 5.10)  
  
This perinuclear pool of Par6 in OCRL1 depleted cells was likely to be in complex 
with aPKC and possibly Cdc42, forming the Cdc42–Par6–aPKC complex. To test for 
this we checked the localisation of aPKC and Cdc42 in control and OCRL1 depleted 
cells. The perinuclear accumulations of Par6 which co-localised with Gp135 above 
(figure 5.10) also co-localised with aPKC (figure 5.11B).  Interestingly, the vesicular 
pool of aPKC and Par6 was only apparent in single OCRL1 depleted cells (figure 
5.11B top panel). In pairs of OCRL1 depleted cells a different pattern of localisation 
was observed. Pairs of OCRL1 depleted cells displayed enriched localisation of Par6 
in a region of the lateral membrane (figure 5.11B second panel). This pair of cells 
may have formed a lateral lumen which was not vet resolvable by confocal 
microscopy. Control cells showed a similar change in localisation between single 
and paired cells; in single cells there was a large intracellular pool of aPKC and Par6 
which was re-localised to a region near the tight junction in pairs of cells (figure 
5.11A XZ images). To localise Cdc42, we expressed Cdc42 as a GFP tagged construct. 
In OCRL1 depleted cells, some of the vesicular Gp135 was also positive for Cdc42, 
indicated in higher magnification images (figure 5.12), suggesting the possibility 
that trafficking of the entire Cdc42–Par6–aPKC complex was disrupted in cells 
without OCRL1. 
   
In the same experiment as figure 5.11, we localised the basolateral polarity protein 
scribble in control and OCRL1 depleted cells. In single control cells, scribble 
primarily localised to the plasma membrane but was re-localised to the lateral 
border in pairs of cells (figure 5.11A). In OCRL1 depleted cells, scribble was primarily 
located on the peripheral membrane similarly to controls and was not present on 
the vesicular pool containing Gp135 and the Par6-aPKC polarity complex (figure 
5.11B). These results suggest that OCRL1 depletion does not affect trafficking of 
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basolateral components and support the specific apical nature of the pathway 
affected by loss of OCRL1. Since scribble marks the lateral domain and Par6 marks 
the apical side of the tight junction, their localisation is to distinct regions of the 
plasma membrane. XZ images of control cells show lateral membrane enrichment 
of scribble separate from apically localised Par6 and aPKC (figure 5.11A). Similarly in 
OCRL1 depleted cells, scribble and Par6 localised in a mutually exclusive manner 
(figure 5.11B). However, lateral scribble was disrupted by the abnormal localisation 
of Par6 and aPKC in OCRL1 depleted cells, where Par6-aPKC localised laterally, 
scribble was excluded (figure 5.11B). These findings suggest that separation of the 
two pathways (apical and basolateral) is maintained after OCRL1 depletion. 
 
In addition to Par6, Par3 is a major component of the Par complex that localises to 
the tight junction. While in pairs of control cells, Par3 localised to the region of the 
tight junction, Par3 localisation in OCRL1 depleted cells was perturbed (figure 5.13). 
In OCRL1 depleted cells, Par3 did not co-localise with the vesicular pool of Gp135, 
showing a different localisation than Par6 (figure 5.11B). Instead, Par3 seemed to 
mark the site of delivery for the vesicular apical cargo along the intercellular 
contact of OCRL1 depleted cells (figure 5.13). However, Par3 did not span the 
length of the cell-cell contact as in control cells, but was condensed to a region near 
the middle of the cell contact (figure 5.13). The reorganisation of Par3 can clearly 
be seen in 3D reconstructions of OCRL1 depleted cells undergoing the early stages 
of lateral lumen formation (figure 5.14). Pools of vesicular Gp135 accumulated at 
sites marked by Par3 which appeared to have been reorganised. As lumens were 
being formed from vesicular apical carriers, Par3 appeared to be reorganised from a 
single horizontal band, resembling a normal arrangement of the tight junction, to a 
circular arrangement around the lumen (figure 5.14). These rings of Par3 likely 
represent the junctional pool of Par3, since rings of Par3 co-localised with ZO-1 in 
OCRL1 depleted cells that had formed lateral lumens (figure 5.15). 
 
We showed above (figure 5.11B) that abnormal lateral localisations of Par6 and 
aPKC disrupted the lateral localisation of the basolateral protein scribble. Besides 
the Scribble complex, there are additional polarity proteins involved in basolateral 
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membrane formation including Par1b. Par1b is particularly relevant as it has been 
shown to regulate events at the basement membrane that influence the 
localisation of the apical membrane. Over-expression of Par1b induced lateral 
lumens in 2D cultures of MDCK cells similar to depletion of OCRL1 (Cohen et al., 
2004a, 200b, 2007 and 2011). In OCRL1 depleted cells, the localisation of Par1b was 
similar to the localisation of scribble, correctly localising to the lateral membrane 
but disrupted by aberrant localisation of apical components to the lateral 
membrane (figure 5.16). Par1b was excluded from the site of early lumen formation 
in the lateral domain, characterised by trafficking of Gp135 to a region in the cell-
cell contact. This can be seen more clearly in XZ images (figure 5.17), showing 
lateral localisation of Par1b disrupted by a cluster of Gp135 vesicles. Therefore in 
OCRL1 depleted cells, the tight junction and apical membrane is formed in the 
lateral membrane between cells which interrupts basolateral determinants such as 
scribble and Par-1b.   
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Figure 5.10: OCRL1 depletion redistributes Par6 to a perinuclear region. MDCK 
cells were grown and subjected to RNAi as in figure 5.2. Cells were fixed and 
permeabilised for staining with Gp135 antibodies (green), Par6 antibodies (red) and 
the DNA stain DAPI (blue). Representative single confocal sections are shown (n=10 
cells observed per treatment across 1 experiment). Higher magnification images are 
shown in the bottom panel of the OCRL1 depleted cell. White arrows indicate 
regions where Gp135 and Par6 co-localise in OCRL1 depleted cells. Scale bar 5 µM. 
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Figure 5.11: Par6 and aPKC are trafficked to lateral lumens. MDCK cells were 
grown and subjected to RNAi as in figure 5.2. Cells were fixed and stained with 
antibodies to scribble (red), Par6 (green) and aPKC (blue). Representative single 
confocal sections are shown of single and paired cells treated with non-targeting 
control (A) or OCRL1 siRNA (B). n=10 cells observed per treatment across 2 
experiments. An XZ reconstruction is shown of a pair of control cells (A) and a 3D 
reconstruction is shown of a pair of OCRL1 depleted cells (B). Reconstructions were 
from Z stacks of 20 confocal sections and were carried out in ImageJ. Scale bar 10 
µM. 
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Figure 5.12: Cdc42 partially co-localises with vesicular Gp135. MDCK cells were 
grown and subjected to RNAi as in figure 5.2. 6 hours after RNAi the cells were 
transfected with Cdc42-GFP DNA and left for a further 17 hours. Cells were fixed 
and permeabilised for staining with antibodies to Gp135 (red). Representative 
single confocal sections are shown of single control and OCRL1 depleted cells (n=10 
cells observed per treatment across 3 experiments). Higher magnification images 
are shown in the inset of the OCRL1 depleted cells. White arrows indicate regions 
where Gp135 and Cdc42-GFP co-localise. Scale bar 10 µM. 
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Figure 5.13: Vesicular Gp135 is targeted to Par3 on the lateral membrane. MDCK 
cells were grown and subjected to RNAi as in figure 5.2. Cells were fixed and 
permeabilised for staining with antibodies to Gp135 (red), Par3 (green) and the 
DNA stain DAPI (blue). Images shown are representative of all paired control and 
OCRL1 depleted cells on the coverslip of a single experiment (n=20). White arrows 
indicate accumulations of Gp135 between bands of Par3 in OCRL1 depleted cells. 
Scale bar 10 µM. 
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Figure 5.14: Par3 is reorganised as lateral lumens are formed. MDCK cells were 
grown and subjected to RNAi as in figure 5.2. Cells were fixed and stained with 
antibodies to Gp135 (red), Par3 (green) and the DNA stain DAPI (blue). All images 
shown are 3D reconstructions in ImageJ from Z-stacks of 20 confocal sections set to 
0% transparency. Regions of image 1 and 2 are shown at higher magnification in the 
bottom panel. Arrows indicate reorganisation of Par3 into ring-like structures. Blue 
arrows indicate parts of the ring facing the bottom of the image stack, and white 
arrows indicate parts of the ring towards the top of the stack. Scale bar 10 µM. 
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Figure 5.15: Par3 marks the tight junction in cells that have formed lateral lumens. 
MDCK cells were grown and subjected to RNAi as in figure 5.2. Cells were fixed and 
permeabilised for staining with antibodies to the tight junction marker ZO-1 (red), 
Par3 (green) and the DNA stain DAPI (blue). Images shown are representative of all 
paired control and OCRL1 depleted cells on the coverslip of a single experiment 
(n=20). White arrows indicate sites of ZO-1 and Par3 co-localisation. Scale bar 10 
µM. 
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Figure 5.16: Lumen formation initiates in the lateral membrane marked by Par1b. 
MDCK cells stably expressing GFP-Gp135 were grown and subjected to RNAi as in 
figure 5.2. Cells were fixed and stained with antibodies to Par1b (red), and the DNA 
stain DAPI (blue). Images shown are representative of all paired control and OCRL1 
depleted cells on the coverslip of a single experiment (n=20). White arrows indicate 
lateral localisation of Par1b in control cells and sites of Gp135 delivery in OCRL1 
depleted cells. Scale bar 10 µM. 
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Figure 5.17: XZ images of early lumen formation in the lateral membrane. MDCK 
cells stably expressing GFP-Gp135 were grown and subjected to RNAi as in figure 
5.2. Cells were fixed and stained with Par1b antibodies (red), and the DNA stain 
DAPI (blue). XZ images were constructed from Z-stacks of 20 single confocal 
sections. White arrows indicate lateral localisation of Par1b in control cells and sites 
of Gp135 delivery in OCRL1 depleted cells. Scale bar 10 µM. 
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PI(4,5)P2 is enriched on apical carriers when OCRL1 is depleted 
 
OCRL1 is localised to the TGN and a variety of endosome populations. Since OCRL1 
is a 5-phosphatase It is likely that OCRL1 functions to regulate the levels of PI(4,5)P2 
on these compartments. Small levels of PI(4,5)P2 on endosomes is thought to aid 
the budding process by recruiting proteins involved in membrane curvature and by 
promoting F-actin organisation near the bud. Therefore PI(4,5)P2 may be present on 
the TGN and endosomes normally at a low but functionally important level which 
would need to be regulated spatially and temporally by phosphatases such as 
OCRL1.  
  
When OCRL1 is depleted, the population of PI(4,5)P2 at the Golgi apparatus and 
endosomes might increase beyond normal levels, affecting endosome function. In 
yeast, inactivation of synaptojanins results in an accumulation of PI(4,5)P2 
intracellularly due to the lack 5-phosphatase activity (Stefan et al. in 2002). In HeLa 
cells, OCRL1 depletion results in detectable levels of PI(4,5)P2 intracellularly, using 
the GFP tagged PLCδ-PH probe (Vicinanza et al., 2011). The intracellular PI(4,5)P2 in 
these cells co-localised with the transferrin receptor, suggesting increasing the level 
of this phosphoinositide may affect trafficking pathways (Vicinanza et al., 2011). To 
determine whether OCRL1 depletion effects the intracellular levels of PI(4,5)P2 in 
MDCK cells, we also used the PH domain of PLCδ, expressed as a GFP fusion 
protein, as in figure 4.9. In OCRL1 depleted cells polarising for the first time but 
lacking OCRL1, pools of PI(4,5)P2 were visible in a perinuclear region which was 
clearly absent from control cells (figure 5.18). We next checked whether this pool of 
PI(4,5)P2 co-localised with the vesicular Gp135 seen in the absence of OCRL1. This 
intracellular pool of PI(4,5)P2 co-localised with the perinuclear Gp135 present when 
cells were depleted of OCRL1 (figure 5.19), indicating PI(4,5)P2 enrichment on apical 
carriers.  
 
Elevated levels of PI(4,5)P2 on endosomes when OCRL1 is depleted has been 
reported for other renal proximal tubule cell lines, namely HK-2 cells (Vicinanza et 
al., 2011). In these cells, the PI(4,5)P2 induced the accumulation of F-actin on 
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endosomal membranes (Vicinanza et al., 2011). Images of MDCK cells depleted of 
OCRL1 above (figure 5.2) suggested F-actin was present intracellularly, co-localising 
with vesicular Gp135 in the perinuclear region (figure 5.2B). Interestingly, at this 
early stage in polarisation, when cells were growing in isolation, even control cells 
had a large perinuclear cluster of Gp135, however no detectable F-actin was 
present on these structures. These observations suggest the abundance of F-actin 
in the perinuclear region was specific to loss of OCRL1. We checked to see whether 
this punctate F-actin co-localised with the PI(4,5)P2 positive vesicles seen in the 
absence of OCRL1. In OCRL1 depleted cells, F-actin, PI(4,5)P2 and Gp135 was all 
found to be enriched in the perinuclear region of the cell (figure 5.20). Previously 
the Gp135 compartment was identified as Rab11 and Rab8 positive, expressing the 
PH domain of PLCδ in OCRL1 depleted cells and staining for Rab11 revealed 
PI(4,5)P2 to be present on this endosomal compartment but not at detectable levels 
in control cells (figure 5.21). In summary, these results suggest that OCRL1 
depletion in MDCK cells leads to the accumulation of PI(4,5)P2 and F-actin on apical 
recycling endosomes, potentially blocking exit of apical cargo such as Gp135 from 
this compartment.   
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Figure 5.18: PI(4,5)P2 accumulates intracellularly in live OCRL1 depleted cells. 
MDCK cells were grown on MaTek dishes and subjected to RNAi as in figure 5.2. 6 
hours after RNAi the cells were transfected with PLCδ-PH-GFP DNA (PI(4,5)P2 
binding domain) and left for a further 17 hours. 1 hour before imaging the cells 
were incubated with the live cell DNA stain Hoechst 33342 (blue) which was 
washed off before analysis. Cells were imaged in phenol free media on a 
microscope stage pre-warmed to 37 οC. Single confocal sections of single cells are 
shown. A higher magnification image of the OCRL1 depleted cell is shown in the 
inset. White arrow indicates vesicular accumulations of PI(4,5)P2 in an OCRL1 
depleted cell. Images shown are representative of all control and OCRL1 depleted 
cells observed in 3 experiment (n=15). Scale bar 10 µM. 
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Figure 5.19: PI(4,5)P2 co-localised with internal Gp135 after OCRL1 depletion. 
MDCK cells were grown and subjected to RNAi as in figure 5.2 and transfected with 
PLCδ-PH-GFP DNA (PI(4,5)P2 binding domain) as in figure 5.18. Cells were fixed and 
permeabilised for staining with antibodies to Gp135 (red). Single confocal sections 
are shown of single control and OCRL1 depleted cells (n=10, 2 experiments). Higher 
magnification images of OCRL1 depleted cells are shown in the insets. Scale bar 10 
µM. 
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Figure 5.20: F-actin accumulates on PI(4,5)P2 positive pools of Gp135. MDCK cells 
were grown and subjected to RNAi as in figure 5.2 and transfected with PLCδ-PH-
GFP DNA (PI(4,5)P2 binding domain) as in figure 5.18. Cells were fixed and 
permeabilised for staining with antibodies to Gp135 (red) and the actin stain Cy5-
phalloidin (blue). Single confocal sections are shown of control and OCRL1 depleted 
cells (n=10, 2 experiments). Higher magnification images are shown of the OCRL1 
depleted cell. Scale bar 10 µM. 
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Figure 5.21: Internal PI(4,5)P2 co-localises with Rab11A upon OCRL1 depletion. 
MDCK cells were grown and subjected to RNAi as in figure 5.2 and transfected with 
PLCδ-PH-GFP DNA (PI(4,5)P2 binding domain) as in figure 5.18. Cells were fixed and 
permeabilised for staining with Rab11A antibodies (red) and the DNA stain DAPI 
(blue). Single confocal sections are shown of control and OCRL1 depleted cells 
(n=10, 2 experiments). Higher magnification images are shown of the OCRL1 
depleted cell. White arrows indicate the regions of PI(4,5)P2 and Rab11A co-
localisation in an OCRL1 depleted cell. Scale bar 10 µM. 
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Apical recycling requires down-regulation of 5-phosphoinositides 
 
Since PI(4,5)P2 and F-actin accumulate on endosomes without OCRL1 (figure 5.20 
and figure 5.21), one possibility is that elevated levels of PI(4,5)P2 on the 
membranes of these compartments blocks exit of apical cargo. To test this, we 
carried out a series of rescue experiments where endogenous OCRL1 was depleted 
with siRNA oligos specific for canine OCRL1 and recombinant full length human 
OCRL1 or a phosphatase-null mutant was re-expressed as a GFP fusion protein. The 
aim of these experiments was to determine whether the phosphatase domain of 
OCRL1, which down-regulates the levels of PI(4,5)P2, is required to rescue the apical 
recycling defect induced by OCRL1 depletion.  
  
Firstly, we co-transfected a GFP expressing plasmid together with control or OCRL1 
siRNA to demonstrate that addition of the plasmid DNA did not affect the results of 
the experiment. OCRL1 depleted cells expressing GFP appeared the same as un-
transfected neighbours, accumulating Gp135 entirely in a perinuclear pool (Knock-
down; figure 5.22A). Similarly, cells treated with control siRNA and expressing GFP 
were comparable to neighbouring cells and Gp135 localised to the peripheral 
membrane (Knock-down control; figure 5.22B). These results can be clearly seen in 
higher magnification images of GFP expressing cells neighbouring un-transfected 
cells (figure 5.22A/B).  
  
We next carried out the same experiment using full length OCRL1 tagged with GFP 
or a phosphatase-null mutant. OCRL1 depleted cells expressing the full length 
protein with phosphatase domain intact was able to rescue recycling of Gp135. In 
OCRL1 depleted cells re-expressing the full length protein, Gp135 predominately 
localised to the plasma membrane (Rescue; figure 5.22C) and these cells were 
comparable to cells transfected with a combination of non-targeting control siRNA 
and GFP (Knock-down control; figure 5.22B). Cells not expressing full length OCRL1 
and treated with OCRL1 siRNA maintained the recycling defect (Rescue; figure 
5.22C), indicating that expression of full length human OCRL1 was responsible for 
rescuing the phenotype. Cells rescued by re-expressing OCRL1 neighbouring non-
191 
  
expressing OCRL1 depleted cells are shown in higher magnification images (Rescue; 
figure 5.22C). These results suggest that re-expression of OCRL1 can rescue the 
recycling defect seen upon depletion of OCRL1 and indicate that these effects are 
specific to OCRL1 levels. We next carried out similar rescue experiments with the 
phosphatase-null mutant OCRL1 (Rescue control; figure 5.22D). Cells depleted of 
OCRL1 but expressing the phosphatase-null mutant OCRL1 were indistinguishable 
from neighbouring cells not expressing the protein and were comparable to OCRL1 
depleted cells expressing GFP alone (Knock-down control; figure 5.22B); therefore 
OCRL1 lacking phosphatase activity was unable to rescue the recycling defect 
caused by loss of the endogenous protein (Rescue control; figure 5.22D). These 
results suggest that the phosphatase activity of OCRL1 is required to rescue apical 
recycling in OCRL1 depleted cells.  
 
The results of the rescue experiment can be seen clearly in XZ images of cells in this 
experiment. Cells expressing GFP and treated with OCRL1 siRNA (Knock down; 
figure 5.23A) or control siRNA (Knock-down control; figure 5.23B) were similar in 
appearance to their un-transfected neighbours. However, cells treated with OCRL1 
siRNA and transfected with full length OCRL1 were not comparable to their un-
transfected neighbours (Rescue; figure 5.23C). In these cells, Gp135 localised to the 
plasma membrane of the re-expressing cell but was absent from the plasma 
membrane in the un-transfected neighbour (Rescue; figure 5.23C). In contrast, this 
effect was not observed with cells re-expressing the phosphatase-null mutant 
OCRL1. Despite expression of the mutant OCRL1, both the transfected cell and its 
un-transfected neighbour lost the plasma membrane localisation of Gp135 which 
accumulated intracellularly (Rescue control; figure 5.23D). These results suggest the 
phosphatase domain of OCRL1 is required for endosomal recycling of Gp135 to the 
plasma membrane.  
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Figure 5.22A: The phenotype of OCRL1 depletion is unaffected by expression of 
GFP. MDCK cells were grown as in figure 5.2. 6 hours after plating the cells were co-
transfected with OCRL1 siRNA and a GFP expressing plasmid and left for a further 
17 hours. Cells were fixed and permeabilised for staining with Gp135 antibodies 
(red). Representative single confocal sections are shown of transfected OCRL1 
depleted cells and their un-transfected neighbours (*). Experiment repeated twice, 
results shown from a single experiment. A higher magnification image is shown of 
the merged OCRL1 depleted cell. White arrow indicates perinuclear pool of Gp135 
in a transfected cell. Scale bar 10 µM. 
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Figure 5.22B: The appearance of control cells is unaffected by expression of GFP. 
MDCK cells were grown, treated with non-targeting control siRNA, transfected with 
GFP, fixed and stained as in A. Representative single confocal sections are shown of 
transfected control cells and their un-transfected neighbours (*).Experiment 
repeated twice, results shown from a single experiment. A higher magnification 
image is shown of the merged control cell. White arrow indicates peripheral 
localisation of Gp135 in transfected cell. Scale bar 10 µM. 
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Figure 5.22C: Re-expression of full length OCRL1 rescues apical recycling. MDCK 
cells were grown, treated with OCRL1 siRNA, transfected with OCRL1-GFP, fixed and 
stained as in A. Representative confocal sections are shown of transfected cells and 
their un-transfected neighbours (*).Experiment repeated twice, results shown from 
a single experiment. Higher magnification images are shown of the merged 
channels. White arrows indicate peripheral localisation of Gp135 in transfected cells 
which is absent from un-transfected cells. Scale bar 10 µM. 
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Figure 5.22D: The phosphatase domain of OCRL1 is required to rescue apical 
recycling. MDCK cells were grown, treated with OCRL1 siRNA, transfected with 
OCRL1-ΔPhosphatase-GFP, fixed and stained as in A. Representative confocal 
sections are shown of transfected cells and their neighbours (*). Experiment 
repeated twice, results shown from a single experiment. Higher magnification 
images are shown of the merged channels. White arrows indicate perinuclear 
localisation of Gp135 in transfected cells which is also present in un-transfected 
cells. Scale bar 10 µM. 
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Figure 5.23A-B: XZ images showing the expression of GFP does not affect the 
phenotype of OCRL1 depletion and control. Cells were from the same coverslips as 
figure 5.22A and B. MDCK cells treated with OCRL1 siRNA or non-targeting control 
siRNA were transfected with GFP expression plasmid, fixed and stained with 
antibodies to Gp135 (red) and the DNA stain DAPI (blue). XZ images were 
constructed from Z-stacks of 40 confocal sections. A: OCRL1 depleted cells 
expressing GFP, neighbouring un-transfected cells (*). White arrow indicates 
perinuclear Gp135 in cell expressing GFP. B: Cells treated with control siRNA 
expressing GFP, neighbouring un-transfected cells (*). White arrow indicates 
peripheral localisation of Gp135. Experiment repeated twice, results shown from a 
single experiment. Scale bar 5 µM. 
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Figure 5.23C-D: XZ images showing full length OCRL1 is required to rescue apical 
recycling. Cells were from the same coverslips as figure 5.22C and D. MDCK cells 
treated with OCRL1 siRNA were transfected with recombinant GFP fusion proteins, 
fixed and stained with antibodies to Gp135 (red) and the DNA stain DAPI (blue). XZ 
images were constructed from Z-stacks of 40 confocal sections. C: OCRL1 depleted 
cells expressing full length OCRL1-GFP, neighbouring un-transfected cells (*). White 
arrow indicates peripheral localisation of Gp135 in cell expressing OCRL1-GFP. D: 
Cells treated with OCRL1 siRNA expressing Δ-Phosphatase-GFP, neighbouring un-
transfected cells (*). White arrow indicates perinuclear localisation of Gp135. 
Experiment repeated twice, results shown from a single experiment. Scale bar 5 
µM. 
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OCRL1 down-regulates F-actin on vesicular carriers in other renal cell lines.  
 
The results above indicate OCRL1 down-regulates PI(4,5)P2 and F-actin on apical 
recycling endosomes in MDCK cells to facilitate cargo exit from this compartment. 
In this section, we tested whether these results were specific to MDCK cells by 
looking at the distribution of F-actin in other renal cell lines. There are several 
human proximal tubular cell lines, such as HK-2, but these have problems with de-
differentiation (Orosz et al 2004). We decided to work with a cell line derived from 
a human renal cell carcinoma where the genetic lesion causing de-differentiation 
had been reverted by re-expression of von Hippel Lindau protein (VHL). In addition, 
these cells have good function of their apical junctions (Harten et al 2009). This 
renal cell line (RCC4) was kindly provided by Prof. Patrick Maxwell (Division of 
Medicine, Rayne Institute, University College London, UK). OCRL1 was depleted for 
48 hours with human specific oligonucleotides and F-actin was visualised by using 
phalloidin. Without OCRL1, these cells accumulated punctate F-actin in a 
perinuclear region, not seen in controls (figure 5.24). However, unlike MDCK cells, 
OCRL1 did not seem to affect cell number within the time-frame of the experiment, 
suggested by the similar number of nuclei in each confocal section (figure 3.24).  
 
We next looked at the effects of OCRL1 depletion on actin distribution in the hTERT 
immortalised human renal cell line (NHPTK), used previously in Chapter 3. In 
Chapter 3 we showed that OCRL1 depletion affected the overall morphology of 
NHPTK monolayers (figure 3.12). Looking more closely at these cells, we observed 
punctate F-actin staining on perinuclear vesicles and occasionally perinuclear 
vacuoles were observed (figure 5.25). These results indicate that OCRL1 might 
regulate F-actin on trafficking intermediates in other renal cell lines. In addition, the 
formation of vacuoles in the NHPTK cell line indicates frustrated plasma membrane 
delivery of cargo from these compartments when OCRL1 is depleted.   
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Figure 5.24: OCRL1 depleted RCC4 human renal cells accumulate actin 
intracellularly. RCC4 stably expressing pVHL were grown for several days. Cells 
were transfected with non‐targeting control or a pool of human specific OCRL1 
siRNAs and analysed 48 hours later. Cells were fixed and permeabilised for staining 
with the F-actin marker phalloidin (green) and the DNA stain DAPI (blue). 
Representative single confocal sections are shown of cells on the coverslip, 
experiment repeated twice. White arrows indicate punctate F-actin staining in 
OCRL1 depleted cells which was absent from controls. Scale bar 10 µM. 
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Figure 5.25: OCRL1 depleted NHPTK human renal cells accumulate actin 
intracellularly. NHPTK cells were grown for several days in culture. Cells were 
transfected with non‐targeting control or a pool of human specific OCRL1 siRNA and 
analysed 48 hours later. Cells were fixed and stained with the F-actin stain 
phalloidin (green) and the DNA stain DAPI (blue). Representative single confocal 
sections are shown of cells on the coverslip, experiment repeated twice. Higher 
magnification images are shown in the inset. White arrows indicate punctate F-
actin staining and vacuoles in OCRL1 depleted cells. Scale bar 10 µM. 
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Summary 
  
In the previous chapter, loss of OCRL1 affected the gross organisation of polarised 
membrane domains. OCRL1 depleted cells internalised their apical domain in the 
form of vacuolar apical compartments (VACs) and subsequently lateralised their 
apical domain to form lumens between cells. In the previous chapter, VACs and 
lumens were observed in cells depleted of OCRL1 for several days, suggesting the 
formation of these structures could be secondary to events that occur sooner after 
OCRL1 depletion. In this chapter, we aimed to determine the primary role of OCRL1 
in polarisation by looking at the first events to occur when the protein was 
depleted.   
 
In order to study the role of OCRL1 in early polarisation, we made several changes 
to the experimental protocol used in the previous chapter. Briefly, cells were 
depleted of OCRL1 for 17-24 hours instead of 48-72 hours, allowing the earliest 
events to be observed. In addition, rather than depleting monolayers of OCRL1, 
RNAi was carried out pre-monolayer formation, on single cells growing in isolation. 
Previously, monolayers were allowed to form intercellular contacts and polarise 
normally for several days before RNAi. Depletion of OCRL1 in monolayers would 
require extensive reorganisation of pre-formed junctions and a switch in polarity 
orientation from a vertical to a horizontal plane. In this chapter, OCRL1 was 
depleted in un-polarised cells plated for just a few hours before RNAi, so that 
junction formation and polarisation would begin in the absence of OCRL1, allowing 
the effects of OCRL1 depletion on these early events to be studied.  
 
Single cells depleted of OCRL1 behaved similarly to monolayers depleted of OCRL1, 
forming lateral lumens between cells, paired either as a result of cell division or 
migration on the coverslip. However, lateral lumens developed in monolayers after 
approximately 72 hours without OCRL1 and formed via an intermediary VAC-like 
structure. In contrast, when un-polarised cells were depleted of OCRL1, lumens 
appeared within 24 hours and almost always formed without an intermediary VAC. 
Instead, vesicular apical cargo was trafficked directly from a perinuclear region to 
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the site of lumen formation. Interestingly, a similar pool of vesicular apical material 
was observed pre-vacuole formation in monolayers depleted of OCRL1 for just 24 
hours, suggesting the VACs observed at 48 hours are formed from this material. 
Similarly, in other studies VACs form by the fusion of apical carriers when trafficking 
to the plasma membrane is prevented (Gilbert et al., 1991; van Zeijl and Matlin, 
1990), further suggesting apical trafficking defects in the absence of OCRL1. The 
requirement for cells growing in monolayers to reorganise junctions and repolarise 
might delay lateral lumen formation, resulting in the fusion of apical carriers to 
form VAC-like structures. In contrast, un-polarised cells depleted of OCRL1 begin 
polarising in the horizontal plane without the need for extensive reorganisation, 
which might explain the time scale difference of lumen formation between 
monolayers and single cells. However, the common accumulation of vesicular apical 
cargo in both experimental systems suggested this may be a primary effect of 
OCRL1 loss. The rest of the chapter focussed on characterising the vesicular cargo 
that accumulated upon OCRL1 depletion rather than the vacuoles which formed as 
a consequence of this effect. 
 
A number of findings suggested OCRL1 depletion disrupted apical recycling 
pathways, leading to the accumulation of apical vesicles intracellularly. Firstly, the 
vesicular pool of apical cargo observed upon OCRL1 depletion appeared to originate 
from a recycling pool of the Rab11/Rab8 apical trafficking pathway. In addition, 
FRAP analysis confirmed that a small population of apical cargo was subjected to 
endocytic recycling normally, suggesting the exaggerated pool of apical material 
observed in OCRL1 depleted cells resulted from an inability to recycle cargo back to 
the cell surface. OCRL1 has previously been implicated to regulate cargo exit from 
recycling endosomes by down-regulating PI(4,5)P2 and F-actin on these membranes 
(Vicinanza et al., 2011). Similarly, expression of PLCδ(PH)-GFP in MDCK cells 
revealed ectopic accumulations of PI(4,5)P2 and F-actin on recycling endosomes 
when OCRL1 was depleted. Rescue experiments confirmed that down-regulation of 
5-phosphoinostides was required for cargo to exit from endosomes; the catalytic 
activity of OCRL1 was required to recover apical recycling to the cell surface. These 
results indicate the block in recycling observed when OCRL1 was depleted was due 
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to elevated levels of PI(4,5)P2 on endosomes. However these affects were only 
temporary; eventually the perinuclear apical material was trafficked to the lateral 
membrane to form a lumen. The rest of this chapter sought to understand the 
mechanism of lumen formation by studying the distribution of key polarity proteins 
responsible for positioning the apical membrane.  
 
Apical polarity complexes are thought to be targeted to the apex of the cell early 
during development where they regulate junction formation and induce expansion 
of the apical membrane. OCRL1 depleted cells formed intact apical membranes and 
developed junctions, therefore the function of these polarity complexes appeared 
to be unaffected by loss of OCRL1. However, the formation of the apical membrane 
in the wrong place suggested these apical polarity complexes might be aberrantly 
targeted to the lateral membrane in the absence of OCRL1. We looked at the 
localisation of a number of these proteins during various stages of lumen 
formation. Interestingly, the Rab11/Rab8 positive perinuclear cluster of apical cargo 
also carried the apical polarity complex Par6-aPKC and Cdc42, suggesting this 
complex is trafficked to the site of lumen formation in a similar manner to Gp135. 
In contrast, the apical polarity protein Par3 was not present on recycling 
endosomes of OCRL1 depleted cells; instead Par3 was enriched at the position of 
lumen formation and appeared to mark the site for insertion of the apical 
membrane. During early lumen formation, apical cargo including Gp135 and Par6-
aPKC was delivered to Par3 on the lateral membrane, which reorganised from a 
single band to a ring like structure around the lumen as it was formed. Although 
Par3 localised to the site of lumen formation, it was not clear why the apical 
membrane was inserted at this site in OCRL1 depleted cells. However, one 
possibility is for the molecular mechanism of lumen formation in OCRL1 depleted 
cells to resemble lumenogenesis in cysts, which is well characterised and discussed 
below.  
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Discussion 
 
In this chapter, OCRL1 depletion blocked exit of apical cargo from Rab11/Rab8 
positive compartments which in MDCK cells correspond to apical recycling 
endosomes. In a number of recent studies, OCRL1 has been implicated via its 5-
phosphatase activity to be essential for endosome function. Depletion of dOCRL1 in 
Drosophila induced the appearance of enlarged endocytic vacuoles enriched in 
PI(4,5)P2 and F-actin which caused the subsequent mis-targeting of PI(4,5)P2 
binding proteins to these membranes (Ben El Kadhi et al, 2011). Similarly Lowe 
Syndrome cells display ectopic accumulations of PI(4,5)P2 and associated F-actin on 
endosomes, which cause a number of recycling receptors to be retained 
intracellularly (Vicinanza et al., 2011). These findings together with the results of 
this chapter indicate that PI(4,5)P2 homeostasis is essential for endosome function. 
However the precise role of OCRL1 at endosomes remains unclear, possible 
explanations are discussed below.  
 
OCRL1 becomes associated with vesicles early in the endocytic pathway (Erdmann 
et al., 2007) and appears to persist on these membranes throughout endosome 
maturation (Vicinanza et al., 2011), suggesting OCRL1 functions during several 
stages in the endocytic pathway. The finding that PI(4,5)P2 levels rise on endosomes 
when OCRL1 is depleted suggests the function of OCRL1 in the endocytic pathway is 
to facilitate PI(4,5)P2 turnover. PI(4,5)P2 is an established regulator of endocytosis, 
recruiting numerous components of the clathrin machinery (Haucke, 2005), and 
facilitating invagination by promoting actin polymerisation near the bud (Smythe 
and Ayscough, 2006). Therefore it is likely that OCRL1 functions post internalisation 
to remove this functional pool of PI(4,5)P2, thereby releasing the endocytic 
machinery from the newly formed vesicle. However, the reason OCRL1 persists on 
vesicles after internalisation is not clear. One possibility is that OCRL1 facilitates a 
phosphoinositide switch from plasma membrane derived PI(4,5)P2 rich endocytic 
vesicles to endosomes containing PI(3)P. Therefore OCRL1 might function on 
endosomes to maintain organelle identity by ensuring the plasma membrane and 
intracellular membranes have distinct populations of phosphoinositides.  
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Alternatively, the function of OCRL1 at endosomes might be similar to the proposed 
role of OCRL1 during endocytosis, to regulate a physiologically functional pool of 
PI(4,5)P2. An endosomal pool of PI(4,5)P2 was not observed in our control cells, 
however PI(4,5)P2 has previously been detected on endosomes and other 
intracellular membranes of untreated cells using high resolution techniques (Watt 
et al., 2002), suggesting low abundance of PI(4,5)P2 and limited resolution might 
explain the lack of detection in our control cells. In addition, the observation that a 
PI(4,5)P2 synthesising enzyme (PIPKIγi5) localises to endosomes suggests synthesis 
of 5-phosphoinositides takes place on these membranes (Schill and Anderson, 
2009; Sun et al., 2013). Interestingly, one of these studies demonstrated a 
requirement for PIPKIγi5 to sort the epidermal growth factor receptor (EGFR) from 
early endosomes into late endocytic compartments (Sun et al., 2013), further 
suggesting pools of PI(4,5)P2 on endosomes have functional roles.  
 
Micro-domains of PI(4,5)P2 on endosomes might facilitate budding and vesicle 
biogenesis in a manner comparable to the role of PI(4,5)P2 in endocytosis. For 
example, PI(4,5)P2 could mediate cargo sorting into carriers for progression along 
the endocytic pathway, or it may induce local F-actin polymerisation to facilitate 
membrane curvature. Evidence for PI(4,5)P2 having a role in regulating actin 
polymerisation on endosomes comes from the finding that loss of OCRL1 increased 
the level of F-actin associated with these membranes in a N-WASP-dependent 
pathway (Vicinanza et al., 2011). Therefore, loss of OCRL1 in these cells might 
exaggerate a normal pathway involving PI(4,5)P2 and N-WASP actin polymerisation. 
We similarly observed ectopic levels of F-actin on endosomes in OCRL1 depleted 
cells, however we were unable to rescue recycling with actin depolymerising agents 
such as Latrunculin-A and Cytochalasin-D (data not shown). Therefore it remains 
unclear whether F-actin accumulation was responsible for blocking endosome 
function in our OCRL1 depleted cells.  
 
The first part of this chapter focussed on the recycling defects of apical cargo 
induced by OCRL1 depletion. In the second part of this chapter we sought to 
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understand why OCRL1 depleted cells subsequently targeted this material to the 
lateral membrane. One possibility is that the internalisation of the apical membrane 
induced a loss of polarity similar to the response of cells when calcium is depleted. 
Subsequently, OCRL1 depleted cells might attempt to re-establish polarity by 
targeting the apical vesicles back to the cell periphery. There is some evidence to 
suggest apical membrane is normally trafficked to the lateral membrane in a region 
near the junction. For example, the VACs in calcium switch assays are exocytosed 
near the junction when calcium is restored. In addition, in early polarisation of our 
control cells, we saw faint clusters of apical vesicles near the cell-cell contact. 
Although the VACs in calcium switch assays and OCRL1 depleted cells appear to be 
exocytosed at the same site near the junction, there must be fundamental 
differences because VAC exocytosis in calcium switch experiments re-form the 
apical membrane at the cell apex whereas OCRL1 depleted cells maintain the apical 
membrane from the VAC in the lateral region of the cell.  
 
One possibility is that OCRL1 depletion promotes hepatic-like lumen polarity in a 
similar manner to over-expression of Par1b (Cohen et al., 2004a, 2004b, 2007 and 
2011), discussed in Chapter 4. Interestingly, hepatic cell polarisation occurs in two 
stages; upon plating at low confluence hepatic cell lines initially adopt columnar 
polarity similar to MDCK cells (Cohen et al., 2007; Decaens et al., 1996). Then, over 
a period of approximately two weeks, columnar cells first internalise their apical 
membrane to become non-polarised before subsequently repolarising with hepatic 
polarity (Cohen et al., 2007; Decaens et al., 1996). A similar process could occur 
when OCRL1 is depleted in MDCK cells, whereby a block in apical recycling initially 
results in cells becoming non-polarised before cells adopt hepatic-like polarity upon 
re-polarising. However, in this chapter, OCRL1 depleted cells did not appear 
hepatic-like. In 2D cultures of hepatic cell lines such as WIFB, luminal domains form 
in the lateral membrane between neighbouring cells (Treyer and Müsch, 2013). 
Although pairs of OCRL1 depleted cells formed luminal domains between them in 
the region of the cell-cell contact, additional cell divisions reinforced the apical 
domain initiated at the 2-cell stage. For example in figure 5.2B, 6 OCRL1 depleted 
cells shared a single lumen and the cells appeared to have normal cell-cell contacts.  
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An alternative possibility is that OCRL1 depleted cells behave like cysts grown in 3D 
culture and lumen formation is a co-ordinated process in these cells. The pathway 
involved in lumen formation of MDCK cyst cultures contains many of the same 
components as the pathway identified here for lateral lumen formation of OCRL1 
depleted cells. For example, lumen formation in cysts is initiated by delivery of 
apical determinants such as aPKC-Par6-Cdc42 and Gp135 to the lateral membrane 
by a Rab8/Rab11 dependent trafficking pathway (Bryant et al., 2010). Another 
parallel between lumen formation in cysts and OCRL1 depleted cells was the 
formation of the apical membrane at sites marked by Par3 (Bryant et al., 2010). 
Although the molecular mechanism of lumen formation in OCRL1 depleted cells 
appears similar to lumen formation in MDCK cysts, the primary reason for lateral 
lumen formation in MDCK cells remained unclear. It’s possible that lateral lumens 
are not a product of disrupted apical trafficking pathways, but that loss of OCRL1 
induces additional problems leading to mis-localised apical membranes. In the next 
chapter, other effects of OCRL1 depletion are explored which might explain lateral 
lumen formation.  
  
 
 
 
 
 
 
 
 
 
 
 
  
208 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Six 
 
OCRL1 and cell division in MDCK cells 
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Overview 
 
In the previous chapter, OCRL1 depletion was shown to disrupt polarised trafficking 
pathways. In polarised epithelia, polarisation is co-ordinated with cell division so 
that divisions within the epithelium reinforce rather than disrupt cell polarity. 
Apical lumen formation in 3D culture is initiated at the two cell stage, after mitosis 
but before the onset of cytokinesis. One possibility is for cells to utilise the 
cytokinetic machinery to initiate apical membrane formation. For example, prior to 
cytokinesis, the midbody is positioned between the daughter cells and may act as 
the spatial cue to form the apical membrane (Datta et al., 2011). Therefore the 
positioning of the midbody might be important for determining where the apical 
membrane is initially formed.  
 
OCRL1 depleted cells growing in 2D culture form apical lumens in the lateral 
membrane rather than at the apex of the cell. As discussed in the previous chapter, 
the pathway involved in lumen formation of MDCK cysts growing in 3D culture 
contains many of the same components as the pathway identified for lateral lumen 
formation of OCRL1 depleted cells. Lateral lumen formation in OCRL1 depleted cells 
occurs as early as the two cell stage (see figure 5.2 and figure 5.3) and subsequent 
divisions reinforce the lumen so that as many as six cells contribute to the apical 
membrane (figure 5.2). Therefore OCRL1 depletion in 2D culture produces lumens 
similar to those seen in 3D cyst cultures. Lumen formation in OCRL1 depleted cells 
is preceded by the accumulation of key apical polarity proteins such as the Par 
polarity complex and luminal proteins such as Gp135 in Rab11 positive recycling 
endosomes. These apical components appeared to be subsequently trafficked to a 
region on the lateral membrane between adjacent cells, where the lumen formed. 
In the previous chapter, it was unclear why the vesicular apical cargo accumulated 
in this region of the lateral membrane. However, in 3D culture, lumen formation is 
thought to occur by the targeting of apical vesicles to the site of cytokinesis. Given 
the link between cytokinesis and apical membrane formation, lumen formation 
may be co-ordinated with cytokinesis in OCRL1 depleted cells.  
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Recently OCRL1 has been implicated in multiple stages of cytokinesis. In Drosophila, 
depletion of dOCRL1 resulted in a high failure rate of furrowing and cells were 
multinucleated (Ben El Kadhi et al., 2011). Furrowing failed in these cells due to 
ectopic accumulation of PI(4,5)P2 on endosomes which targeted essential 
components such as RhoA, myosin and anillin towards endosomes at the expense 
of the cytokinetic ring (Ben El Kadhi et al., 2011). OCRL1 has also been implicated to 
be involved in the post furrowing stages of cytokinesis. In HeLa cells, OCRL1 is 
localised to the intercellular bridge by interacting with Rab35 (Dambournet et al., 
2011). Depletion of Rab35 or OCRL1 inhibited cytokinesis abscission and was 
associated with elevated F-actin and PI(4,5)P2 in the intercellular bridge 
(Dambournet et al., 2011), suggesting that PI(4,5)P2 regulation by OCRL1 is required 
for successful cytokinesis. This study was carried out in non-polarised cell lines 
therefore it is not known whether OCRL1 similarly functions in polarised cells. This 
chapter investigates whether OCRL1 regulates cytokinesis in the MDCK cell line 
which may explain the polarity defects observed in previous chapters.  
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OCRL1 depletion delays abscission of the intercellular bridge 
 
To establish whether OCRL1 plays a role in cytokinesis in the MDCK cell line, the 
microtubules were visualised with α-tubulin antibodies. The midbody and 
intercellular bridge can be observed as a highly dense structure at the centre of two 
microtubule bundles between daughter cells. The same siRNA protocol was used in 
this chapter as the previous chapter, so that the microtubules could be visualised in 
cells undergoing lumen formation. Cells were plated and depleted of OCRL1 over 
the course of 24 hours, approximately 4 hours to adhere to the coverslip and 20 
hours of siRNA treatment. Following an initial lag phase, MDCK cells have an 
approximate doubling time of 21 hours during logarithmic growth (Cho et al., 1989), 
therefore the majority of cells in this experiment would have had the opportunity 
to begin dividing without OCRL1. We noticed the number of cells connected by a α-
tubulin-positive intercellular bridge increased when OCRL1 was depleted, this is 
shown in figure 6.1 and quantified in figure 6.2. In control cells, 4% of the 
population was connected by an intercellular bridge compared to 19% after OCRL1 
depletion (500 cells per treatment, p = 0.0003, student's T -test). In contrast to the 
increase in unresolved intercellular bridges, the number of cells undergoing mitosis 
was not statistically different, 3.5% of the OCRL1 depleted population was 
undergoing mitosis compared to 4% of the control population (p=0.9, students T-
test). These results indicate that only the abscission stage was delayed during the 
first round of cell division after OCRL1 depletion. Similar results were shown 
previously in the HeLa cell line, where the number of cells connected by an 
intercellular bridge increased from 9.1% in control cells to 19.3% after OCRL1 
depletion (Dambournet et al., 2011).  
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Figure 6.1: OCRL1 depletion delays abscission. MDCK cells were plated for 4 hours 
before transfection with non-targeting control or OCRL1 siRNA. 20 hours later, the 
cells were fixed/permeabilised and immunostained with α-tubulin antibodies (red) 
and the DNA stain DAPI (blue). Images shown are compressed stacks of 10 confocal 
sections spanning from the bottom to the top of the cell layer from two 
experiments. White arrows indicate the intercellular bridge formed between pairs 
of daughter cells. Scale bar 10 µM. 
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Figure 6.2: Quantification of the abscission defects in OCRL1 depleted cells. Cells 
were from the same coverslip as Figure 6.1. Confocal stacks containing 10 confocal 
sections were taken across the coverslip of cells treated with non-targeting control 
or OCRL1 siRNA in 2 experiments. 10 stacks were used per treatment which 
amounted to approximately 500 cells per treatment. The number of cells in late 
stage cytokinesis or mitosis is plotted as a percentage of the total cell count. 
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OCRL1 localises to spindle poles and the midbody of dividing cells 
 
Previously, OCRL1 was shown to localise to the Golgi apparatus, trafficking 
intermediates and tight junctions of non-dividing MDCK cells. During cytokinesis of 
MDCK cells, there was a punctate population of OCRL1 near the midbody of the 
intercellular bridge (figure 6.3), as shown previously in the HeLa cell line 
(Dambournet et al., 2011). The midbody is positioned at the centre of the 
intercellular bridge, identified by the absence of staining with α-tubulin antibodies 
in contrast to the rest of the intercellular bridge. Higher magnification images of 
OCRL1 in MDCK cells revealed OCRL1 to be concentrated symmetrically either side 
of the midbody in two of the intercellular bridges formed between cells (pairs 1 and 
3; lower panels figure 6.3) and concentrated more densely on one side of the 
midbody in one pair of cells (pair 2; lower panels figure 6.3). Several studies report 
an accumulation of membrane vesicles at the midbody (Goss and Toomre, 2008; 
Pohl and Jentsch, 2008), with some populations delivered symmetrically by both 
daughter cells (Goss and Toomre, 2008) and others asymmetrically (Gromley et al., 
2005). Therefore the midbody localisation of OCRL1 is likely to correspond to OCRL1 
positive vesicles.   
    
In addition to observing the localisation of OCRL1 in cytokinesis, we noticed OCRL1 
localised to the spindle poles of mitotic cells prior to cytokinesis (figure 6.4), which 
was not shown previously (Dambournet et al., 2011). During mitosis, the punctate 
staining of OCRL1 observed at spindle poles occurred in a region where the 
centrioles likely reside (figure 6.4). In addition, numerous OCRL1 positive vesicles 
were focused around the pole, indicated with arrows in the OCRL1 channel only 
(figure 6.4). During mitosis, the Golgi apparatus fragments into clusters near spindle 
poles (Seemann et al., 2002), along with recycling endosomes (Hobdy-Henderson et 
al., 2003; Takatsu et al., 2013). Therefore OCRL1 positive vesicles at spindle poles 
could correspond to either of these compartments.  
  
In Chapter 5, we showed that OCRL1 depletion resulted in a block of cargo exit from 
Rab11 and Rab8 positive recycling endosomes. During cytokinesis, this 
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compartment traffics the cytokinetic machinery to the site and provides the 
membrane required for furrowing and abscission (Montagnac et al., 2008). Other 
recycling pathways have been shown to be essential for completing cytokinesis, 
such as the fast rab35 recycling route (Kouranti et al., 2006). In the HeLa cell line, 
OCRL1 was targeted to the intercellular bridge in a Rab35 dependent manner 
(Dambournet et al., 2011). OCRL1 is likely delivered to the midbody by direct 
interactions with Rab35 on vesicles trafficked to the site (Dambournet et al., 2011). 
Here we noticed Rab8 also accumulated at the intercellular bridge (figure 6.5), 
suggesting the possibility that OCRL1 targets the intercellular bridge through 
interactions with Rab8 GTPase as well as Rab35.  
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Figure 6.3: OCRL1 localises to the intercellular bridge during cytokinesis. Wild type 
MDCK cells were grown for 24 hours, fixed and permeabilised for immunostaining 
with antibodies to α-tubulin (green), OCRL1 (red) and the DNA stain DAPI (blue). 
Higher magnification images of the merged channels are shown in the bottom 
panel. White arrows indicate the midbody. Images shown are representative of all 
cells observed connected by a midbody on the coverslip (n=20) of 2 experiments. 
Scale bar 10 µM. 
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Figure 6.4: OCRL1 localises to the spindle poles during mitosis. Wild type MDCK 
cells were grown for 24 hours, fixed and permeabilised for immunostaining with 
antibodies to α-tubulin (green), OCRL1 (red) and the DNA stain DAPI (blue). Images 
shown are compressed stacks of 4 confocal sections spanning the top and the 
bottom of the mitotic spindle apparatus. Higher magnification images are shown of 
the merged channels in the bottom panel. Small white arrows indicate OCRL1 
positive vesicles and big white arrows indicate the spindle poles. Images shown are 
representative of all dividing cells observed on the coverslip (n=10) of 2 
experiments. Scale bar 10 µM. 
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Figure 6.5: Rab8 GTPase localises to the midbody during cytokinesis. Wild type 
MDCK cells were grown for 24 hours, fixed and permeabilised for immunostaining 
with antibodies to α-tubulin (green), Rab8 (red) and the DNA stain DAPI (blue). 
Higher magnification images are shown of the merged channels in the bottom 
panel (1 and 2). White arrows indicate localisation of the midbody. Images shown 
are single confocal sections that are representative of all cells observed connected 
by a midbody on the coverslip (n=20) of 2 experiments. Scale bar 10 µM. 
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The midbody marks the site of lateral lumen formation 
 
MDCK cells depleted of OCRL1 display defects in both cell polarity and cytokinesis. 
To determine whether the polarity phenotype is related to the cytokinesis defect 
we looked at the trafficking of the luminal marker Gp135 in cells during cytokinesis. 
Previously, pools of Gp135 were shown to target an uncharacterised site in the 
lateral membrane between pairs of OCRL1 depleted cells (Chapter 5). We studied 
the localisation of Gp135 again but also looked at the microtubules to indicate 
stages of cell division. There is some evidence to suggest polarisation of apical and 
basolateral membranes is maintained throughout cell division, kept in place by tight 
junctions that remain intact (Reinsch and Karsenti, 1994). When GFP-Gp135 
expressing cells underwent cell division, most of the protein remained on the cell 
surface, with a smaller intracellular pool of vesicles localised to spindle poles (figure 
6.6). When OCRL1 depleted cells divided, GFP-Gp135 was absent from the plasma 
membrane and entirely localised to clusters of vesicles segregated to spindle poles 
(figure 6.6). In Chapter 5, we observed single OCRL1 depleted cells at interphase 
accumulate Gp135 in recycling endosomes (figure 5.2 and 5.7B), therefore a block 
in apical recycling prior to cell division likely results in the accumulation of recycling 
endosomes which become segregated to spindle poles when OCRL1 depleted cells 
divide.  
 
We next investigated the localisation of Gp135 in cells undergoing cytokinesis. In 
control cells connected by an intercellular bridge, Gp135 was mostly localised to the 
peripheral membrane (figure 6.7), suggesting limited trafficking of apical cargo 
along the intercellular bridge. In OCRL1 depleted cells, Gp135 accumulated near the 
midbody of the intercellular bridge (figure 6.7). A 3D reconstruction revealed that 
these cells also had perinuclear pools of Gp135 (figure 6.7), suggesting the recycling 
pool of Gp135 that accumulates in the absence of OCRL1 is delivered to the site of 
abscission when the cell undergoes division. Similar results were found with MDCK 
cells stably expressing GFP-Gp135 which was present on the plasma membrane of 
control cells during late stage cytokinesis but accumulated near the midbody in cells 
depleted of OCRL1 (figure 6.8). Therefore the site of apical membrane trafficking in 
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cells depleted of OCRL1, as a prelude to aberrant lumen formation, appears to be 
the site of abscission. 
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Figure 6.6: Intracellular GFP-Gp135 clusters near spindle poles during mitosis. 
MDCK cells stably expressing GFP-Gp135 were grown for 4 hours before treatment 
with non-targeting control siRNA or a pool of OCRL1 siRNA. 20 hours later, cells 
were fixed and permeabilised for immunostaining with antibodies to α-tubulin 
(red). Single confocal sections were taken of pairs of GFP-Gp135 expressing cells. 
Images shown are representative of all expressing cells undergoing division (n=10) 
from 2 experiments. White arrows indicate vesicular pools of Gp135 near spindle 
poles. Scale bar 10 µM. 
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Figure 6.7: Gp135 is trafficked to the midbody in cells depleted of OCRL1. MDCK 
cells were grown and subjected to RNAi as in figure 6.6. Cells were fixed and 
permeabilised for immunostaining with antibodies to α-tubulin (red), Gp135 (green) 
and the DNA stain DAPI (blue). Images shown are single confocal sections of 
representative cells on the coverslip (n=10 per 2 experiments). The bottom panel is 
a 3D reconstruction of a pair of OCRL1 depleted cells (ImageJ; Z stack of 20 confocal 
sections). Scale bar 10 µM. 
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Figure 6.8: GFP-Gp135 is trafficked to the midbody in cells depleted of OCRL1. 
MDCK cells were grown and subjected to RNAi as in figure 6.6. Cells were fixed and 
permeabilised for immunostaining with antibodies to α-tubulin (red) and the DNA 
stain DAPI (blue). Images shown are representative of all expressing cells in late 
stage cytokinesis (n=5) from a single experiment. Scale bar 10 µM. 
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OCRL1 depletion disrupts spindle orientation and midbody positioning 
  
Although trafficking of recycling endosomes to the midbody is a normal occurrence, 
this appears to coincide with lateral lumen formation in OCRL1 depleted cells. A 
number of key differences might explain the phenotype observed when OCRL1 is 
depleted. Firstly, recycling endosomes accumulate and secondly they are highly 
apical in composition, suggesting an excessive amount of apical cargo is delivered 
to the midbody when OCRL1 depleted cells divide. However, midbodies are 
expected to be found apically and not in the lateral membrane, leaving the link 
between midbodies and lateral lumens perplexing. Therefore we next investigated 
the localisation of midbodies in monolayers of MDCK cells depleted of OCRL1 for 24 
hours. Midbodies were only found towards the apical side of control monolayers, 
but were localised more basally in the absence of OCRL1 (figure 6.9).  
 
Mis-localisation of midbodies has been shown to induce the formation of lateral 
lumens when Cdc42 is depleted in 3D cultures of MDCK cells (Jaffe et al., 2008; 
Rodriguez-Fraticelli et al., 2010). Cdc42 regulates the orientation of the mitotic 
spindle, which determines the location of the midbody (Jaffe et al., 2008; 
Rodriguez-Fraticelli et al., 2010). In MDCK cells, spindle orientation is tightly 
controlled, positioned parallel to the plane of the monolayer (Reinsch and Karsenti, 
1994). Both spindle poles can usually be seen in a single confocal section less than 
0.7 µM depth (Reinsch and Karsenti, 1994). We also observed mitotic spindles 
parallel to the monolayer in control cells, with spindle poles appearing in the same 
single confocal section (figure 6.10). However, in the absence of OCRL1, mitotic 
spindle poles could not be resolved in single confocal sections, with one pole 
appearing at the basal side of the cell and the other more apically (figure 6.10). This 
can be seen more clearly in XZ images of mitotic cells, where spindle poles aligned 
along a horizontal axis in control cells and deviated from this axis in the absence of 
OCRL1 (figure 6.11). Therefore mis-localised midbodies, possibly due to aberrant 
spindle orientations, might explain lateral membrane targeting of apical endosomes 
in the absence of OCRL1.  
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Figure 6.9: OCRL1 depletion disrupts midbody positioning. MDCK cells were grown 
and subjected to RNAi as in figure 6.6. Cells were fixed and permeabilised for 
immunostaining with antibodies to α-tubulin (red). Images shown are single 
confocal sections taken from Z stacks spanning from the bottom to the top of the 
cell layer. A total of 10 stacks were taken across 2 experiments. The basal, middle 
and apical side of the monolayers from one experiment are shown. White arrows 
indicate the midbodies of cells connected by an intercellular bride. Inset images 
show a zoom of an area of the section containing midbodies. Scale bar 20 µM. 
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Figure 6.10: OCRL1 depletion disrupts mitotic spindle orientation. MDCK cells 
were grown and subjected to RNAi as in figure 6.6. Cells were fixed and 
permeabilised for immunostaining with antibodies to α-tubulin (white). Images 
shown are single confocal sections taken from Z stacks spanning from the bottom 
to the top of the cell layer. Images are representative of n=6 cells observed across 2 
experiments. The basal, middle and apical side of the spindle pole are shown. Scale 
bar 10 µM. 
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Figure 6.11: XZ images of mitotic spindle orientation. MDCK cells were on the 
same coverslip as cells in figure 6.10. The microtubules are shown in white. XZ 
images were reconstructed from Z-stacks of confocal sections spanning from the 
bottom to the top of the cell layer. The relative orientations of spindle poles are 
shown by the red line which connects the middle of the brightest point of each 
spindle. Images are representative of n=6 cells observed across 2 experiments. 
Scale bar 5 µM. 
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Summary 
 
This chapter aimed to investigate whether OCRL1 depleted cells with polarity 
defects also have disrupted cell division. In polarised cell types such as the MDCK 
cell line, these two processes are closely related. For example, the orientation of 
cell division has been shown to affect the positioning of the apical membrane (Qin 
et al., 2010; Rodriguez-Fraticelli et al., 2010). These findings might be explained by 
the observation that during cell division, trafficking pathways deliver apical cargo 
along the microtubules of the mitotic spindle and midzone microtubules to the 
abscission site which normally occurs just beneath the developing lumen (Schlüter 
et al., 2009). Abnormal orientations of the mitotic spindle apparatus affects the 
positioning of the midbody in 3D cultures (Jaffe et al., 2008), which directs apical 
trafficking away from the single developing lumen and results in the multiple lateral 
lumen phenotype seen in these experiments (Jaffe et al., 2008; Qin et al., 2010; 
Rodriguez-Fraticelli et al., 2010). In monolayers of MDCK cells, a similar process is 
thought to occur and abscission takes place just beneath the apical surface (Reinsch 
and Karsenti, 1994). Since OCRL1 has already been implicated to regulate 
cytokinesis in non-polarised cells, it was possible that defects in cytokinesis coupled 
with the recycling defects identified in Chapter 5 could explain the formation of 
lateral lumens when MDCK cells were depleted of OCRL1 (Chapter 4).   
  
OCRL1 has previously been shown to localise near the midbody during cytokinesis 
of HeLa cells (Dambournet et al., 2011). Similarly in MDCK cells, we found OCRL1 
localised either side of the abscission site during cytokinesis. In addition, we noticed 
cells in earlier stages of cell division accumulated vesicular pools positive for OCRL1 
near the spindle poles, which has not been reported previously. In HeLa cells, 
OCRL1 localises to the midbody in a Rab35 dependent manner (Dambournet et al., 
2011). OCRL1 is likely delivered to the abscission site by direct interactions with 
Rab35 in endocytic recycling pathways. Similarly, Rab8 and Rab11 pathways have 
been shown to deliver membrane to the cytokinetic furrow (Fielding et al., 2005; 
Pohl and Jentsch, 2008). Although we did not look at Rab35, we found Rab8 
enriched at the abscission site, highlighting the possibility that interactions with 
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Rab8 as well as Rab35 endocytic recycling pathways could localise OCRL1 to the 
midbody. OCRL1 appears to have a functional role in cytokinesis. When we 
depleted monolayers of MDCK cells of OCRL1, we found an accumulation of cells in 
the pre-abscission stage, similar to previous findings in the HeLa cell line 
(Dambournet et al., 2011).  
   
The results of the first part of this chapter indicate that OCRL1 depleted MDCK cells 
display abscission defects. In the last part of this chapter, we sought to understand 
whether the defects in cytokinesis were linked to the polarisation defects explored 
previously. In particular, we showed in the previous chapter that OCRL1 depleted 
cells delivered apical endosomal membrane to an uncharacterised site between 
pairs of cells. The results here indicate that this site is marked by the midbody, 
which appeared to be mis-localised when OCRL1 was depleted, suggesting lateral 
lumens could result from a combination of recycling and cytokinesis defects, 
discussed in more detail next.   
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Discussion 
 
The results of this chapter provide some evidence that MDCK cells without OCRL1 
exhibit delayed progression through the final stages of cytokinesis which primarily 
involves severing of the intercellular bridge. The complete mechanistic details of 
abscission remain unclear, however it is thought to begin with a secondary 
ingression of the membrane on one side of the midbody (Neto et al., 2011). Fusion 
of endosomes with the membrane might contribute to thinning of the intercellular 
bridge during this process (Schiel et al., 2011). The final membrane scission event is 
mediated by the ESCRT (endosomal sorting complexes required for transport) 
machinery. Helices of ESCRT-III are thought to bring the two membranes in close 
proximity until spontaneous scission occurs (Guizetti et al., 2011). Enrichment of 
PI(3)P at the midbody facilitates the recruitment of ESCRT-III components to the 
abscission site (Sagona et al., 2010). However, prior to abscission, PI(4,5)P2 is the 
dominant phosphoinositide at the site of cytokinesis. At this stage, PI(4,5)P2 is 
essential for recruiting contractile ring components and promoting the assembly of 
actin filaments required during furrowing (Logan and Mandato, 2006). One possible 
role for OCRL1 in abscission might be to down-regulate the levels of PI(4,5)P2 at the 
midbody to facilitate the change in lipid composition towards PI(3)P. In addition, 
disassembly of the actin cytoskeleton as well as the microtubules is required to 
complete cytokinesis (Schweitzer and D'Souza-Schorey, 2004). Since PI(4,5)P2 
promotes actin filament assembly,  de-phosphorylation of PI(4,5)P2 by OCRL1 could 
mediate disassembly of the actin cytoskeleton during abscission, as suggested by 
Dambournet and colleagues. 
  
In addition to finding OCRL1 at the midbody, we noticed OCRL1 localised near the 
spindle poles of dividing cells, where the centrosomes reside. OCRL1 has an ASPM, 
SPD-2, Hydin (ASH) domain which is frequently present in proteins associated with 
cilia and centrosomes (Ponting et al., 2006). Consistent with OCRL1 having this 
domain, OCRL1 has been reported to localise to the basal bodies of cilia (Coon et 
al., 2012), which are formed from centrioles. The localisation of OCRL1 to spindle 
poles might resemble the localisation of OCRL1 to cilia basal bodies, which occurs in 
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a Rab8 dependent manner (Coon et al., 2012). We also noticed OCRL1 in more 
peripheral puncta around spindle poles; therefore the centrosomal staining of 
OCRL1 at spindle poles could represent a dense accumulation of OCRL1 positive 
endosomal vesicles. Since membrane traffic is directed towards the midbody during 
cytokinesis, it is likely that some of the OCRL1 positive vesicles that accumulate 
during mitosis are trafficked along this pathway, potentially explaining the midbody 
localisation of OCRL1.  
  
In the previous chapter, OCRL1 was implicated as a regulator of apical recycling 
pathways. Cells without OCRL1 accumulated Rab11 and Rab8 positive recycling 
endosomes and cargo exit from these compartments appeared to be blocked. 
Recycling endosomes play an important role in cytokinesis, delivering proteins 
involved in cytokinesis to the abscission site as well as providing the new 
membrane required (Montagnac et al., 2008). The role of recycling endosomes in 
cytokinesis appears to be critical since depletion of Rab11 or expression of a 
dominant-negative mutant causes significant abscission defects (Wilson et al., 
2005). Since abscission requires membrane trafficking, the abscission defects 
observed in this chapter could be secondary to the effects of OCRL1 loss on 
recycling pathways. Alternatively, the role of OCRL1 in abscission might be distinct 
from it’s role in regulating recycling, as discussed above.  
  
In polarised cell types, there appears to be an additional level of cross-talk, since 
membrane trafficking and cytokinesis may be co-ordinated with apical membrane 
formation. One possibility is that the defects in apical recycling coupled with the 
defects in abscission result in abnormal polarity when OCRL1 is depleted. The next 
section details how membrane traffic and cytokinesis is co-ordinated with 
polarisation normally, and then discusses how this might be disrupted with loss of 
OCRL1.   
    
During cell division, trafficking pathways are modified to accommodate fluctuations 
in cell volume and plasma membrane surface area. At the onset of mitosis, 
recycling to the plasma membrane slows, resulting in an intracellular accumulation 
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of endosomes (figure 6.12A). However whilst the pool of intracellular apical 
recycling cargo is likely to increase during early mitosis, it is thought that the 
majority of the apical membrane is maintained on the plasma membrane 
throughout cell division (Schlüter et al., 2009), indicated in figure 6.12A-E. Our 
results were in agreement with this view, control cells undergoing mitosis 
maintained GFP-Gp135 on the cell surface, but also had clusters of vesicular GFP-
Gp135 around spindle poles. Recycling resumes during cytokinesis, with traffic 
directed towards the plane of division (Boucrot and Kirchhausen, 2007), indicated in 
figure 6.12C-D. In our control cells, the intracellular Gp135 that was seen during 
mitosis was no longer apparent towards the end of cytokinesis, when cells had 
formed an intracellular bridge. Instead, Gp135 was only detectable on the cell 
surface, consistent with the view that apical cargo is re-delivered to the apical 
membrane during cytokinesis. One way in which cytokinesis is co-ordinated with 
polarisation is through the apical positioning of the midbody (Fleming et al., 2007; 
Reinsch and Karsenti, 1994). As the contractile ring furrows asymmetrically 
(indicated by a black arrow, figure 6.12D), progressing from the basal side, the 
midbody is formed just near the apical membrane and the junctions rapidly form 
beneath it (Herszterg et al., 2013), indicated in figure 6.12D. Positioning of the 
midbody apically ensures any trafficking of apical cargo along midzone 
microtubules is targeted towards the apical membrane and minimal disruptions 
occur to the epithelial barrier during abscission.  
   
Our results suggest that in MDCK cells, OCRL1 regulates apical recycling to the 
plasma membrane from recycling endosomes. Depleting OCRL1 induced a block in 
apical recycling such that the established apical domain was entirely lost from the 
cell surface and apical cargo accumulated in Rab11 and Rab8 positive recycling 
endosomes. Subsequently, when OCRL1 depleted cells divide, the dense pool of 
apical vesicles were segregated into clusters around spindle poles (figure 6.12G-H), 
as in control cells. Since Rab11 and Rab8 regulate pathways that traffic to the site of 
cytokinesis, the apical vesicles appeared to be trafficked to the midbody along this 
pathway (figure 6.12I). A key difference between control cells and OCRL1 depleted 
cells at this stage might be the amount of apical cargo present on recycling 
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endosomes. In OCRL1 depleted cells, the recycling endosomes accumulate key 
apical determinates such as Par6, aPKC, Cdc42 and Gp135 which are delivered in 
excess to the midbody during cytokinesis. In addition, there is some evidence that 
diffusion is limited within the membrane of the cleavage furrow and midbody 
(Schmidt and Nichols, 2004). The barrier to lateral diffusion of proteins and lipids 
may be due to the high density of cortical proteins such as the septins in the 
cleavage furrow (Schmidt and Nichols, 2004). Therefore loss of the apical 
membrane at the apex of the cell followed by routing of apical traffic during cell 
division to a region of the membrane where diffusion is limited could further 
promote localised apical membrane formation at the site of abscission (figure 
6.12J). Thus, one possibility is that aberrant traffic is primarily responsible for 
misplacing apical domains in MDCK cells lacking OCRL1. 
    
However, we noticed a number of additional problems in OCRL1 depleted cells that 
might contribute to the lateral lumen phenotype. The mitotic spindle appeared mis-
orientated in cells without OCRL1 (figure 6.12H), which may explain why midbodies 
were also mis-localised. Instead of positioning the midbodies apically, OCRL1 
depleted cells appeared to position the midbodies laterally (figure 6.12I). These 
results suggest that without OCRL1, defective recycling coupled with abnormal 
cytokinesis results in mis-positioning of the apical membrane to form lateral apical 
lumens.  
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Figure 6.12: Model of OCRL1 depletion and disrupted co-ordination between cell 
division and polarisation. In MDCK cells, OCRL1 depletion bocks recycling of apical 
cargo to the plasma membrane. The apical cargo that is internalised as a result is 
trafficked along midzone microtubules along the normal pathway as OCRL1 
depleted cells divide. However a combination of excessive trafficking of apical cargo 
to the cytokinesis site and mis-localisation of midbodies results in the formation of 
lateral lumens in OCRL1 depleted cells. See main text for details. 
 
235 
  
A number of observations support a model that involves both cytokinesis and 
trafficking defects in the absence of OCRL1. Several studies suggest that apical 
membrane formation is consistently coupled to cell division. Disrupting the 
orientation of the mitotic spindle by silencing of Cdc42 leads to the multi-lumen 
phenotype in 3D cultures (Jaffe et al., 2008, Qin et al., 2010; Rodriguez-Fraticelli et 
al., 2010). Multiple lumens form when cells no longer co-ordinate apical trafficking 
to a single common lumen at the cell apex and instead traffic apical cargo to the 
lateral region between cells. It has been suggested that the apical membrane 
originates where the midbody is formed during cytokinesis (Schlüter et al., 2009), 
and lateral apical lumens result from mis-localised midbodies as a result of 
abnormal spindle orientations (Jaffe et al., 2008, Qin et al., 2010; Rodriguez-
Fraticelli et al., 2010). These findings indicate that apical trafficking to the midbody 
occurs in all cell divisions. The midbody is normally formed just beneath the 
established apical domain which might ensure correct targeting of apical proteins 
to the apical membrane during cytokinesis (Fleming et al., 2007; Reinsch and 
Karsenti, 1994). We found that midbodies were not localised apically in OCRL1 
depleted cells. Instead they appeared to form in the middle of the monolayer or 
more basally. If midbody positioning is key to determining where on the membrane 
the apical domain develops, mis-localised midbodies may explain lateral lumens in 
OCRL1 depleted cells.  
   
As mentioned above, one possibility is that OCRL1 depletion disrupts mitotic 
spindle orientation, resulting in abnormal midbody positioning in a similar manner 
to Cdc42 depletion. We provided some evidence that this may be the case, since 
several OCRL1 depleted cells we looked at had mitotic spindle angles that deviated 
from the horizontal plane. However, other mechanisms are involved in localising 
the midbody. Asymmetric furrowing of the contractile ring ensures the midbody is 
formed apically in polarised cell types (Maddox et al., 2007). Components involved 
in furrowing such as myosin-2 distribute more densely on the basal side which 
strengthens ingression from this side of the contractile ring (Maddox et al., 2007). 
The asymmetric distribution of the furrowing machinery appears to be regulated by 
anillin and the septins since depletion of either of these proteins results in a 
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symmetric distribution (Maddox et al., 2007). It is not clear how OCRL1 loss would 
affect the furrowing mechanism. However, one possibility is that OCRL1 depletion 
disrupts the localisation of anillin. Localisation of anillin to the furrow requires 
PI(4,5)P2; the PH domain of anillin interacts with PI(4,5)P2, which is normally 
enriched in the furrow (Liu et al., 2012). Disrupting the levels of PI(4,5)P2 or 
mutating the PH domain of anillin to disrupt the interaction between anillin and 
PI(4,5)P2 blocks anillin from localising to the furrow (Ben El Kadhi et al., 2011; Liu et 
al., 2012). Therefore in MDCK cells, depletion of OCRL1 might disrupt anillin 
localisation through effects on PI(4,5)P2 levels, which could potentially explain the 
aberrant localisation of midbodies seen when OCRL1 is depleted. Although the 
results of this chapter provide a new understanding of the results in Chapter 4 and 
Chapter 5, we identified additional problems with OCRL1 depleted cells involving 
cell division. Future work on the role of OCRL1 in cell division is discussed in the 
next chapter.  
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Chapter Seven 
 
Final conclusions 
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Summary 
  
Studying the role of OCRL1 in polarised epithelial cells confirmed the possibility that 
OCRL1 has specific functions in polarised cells not apparent in other cell types. 
Firstly, we confirmed the previous finding that a small pool of OCRL1 targeted apical 
junctions in MDCK cells, existing in a complex with the tight junction protein ZO-1 
(Grieve et al., 2011). In addition, our findings suggested that OCRL1 may be 
required to maintain the normal morphology of tight junctions. Depleting cells of 
OCRL1 resulted in a larger cytoplasmic pool of vesicular ZO-1 and junctions that 
appeared thinner, suggesting OCRL1 may play a role in pathways that regulate 
junction formation.   
    
A key finding in our investigation was that OCRL1 was required for polarisation.  
Without OCRL1, apical carriers rapidly accumulated intracellularly and a number of 
observations supported the view that this was due to an inability of cells to traffic 
apical cargo from recycling endosomes to the plasma membrane. FRAP analysis 
confirmed that a small population of apical cargo was subjected to endocytic 
recycling from a perinuclear location. Without OCRL1, this perinuclear pool of apical 
cargo was exaggerated, and co-localised with Rab8 and Rab11 GTPases, markers of 
the apical recycling endosome. OCRL1 appears to be recruited to this compartment 
to down-regulate the levels of PI(4,5)P2. Using the PH domain of PLCδ as a probe for 
PI(4,5)P2 we showed ectopic accumulations of this phosphoinositide as well as F-
actin on recycling endosomes. Rescue experiments confirmed this role for OCRL1, 
since full length OCRL1 but not a phosphatase null mutant was able to rescue the 
apical recycling defect. The apical recycling pathway regulated by OCRL1 was 
responsible for trafficking key apical proteins such as the Par polarity complex, 
Cdc42 and Gp135. As cells begun to polarise, the disruptions in apical trafficking 
induced by loss of OCRL1 appeared to have knock-on effects on the organisation of 
the apical membrane.  
  
As mentioned above, OCRL1 depletion initially affected apical trafficking pathways, 
but subsequent effects on the overall architecture of cell polarity were observed. 
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When OCRL1 was depleted in un-polarised cells growing in isolation, single cells 
displayed apical recycling defects. Upon cell division, polarisation was initiated and 
cells incorrectly localised the apical membrane. Similarly, when monolayers of cells 
were depleted of OCRL1, there was a clear progression of events. Cells rapidly 
accumulated apical cargo intracellularly and formed lateral lumens days later. 
Overall, these observations suggest the possibility that disruptions in apical 
trafficking are a primary effect of OCRL1 depletion and lateral lumens may be 
formed as a consequence.  
    
We next investigated whether lumen formation in OCRL1 depleted cells was co-
ordinated with cytokinesis. By observing the state of cell division in cells undergoing 
lumen formation, we determined the site of lumen formation was marked by the 
midbody, with apical trafficking directed towards this site. OCRL1 appeared to have 
a functional role in cytokinesis of MDCK cells. OCRL1 depletion resulted in an 
accumulation of cells in the pre-abscission stage, suggesting OCRL1 depletion delays 
progress through the final stages of cytokinesis. In addition, the midbodies of cells 
without OCRL1 were mis-localised, positioned more basally compared to controls, 
potentially explaining lateral lumen formation in OCRL1 depleted cells.  
   
In summary, OCRL1 has been implicated to regulate numerous trafficking pathways 
in un-polarised cells and has been implicated to regulate cytokinesis in HeLa cells. 
However, the polarised nature of MDCK cells adds additional levels of interplay to 
these cellular processes. Trafficking in these cells is polarised, with specific 
pathways for apical and basolateral domains. In addition, polarity needs to be 
maintained in these cells as they undergo cell division and cytokinesis. To achieve 
this, regulators of cell polarity and polarised trafficking pathways co-ordinate the 
completion of cytokinesis and the formation and function of polarised cells. By 
studying trafficking and cytokinesis in these cells, we revealed that the co-operation 
between polarisation and cytokinesis was disrupted by loss of OCRL1.  
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Future Work 
  
A key finding in our investigation was that OCRL1 regulates apical recycling in MDCK 
cells. Since a phosphatase null mutant OCRL1 was unable to rescue the recycling 
defect but the full length protein was, our results suggest that OCRL1 facilitates 
cargo exit from recycling endosomes by down-regulating the levels of PI(4,5)P2. 
These results together with our finding that PI(4,5)P2 is elevated on recycling 
compartments in the absence of OCRL1 indicate that excess PI(4,5)P2 underlies the 
phenotype of OCRL1 depletion. We would like to carry out a screen for rescue of 
the recycling defect with a kinome siRNA library. Of particular interest would be 
PI(4)P 5-kinases. Since the levels of PI(4,5)P2 are dependent on both its production 
and degradation, reducing the cellular level of PI(4)P 5-kinase activity might 
counteract the rise in PI(4,5)P2 that occurs when OCRL1 is absent. In addition to 
confirming the role of PI(4,5)P2 in the recycling defect, kinases are typically good 
therapeutic targets and the results of this screen might identify candidate kinases 
that when inhibited rescue the effects of OCRL1 loss. 
   
As well as ectopic levels of PI(4,5)P2, recycling compartments were associated with 
detectable levels of F-actin in OCRL1 depleted cells, not seen in controls. Evidence 
for PI(4,5)P2 having a role in regulating actin polymerisation on endosomes in HK-2 
cells comes from the finding that loss of OCRL1 increased the level of F-actin 
associated with these membranes in a N-WASP-dependent pathway (Vicinanza et 
al., 2011). However, as mentioned in Chapter 5, we were unable to rescue recycling 
with actin depolymerising agents such as Latrunculin-A and Cytochalasin-D (data 
not shown). Therefore it remains unclear whether F-actin accumulation was 
responsible for blocking endosome function in our OCRL1 depleted cells. In future 
studies, we would like to confirm the role of actin polymerisation in the phenotype 
of OCRL1 depletion by testing for rescue of apical recycling when components of 
actin polymerisation pathways, such as N-WASP are depleted with siRNA.  
   
The finding that OCRL1 depletion was associated with elevated levels of 
intracellular F-actin was not unique to MDCK cells. We observed intracellular 
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punctate F-actin in a number of human renal cell lines depleted of OCRL1, VHL 
positive RCC4 cells and hTERT immortalised cells (NHPTK). The F-actin positive 
vesicles were localised to a perinuclear region, similar to MDCK cells. In NHPTK 
cells, actin rich vacuoles were also observed which are normally associated with 
disrupted apical trafficking pathways (Vega-Salas et al., 1987). In addition, when 
NHPTK cells were depleted of OCRL1, F-actin was no longer enriched in the apical 
membrane, which instead accumulated in the lateral membrane as well as 
intracellularly. These observations suggest polarisation might be disrupted in 
NHPTK cells depleted of OCRL1. Being of human origin and proximal tubular in 
appearance, NHPTK cells are a more suitable model of the renal cells affected by 
Lowe Syndrome, therefore we would like to use these cells to further investigate 
the role of OCRL1 in polarisation.    
   
Although MDCK cells rapidly internalised their apical membrane when OCRL1 was 
depleted, the cells eventually re-polarised. However, instead of polarising along an 
axis perpendicular to the underlying support, OCRL1 depleted cells polarised along 
a horizontal plane, appearing more similar to 3D cultures than 2D monolayers. A 
key difference between these experimental systems is the presence of an 
asymmetric environment in 2D cultures which is absent when cells are grown in 3D. 
Therefore, one possibility that we did not investigate is that OCRL1 might be 
involved in pathways that detect external polarity cues. For example, integrins 
might be mis-localised in OCRL1 depleted cells which could be tested for. 
Alternatively, OCRL1 might be involved in organising the sub-membranous 
cytoskeletal network in the basal domain, which facilitates laminin remodelling. 
These events are required for proper positioning of the apical membrane and 
therefore might be involved in the phenotype of OCRL1 depletion.  
  
However, a key development in Chapter 6 indicated that lateral lumen formation 
was co-ordinated with cell division in OCRL1 depleted cells. Lateral lumens formed 
at sites marked by the midbody during cytokinesis. In previous chapters, the site of 
apical trafficking and lumen formation had remained elusive, however this finding 
raises additional questions. While we made some observations that suggest 
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cytokinesis may be disrupted by loss of OCRL1, it is not clear whether this is 
separate from the recycling defect that occurs in OCRL1 depleted cells, since 
membrane trafficking is required for successful cytokinesis. In addition, although 
we found both OCRL1 and Rab8 localised to the midbody, it is not clear whether 
Rab8 is responsible for localising OCRL1 to this site, or whether other GTPases such 
as Rab35 target OCRL1 to the midbody in MDCK cells, as in HeLa cells (Dambournet 
et al., 2011). It is possible that the defects in apical recycling and cytokinesis involve 
different OCRL1 regulated pathways. We would like to determine the 
interdependence of these events by carrying out a series of rescue experiments 
designed to check which interactions with OCRL1 are required for rescue of the 
depletion phenotype. One way a specific interaction can be screened for rescue is 
by cloning the binding partners into an expression vector, separated by a short 
linker, allowing the two proteins to adopt their normal confirmation. Initially we 
would carry out a screen of OCRL1-Rab interactions for rescue of the recycling and 
cytokinesis defects. From the results in Chapter 5, we suspect that OCRL1 depletion 
disrupts a Rab8 recycling pathway, however re-expression of OCRL1-Rab8 would 
confirm whether this interaction is required for apical recycling in MDCK cells. It 
would then be interesting to assess whether these cells subsequently develop 
cytokinesis defects, enabling us to determine if the OCRL1-Rab8 interaction is also 
required for cytokinesis. Similar investigations could be carried out with other 
GTPases such as Rab35 as well OCRL1 binding partners in the endocytic pathway.  
  
Since the midbody is normally localised apically in polarised epithelial cells, the 
finding that lateral lumens formed at sites marked by the midbody suggested the 
possibility that abscission is not only delayed by OCRL1 depletion but that it may 
also occur in the wrong place. We investigated this briefly and noticed mitotic 
spindles were mis-orientated in OCRL1 depleted cells and the midbodies were more 
basally located compared to controls. As well as carrying out accurate 
measurement of these effects, a more detailed exploration of the role of OCRL1 in 
mitosis and cytokinesis would be the focus of future studies. These experiments 
would be designed to understand the pathways involved in spindle orientation and 
midbody positioning affected by loss of OCRL1. Interestingly, planar orientation of 
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the mitotic spindle requires intact intercellular junctions, since astral microtubules 
are anchored to the cell cortex by interactions with junctional components (den 
Elzen et al., 2008). Given the previous finding of OCRL1 at junctions (Grieve et al., 
2011), and the results of Chapter 3, we would like to determine whether junctions 
appear disrupted in cells with mis-orientated mitotic spindles. A recent study in 
Drosophila suggests junctions also play a role in asymmetrically positioning 
midbodies (Morais-de-Sá and Sunkel, 2013). During cytokinesis, the apical side of 
the contractile ring contacts the adherens junctions which were required to recruit 
the midbody apically (Morais-de-Sá and Sunkel, 2013). Disrupting the adherens 
junction resulted in more basally localised midbodies and aberrant apical 
membranes (Morais-de-Sá and Sunkel, 2013). Therefore intercellular junctions are 
involved in both aspects of cytokinesis that were disrupted by loss of OCRL1 and we 
would like to look into more detail at the localisation of junctional components in 
dividing OCRL1 depleted cells. However, OCRL1 might be involved in other 
pathways that regulate asymmetric furrowing. As discussed in Chapter 6, one 
possibility is that OCRL1 loss affects asymmetric furrowing by altering the 
distribution of anillin, which interacts with PI(4,5)P2. Since we observed aberrant 
localisations of PI(4,5)P2 in OCRL1 depleted cells, anillin may be mis-localised when 
these cells divide, which is something that could be easily tested for with 
antibodies.   
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Discussion 
    
Our objective was to determine the role of OCRL1 in polarised cell types, using cell 
lines derived from the kidney, which is the organ most affected by Lowe Syndrome 
and Dents-2 disease. We made a number of observations that suggests OCRL1 has 
specific roles in polarised cells. As well as localising to junctions, our findings 
implicate OCRL1 in regulating cell polarity and cell division. These processes are 
critical for maintaining the architecture of the tissues affected by the disease.  
      
OCRL1 has been implicated in a variety of cellular processes across multiple cell 
types. In polarised cell types alone, we found OCRL1 localised to tight junctions in 
mature cells, the Golgi apparatus and trafficking intermediates, and to spindle poles 
and the midbody during cell division. In addition, our results suggest OCRL1 might 
have multiple functions in polarised cells, from intercellular junction formation, 
maturation, apical recycling and cytokinesis. It is likely that OCRL1 is recruited to 
various different sites in the cell by interacting with specific Rab GTPases and their 
effector proteins. At these locations, a common function of OCRL1 exists, to couple 
dephosphorylation of PI(4,5)P2 with membrane identity or cytoskeletal dynamics. 
While OCRL1 regulates multiple cellular processes, the difficulty is determining 
which of these are disrupted in Lowe Syndrome and Dents-2 disease.   
    
Since the results of this investigation have been discussed in detail at the end of 
each chapter, the majority of this final discussion focuses on linking our results to 
diseases associated with loss of OCRL1. The finding that OCRL1 targets intercellular 
junctions is potentially interesting because dysfunctional junctions have been 
connected to kidney disease (Lee et al., 2006). However, whether junctional OCRL1 
is a generalised feature of polarised epithelial cells is yet to be determined. Our 
results suggest a small pool of OCRL1 targets intercellular junctions in MDCK cells. 
As well as MDCK cells, junctional OCRL1 has been detected in the intestinal 
epithelial cell line Caco-2 (Grieve et al., 2011). However, as discussed in Chapter 3, 
several studies of OCRL1 using polarised epithelial cells failed to detect the protein 
at junctions (Cui et al., 2010; Dressman et al., 2010; Vicinanza et al., 2011). 
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Similarly, we failed to detect OCRL1 at junctions in a human renal cell line (NHPTK) 
or a lens epithelial cell line (NTM5). These results suggest that the localisation 
pattern of OCRL1 is cell type specific. Alternatively, junctional targeting of OCRL1 
may occur only temporarily during development. Answering these questions would 
clarify the importance of junctional OCRL1 in Lowe Syndrome. 
     
One problem in particular is the canine and distal tubular origin of MDCK cells, 
which may display different characteristics to human proximal tubule cells, affected 
by the disease. For example, the properties of the tight junction varies between 
distal and proximal cells; higher levels of occludin and ZO-1 in the distal segments 
make proximal tubule junctions comparatively leaky (Gonzalez-Mariscal et al., 2000; 
Kiuchi-Saishin et al., 2002). There are several human proximal tubular cell lines 
which we could use to study OCRL1, such as HK-2, but these have problems with 
de-differentiation (Orosz et al 2004). We attempted to address this issue by using a 
human cell line derived from the kidney of a normal adult male (Herbert et al., 
2013). These cells were selected for their proximal tubule characteristics (Herbert 
et al., 2013). However, as mentioned above, we failed to detect OCRL1 at junctions. 
To elucidate whether junctional OCRL1 is important for Lowe Syndrome, it might be 
interesting to investigate the appearance of the junctions in sections of affected 
tissue. With the provision of having a suitable control, the integrity of the junctions 
could be tested in cells affected by Lowe Syndrome by measurement of the 
transepithelial electrical resistance (TER); the current across the monolayer. These 
studies might provide an indication as to whether junctions are disrupted in Lowe 
Syndrome. 
     
A key finding in our investigation was that OCRL1 depletion perturbed polarisation. 
In MDCK cells, OCRL1 regulated apical recycling endosome function by down-
regulation the levels of PI(4,5)P2. Cells without OCRL1 accumulated apical cargo in 
exaggerated endosomes associated with ectopic levels of PI(4,5)P2 and F-actin. 
Interestingly, we observed intracellular punctate F-actin in a number of human 
renal cell lines depleted of OCRL1. Furthermore, perinuclear punctate F-actin has 
been reported in OCRL1 depleted HK-2 cells (Vicinanza et al., 2011). The 
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reproducibility of this finding suggests regulating the levels of PI(4,5)P2 and F-actin 
on transport intermediates might be a generalised function of OCRL1 and hint at 
the possibility of trafficking defects in Lowe Syndrome. Our results in particular 
suggest OCRL1 is required for trafficking of apical components to the apical 
membrane.  
    
Abnormalities in polarisation have been linked to a variety of diseases. Disrupted 
polarisation of proteins occurs in polycystic kidney disease. For example, the  
normally basolateral proteins epidermal growth factor receptor (EGFR) and the 
Na+K+-ATPase are mis-localised to the apical membrane (Wilson et al., 2000). In 
addition, kidney dysfunction can be due to the failure of cells to traffic proteins to 
the plasma membrane, resulting in their accumulation intracellularly, such as E-
cadherin (Charron et al., 2000). Underlying defects in apical recycling can also lead 
to disruptions in cell polarity and disease. In microvillus inclusion disease, mutations 
in myosin-5b block recycling of apical cargo such as the transferrin receptor to the 
plasma membrane, and cells accumulate large intracellular vacuoles enriched in 
microvilli (Müller et al., 2008). A similar phenotype is observed in Rab8 knockout 
mice (Sato et al., 2007). Of particular interest is the finding that Dents disease 
patients display polarity defects in renal proximal tubule cells (PTCs). Patients with 
Dents disease have mutations in CLCN-5, and not OCRL1 (when it is referred to as 
Dents-2). However the renal symptoms of diseases associated with loss of function 
of OCRL1 and CLCN-5 overlap. In Dents disease, The H+-ATPase displays inverted 
polarity in PTCs, localising to the basolateral domain in contrast to is normal apical 
localisation (Moulin et al., 2003).  
    
Since proper polarisation of epithelial cells lining renal proximal tubules is essential 
for kidney function, it is possible that our findings with MDCK cells extend to Lowe 
Syndrome and Dents-2 disease. A role for OCRL1 in regulating apical recycling can 
potentially explain some phenotypic observations. Analysis of the proximal tubule 
dysfunction in Lowe Syndrome suggests absorption of substances that rely on 
vesicular trafficking are more affected than those that are directly released in the 
cytosol (Bockenhauer et al., 2008). For example, in a sample of patients, loss of low 
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molecular weight proteins was more extensive than loss of glucose (Bockenhauer et 
al., 2008), suggesting an underling trafficking defect. Low molecular weight proteins 
are absorbed from the proximal tubule by receptors such as megalin and cubilin 
which recycle between the apical plasma membrane and recycling endosomes. If 
OCRL1 functions to regulate traffic of apical cargo through recycling endosomes, 
one possibility is that these receptors accumulate intracellularly in Lowe Syndrome 
patients, resulting in a loss of LMW proteins in the ultrafiltrate.  
 
Several findings support the possibility that the renal symptoms of Lowe Syndrome 
involve reduced apical recycling. Firstly, patients with Lowe Syndrome have reduced 
levels of the proteolytic cleavage products of megalin that are normally generated 
in the apical membrane, suggesting they may have reduced amounts of megalin at 
the apical surface (Norden et al., 2002). In a CLCN-5 knock out mouse model for 
Dent's disease, megalin and cubulin appeared redistributed from the brush border 
to intracellular endosomes, suggesting a block in recycling of megalin and cubulin to 
the brush border in the apical membrane (Christensen et al., 2003). Furthermore, 
reduced amounts of megalin have been observed at the apical brush border of the 
renal tubular epithelium of patients with Dents disease (Santo et al., 2004; Yanagida 
et al., 2004). Given our findings in MDCK cells, OCRL1 depletion might interfere with 
the trafficking of apical recycling, including receptors, through recycling 
compartments. If biopsy specimens could be obtained of the renal tubular 
epithelium from patients with Lowe Syndrome, the localisation of apical receptors 
could be examined by immunohistology. In addition, recent advances in animal 
models of Lowe Syndrome should facilitate progress in these investigations 
(Bothwell et al., 2011; Ramirez et al., 2012).  
   
In addition to apico–basal polarity, epithelial cells display planar cell polarity. During 
development of the kidney, formation of tubules requires extensive elongation, 
involving a period of intense proliferation. This type of tubule elongation requires 
oriented cell division in which mitotic cells are oriented along an orthogonal axis in 
the plane of the tissue. Random mitotic spindle orientations interfere with normal 
elongation, giving rise the dilated tubules associated with some forms of polycystic 
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kidney disease (Fedeles and Gallagher, 2013). The finding that OCRL1 is potentially 
involved in pathways that regulate mitotic spindle orientation is worth investigating 
further. The localisation of OCRL1 to mitotic spindle poles has not been reported 
before, although it is known that OCRL1 localises to the abscission site during 
cytokinesis (Dambournet et al., 2011). However, a homologue of OCRL1 (TbOCRL1) 
is involved in spindle formation and mitosis in Trypanosomes (Abbasi et al., 2011). 
Like human OCRL1, TbOCRL1 has no GAP activity but interacts with the only Rho 
GTPase in Trypanosoma brucei, linking TbOCRL1 to a homologue of Rho-kinase 
(Abbasi et al., 2011). In MDCK cells, OCRL1 depletion disrupted the orientation of 
mitotic spindles, however whether OCRL1 interacts with a mammalian Rho GTPase, 
such as Rac or Cdc42 in this pathway remains to be determined. It is important to 
note that patients with Lowe Syndrome do not develop renal cysts. However 
dilation is sometimes observed in the late stages of Lowe Syndrome but it is not 
clear whether this is a cause or effect or tubular atrophy (Gropman et al., 2000). As 
mentioned above, future investigations into the morphology of renal tubules in 
patients and animal models of Lowe Syndrome will give a better indication of the 
underlying pathways disrupted.  
  
The aim of this study was to investigate the role of OCRL1 in polarised cell types. 
Although we focused on the kidney, other tissues affected by Lowe Syndrome are 
highly polarised. Given our finding that OCRL1 disrupts polarisation in renal cells it 
would be interesting to carry out similar investigations in cells derived from other 
tissues affected by Lowe Syndrome. Lens epithelial cells form apical tight junctions 
with ZO-1 and express the same repertoire of polarity proteins as MDCK cells 
(Sugiyama et al., 2008). In addition, neurons are highly asymmetric with polarised 
membrane domains with specialised functions. The endosomal system is crucial for 
establishing and maintaining neuronal polarity, and it is therefore plausible that 
OCRL1 regulates polarised membrane trafficking pathways in neurons.  
 
To study OCRL1 in polarised cell types, we primarily used the MDCK cell line, which 
is widely used as a model of epithelial polarity. In addition to the new finding that 
OCRL1 is critical for ensuring the proper organisation of polarised membrane 
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domains, our results provide some evidence that apical membrane formation is co-
ordinated with cell division. In addition, our findings strengthen the idea that OCRL1 
is involved in the traffic route to the midbody. Whether the dramatic effect of 
OCRL1 depletion on polarisation is unique to MDCK cells is yet to be determined. 
However preliminary findings with a human renal cell line (NHPTK) suggest OCRL1 is 
required for the normal morphology of monolayers. When these cells were 
depleted of OCRL1, F-actin was no longer enriched in the apical membrane and F-
actin accumulated intracellularly on trafficking intermediates, in a similar manner to 
MDCK cells. These observations suggest a generalised function of OCRL1 in 
regulating apical trafficking pathways which fits with the renal symptoms of Lowe 
Syndrome and Dents-2 disease. 
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